BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008;88:125-72. [PMID: 18195085 DOI: 10.1152/physrev.00013.2007] [Cited by in Crossref: 1682] [Cited by in F6Publishing: 1628] [Article Influence: 120.1] [Reference Citation Analysis]
Number Citing Articles
1 Vernetti LA, Senutovitch N, Boltz R, DeBiasio R, Shun TY, Gough A, Taylor DL. A human liver microphysiology platform for investigating physiology, drug safety, and disease models. Exp Biol Med (Maywood). 2016;241:101-114. [PMID: 26202373 DOI: 10.1177/1535370215592121] [Cited by in Crossref: 133] [Cited by in F6Publishing: 114] [Article Influence: 19.0] [Reference Citation Analysis]
2 Yang J, Li M, Zheng QC. Emerging role of Toll-like receptor 4 in hepatocellular carcinoma. J Hepatocell Carcinoma 2015;2:11-7. [PMID: 27508190 DOI: 10.2147/JHC.S44515] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
3 Wang H, Zhang Y, Wang T, You H, Jia J. N-methyl-4-isoleucine cyclosporine attenuates CCl4-induced liver fibrosis in rats by interacting with cyclophilin B and D: NIM811 and CCl4-induced liver fibrosis. Journal of Gastroenterology and Hepatology 2011;26:558-67. [DOI: 10.1111/j.1440-1746.2010.06406.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
4 Qiao H, Zhou Y, Qin X, Cheng J, He Y, Jiang Y. NADPH Oxidase Signaling Pathway Mediates Mesenchymal Stem Cell-Induced Inhibition of Hepatic Stellate Cell Activation. Stem Cells Int 2018;2018:1239143. [PMID: 29861737 DOI: 10.1155/2018/1239143] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
5 Kaimori A, Potter JJ, Choti M, Ding Z, Mezey E, Koteish AA. Histone deacetylase inhibition suppresses the transforming growth factor beta1-induced epithelial-to-mesenchymal transition in hepatocytes. Hepatology. 2010;52:1033-1045. [PMID: 20564330 DOI: 10.1002/hep.23765] [Cited by in Crossref: 67] [Cited by in F6Publishing: 70] [Article Influence: 5.6] [Reference Citation Analysis]
6 Bitencourt S, Stradiot L, Verhulst S, Thoen L, Mannaerts I, van Grunsven LA. Inhibitory effect of dietary capsaicin on liver fibrosis in mice. Mol Nutr Food Res 2015;59:1107-16. [DOI: 10.1002/mnfr.201400649] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
7 Robert S, Gicquel T, Bodin A, Lagente V, Boichot E. Characterization of the MMP/TIMP Imbalance and Collagen Production Induced by IL-1β or TNF-α Release from Human Hepatic Stellate Cells. PLoS One 2016;11:e0153118. [PMID: 27046197 DOI: 10.1371/journal.pone.0153118] [Cited by in Crossref: 74] [Cited by in F6Publishing: 74] [Article Influence: 12.3] [Reference Citation Analysis]
8 Campana L, Iredale J. Matrix Metalloproteinases and Their Inhibitors. Stellate Cells in Health and Disease. Elsevier; 2015. pp. 107-24. [DOI: 10.1016/b978-0-12-800134-9.00007-5] [Cited by in Crossref: 7] [Article Influence: 1.0] [Reference Citation Analysis]
9 Meurer SK, Alsamman M, Sahin H, Wasmuth HE, Kisseleva T, Brenner DA, Trautwein C, Weiskirchen R, Scholten D. Overexpression of endoglin modulates TGF-β1-signalling pathways in a novel immortalized mouse hepatic stellate cell line. PLoS One. 2013;8:e56116. [PMID: 23437087 DOI: 10.1371/journal.pone.0056116] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
10 Wang R, Zhang D, Tang D, Sun K, Peng J, Zhu W, Yin S, Wu Y. Amygdalin inhibits TGFβ1-induced activation of hepatic stellate cells (HSCs) in vitro and CCl4-induced hepatic fibrosis in rats in vivo. Int Immunopharmacol 2021;90:107151. [PMID: 33296784 DOI: 10.1016/j.intimp.2020.107151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Marcos R, Lopes C, Malhão F, Correia-Gomes C, Fonseca S, Lima M, Gebhardt R, Rocha E. Stereological assessment of sexual dimorphism in the rat liver reveals differences in hepatocytes and Kupffer cells but not hepatic stellate cells. J Anat 2016;228:996-1005. [PMID: 26892301 DOI: 10.1111/joa.12448] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
12 McVicker BL, Hamel FG, Simpson RL, Bennett RG. A Selective PPARγ Modulator Reduces Hepatic Fibrosis. Biology (Basel) 2020;9:E151. [PMID: 32630819 DOI: 10.3390/biology9070151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Zhu L, Cheng M, Liu Y, Yao Y, Zhu Z, Zhang B, Mou Q, Cheng Y. Thymosin-β4 inhibits proliferation and induces apoptosis of hepatic stellate cells through PI3K/AKT pathway. Oncotarget 2017;8:68847-53. [PMID: 28978161 DOI: 10.18632/oncotarget.18748] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
14 Carloni V, Luong TV, Rombouts K. Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever. Liver Int. 2014;34:834-843. [PMID: 24397349 DOI: 10.1111/liv.12465] [Cited by in Crossref: 88] [Cited by in F6Publishing: 85] [Article Influence: 11.0] [Reference Citation Analysis]
15 Pfeiffer E, Kegel V, Zeilinger K, Hengstler JG, Nüssler AK, Seehofer D, Damm G. Featured Article: Isolation, characterization, and cultivation of human hepatocytes and non-parenchymal liver cells. Exp Biol Med (Maywood) 2015;240:645-56. [PMID: 25394621 DOI: 10.1177/1535370214558025] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 6.4] [Reference Citation Analysis]
16 Hu PF, Xie WF. Targeted RNA interference for hepatic fibrosis. Expert Opin Biol Ther. 2009;9:1305-1312. [PMID: 19723017 DOI: 10.1517/14712590903213677] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
17 Ebrahimkhani MR, Oakley F, Murphy LB, Mann J, Moles A, Perugorria MJ, Ellis E, Lakey AF, Burt AD, Douglass A, Wright MC, White SA, Jaffré F, Maroteaux L, Mann DA. Stimulating healthy tissue regeneration by targeting the 5-HT₂B receptor in chronic liver disease. Nat Med 2011;17:1668-73. [PMID: 22120177 DOI: 10.1038/nm.2490] [Cited by in Crossref: 136] [Cited by in F6Publishing: 116] [Article Influence: 12.4] [Reference Citation Analysis]
18 Zhong C, Li Y, Yang J, Jin S, Chen G, Li D, Fan X, Lin H. Immunotherapy for Hepatocellular Carcinoma: Current Limits and Prospects. Front Oncol 2021;11:589680. [PMID: 33854960 DOI: 10.3389/fonc.2021.589680] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Jarman EJ, Boulter L. Targeting the Wnt signaling pathway: the challenge of reducing scarring without affecting repair. Expert Opinion on Investigational Drugs 2020;29:179-90. [DOI: 10.1080/13543784.2020.1718105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Katsounas A, Trippler M, Wang B, Polis M, Lempicki RA, Kottilil S, Gerken G, Schlaak JF. CCL5 mRNA is a marker for early fibrosis in chronic hepatitis C and is regulated by interferon-α therapy and toll-like receptor 3 signalling: CCL5 and liver fibrosis in chronic hepatitis C. Journal of Viral Hepatitis 2012;19:128-37. [DOI: 10.1111/j.1365-2893.2011.01503.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
21 Huang HM, Zhou XR, Liu YJ, Fan SJ, Liao LP, Huang J, Shi CC, Yu L, Pen JJ, Luo C, Zhang YY, Li GM. Histone deacetylase inhibitor givinostat alleviates liver fibrosis by regulating hepatic stellate cell activation. Mol Med Rep 2021;23:305. [PMID: 33649839 DOI: 10.3892/mmr.2021.11944] [Reference Citation Analysis]
22 Guimarães EL, Best J, Dollé L, Najimi M, Sokal E, van Grunsven LA. Mitochondrial uncouplers inhibit hepatic stellate cell activation. BMC Gastroenterol 2012;12:68. [PMID: 22686625 DOI: 10.1186/1471-230X-12-68] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
23 van Beuge MM, Prakash J, Lacombe M, Gosens R, Post E, Reker-smit C, Beljaars L, Poelstra K. Reduction of Fibrogenesis by Selective Delivery of a Rho Kinase Inhibitor to Hepatic Stellate Cells in Mice. J Pharmacol Exp Ther 2011;337:628-35. [DOI: 10.1124/jpet.111.179143] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 3.7] [Reference Citation Analysis]
24 Wang Y, Jiang XY, Liu L, Jiang HQ. Phosphatidylinositol 3-kinase/Akt pathway regulates hepatic stellate cell apoptosis. World J Gastroenterol 2008; 14(33): 5186-5191 [PMID: 18777595 DOI: 10.3748/wjg.14.5186] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
25 Schildberg FA, Wojtalla A, Siegmund SV, Endl E, Diehl L, Abdullah Z, Kurts C, Knolle PA. Murine hepatic stellate cells veto CD8 T cell activation by a CD54-dependent mechanism. Hepatology 2011;54:262-72. [DOI: 10.1002/hep.24352] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 4.5] [Reference Citation Analysis]
26 Fausther M, Lavoie EG, Goree JR, Dranoff JA. An Elf2-like transcription factor acts as repressor of the mouse ecto-5'-nucleotidase gene expression in hepatic myofibroblasts. Purinergic Signal 2017;13:417-28. [PMID: 28667437 DOI: 10.1007/s11302-017-9570-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
27 Lamb CL, Cholico GN, Perkins DE, Fewkes MT, Oxford JT, Lujan TJ, Morrill EE, Mitchell KA. Aryl Hydrocarbon Receptor Activation by TCDD Modulates Expression of Extracellular Matrix Remodeling Genes during Experimental Liver Fibrosis. Biomed Res Int 2016;2016:5309328. [PMID: 27672655 DOI: 10.1155/2016/5309328] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
28 Wu Y, Cao Y, Xu K, Zhu Y, Qiao Y, Wu Y, Chen J, Li C, Zeng R, Ge G. Dynamically remodeled hepatic extracellular matrix predicts prognosis of early-stage cirrhosis. Cell Death Dis 2021;12:163. [PMID: 33558482 DOI: 10.1038/s41419-021-03443-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Lee UE, Friedman SL. Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol 2011;25:195-206. [PMID: 21497738 DOI: 10.1016/j.bpg.2011.02.005] [Cited by in Crossref: 525] [Cited by in F6Publishing: 517] [Article Influence: 47.7] [Reference Citation Analysis]
30 Pesce A, Ciurleo R, Bramanti A, Armeli Iapichino EC, Petralia MC, Magro GG, Fagone P, Bramanti P, Nicoletti F, Mangano K. Effects of Combined Admistration of Imatinib and Sorafenib in a Murine Model of Liver Fibrosis. Molecules 2020;25:E4310. [PMID: 32962198 DOI: 10.3390/molecules25184310] [Reference Citation Analysis]
31 Zhou VX, Lolas M, Chang TT. Direct orthotopic implantation of hepatic organoids. J Surg Res. 2017;211:251-260. [PMID: 28501125 DOI: 10.1016/j.jss.2016.12.028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
32 Lee UE, Friedman SL. Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol. 2011;25:195-206. [PMID: 21497738 DOI: 10.1016/j.bpg] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
33 Fausther M, Lavoie EG, Dranoff JA. Contribution of Myofibroblasts of Different Origins to Liver Fibrosis. Curr Pathobiol Rep 2013;1:225-30. [PMID: 23997993 DOI: 10.1007/s40139-013-0020-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
34 Bae M, Park YK, Lee JY. Food components with antifibrotic activity and implications in prevention of liver disease. J Nutr Biochem 2018;55:1-11. [PMID: 29268106 DOI: 10.1016/j.jnutbio.2017.11.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 6.4] [Reference Citation Analysis]
35 Khomich O, Ivanov AV, Bartosch B. Metabolic Hallmarks of Hepatic Stellate Cells in Liver Fibrosis. Cells 2019;9:E24. [PMID: 31861818 DOI: 10.3390/cells9010024] [Cited by in Crossref: 28] [Cited by in F6Publishing: 35] [Article Influence: 9.3] [Reference Citation Analysis]
36 Hung CT, Su TH, Chen YT, Wu YF, Chen YT, Lin SJ, Lin SL, Yang KC. Targeting ER protein TXNDC5 in hepatic stellate cell mitigates liver fibrosis by repressing non-canonical TGFβ signalling. Gut 2021:gutjnl-2021-325065. [PMID: 34933915 DOI: 10.1136/gutjnl-2021-325065] [Reference Citation Analysis]
37 Mòdol T, Brice N, Ruiz de Galarreta M, García Garzón A, Iraburu MJ, Martínez-Irujo JJ, López-Zabalza MJ. Fibronectin peptides as potential regulators of hepatic fibrosis through apoptosis of hepatic stellate cells. J Cell Physiol 2015;230:546-53. [PMID: 24976518 DOI: 10.1002/jcp.24714] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
38 Lua I, Li Y, Zagory JA, Wang KS, French SW, Sévigny J, Asahina K. Characterization of hepatic stellate cells, portal fibroblasts, and mesothelial cells in normal and fibrotic livers. J Hepatol 2016;64:1137-46. [PMID: 26806818 DOI: 10.1016/j.jhep.2016.01.010] [Cited by in Crossref: 71] [Cited by in F6Publishing: 72] [Article Influence: 11.8] [Reference Citation Analysis]
39 Chen P, Luo X, Dai G, Jiang Y, Luo Y, Peng S, Wang H, Xie P, Qu C, Lin W, Hong J, Ning X, Li A. Dexmedetomidine promotes the progression of hepatocellular carcinoma through hepatic stellate cell activation. Exp Mol Med 2020;52:1062-74. [PMID: 32632241 DOI: 10.1038/s12276-020-0461-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
40 Shang L, Hosseini M, Liu X, Kisseleva T, Brenner DA. Human hepatic stellate cell isolation and characterization. J Gastroenterol 2018;53:6-17. [PMID: 29094206 DOI: 10.1007/s00535-017-1404-4] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 8.6] [Reference Citation Analysis]
41 Hung YP, Lee CL. Higher Anti-Liver Fibrosis Effect of Cordyceps militaris-Fermented Product Cultured with Deep Ocean Water via Inhibiting Proinflammatory Factors and Fibrosis-Related Factors Expressions. Mar Drugs 2017;15:E168. [PMID: 28594374 DOI: 10.3390/md15060168] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
42 Cohen-Naftaly M, Friedman SL. Current status of novel antifibrotic therapies in patients with chronic liver disease. Therap Adv Gastroenterol. 2011;4:391-417. [PMID: 22043231 DOI: 10.1177/1756283x11413002] [Cited by in Crossref: 141] [Cited by in F6Publishing: 71] [Article Influence: 12.8] [Reference Citation Analysis]
43 Lin N, Chen Z, Lu Y, Li Y, Hu K, Xu R. Role of activated hepatic stellate cells in proliferation and metastasis of hepatocellular carcinoma: Role of aHSC in HCC development. Hepatol Res 2015;45:326-36. [DOI: 10.1111/hepr.12356] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
44 Kerola A, Lohi J, Heikkilä P, Mutanen A, Jalanko H, Pakarinen MP. Divergent expression of liver transforming growth factor superfamily cytokines after successful portoenterostomy in biliary atresia. Surgery 2019;165:905-11. [PMID: 30686515 DOI: 10.1016/j.surg.2018.12.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
45 Stradiot L, Mannaerts I, van Grunsven LA. P311, Friend, or Foe of Tissue Fibrosis? Front Pharmacol 2018;9:1151. [PMID: 30369881 DOI: 10.3389/fphar.2018.01151] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
46 You H, Wang L, Bu F, Meng H, Pan X, Li J, Zhang Y, Wang A, Yin N, Huang C, Li J. The miR-455-3p/HDAC2 axis plays a pivotal role in the progression and reversal of liver fibrosis and is regulated by epigenetics. FASEB J 2021;35:e21700. [PMID: 34105828 DOI: 10.1096/fj.202002319RRR] [Reference Citation Analysis]
47 Goldberg JS. Monitoring maternal Beta carotene and retinol consumption may decrease the incidence of neurodevelopmental disorders in offspring. Clin Med Insights Reprod Health 2011;6:1-8. [PMID: 24453512 DOI: 10.4137/CMRH.S8372] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
48 de Oliveira RN, Rehder VL, Oliveira AS, Jeraldo Vde L, Linhares AX, Allegretti SM. Anthelmintic activity in vitro and in vivo of Baccharis trimera (Less) DC against immature and adult worms of Schistosoma mansoni. Exp Parasitol 2014;139:63-72. [PMID: 24602876 DOI: 10.1016/j.exppara.2014.02.010] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 6.4] [Reference Citation Analysis]
49 Yoshizato K, Thuy le TT, Shiota G, Kawada N. Discovery of cytoglobin and its roles in physiology and pathology of hepatic stellate cells. Proc Jpn Acad Ser B Phys Biol Sci 2016;92:77-97. [PMID: 26972599 DOI: 10.2183/pjab.92.77] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
50 Wang P, Lei S, Wang X, Xu W, Hu P, Chen F, Zhang X, Yin C, Xie W. MicroRNA-134 deactivates hepatic stellate cells by targeting TGF-β activated kinase 1-binding protein 1. Biochem Cell Biol 2019;97:505-12. [PMID: 30645141 DOI: 10.1139/bcb-2018-0211] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
51 Yoneda A, Sakai-Sawada K, Niitsu Y, Tamura Y. Vitamin A and insulin are required for the maintenance of hepatic stellate cell quiescence. Exp Cell Res 2016;341:8-17. [PMID: 26812497 DOI: 10.1016/j.yexcr.2016.01.012] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
52 Kolesova O, Vanaga I, Laivacuma S, Derovs A, Kolesovs A, Radzina M, Platkajis A, Eglite J, Hagina E, Arutjunana S, Putrins DS, Storozenko J, Rozentale B, Viksna L. Intriguing findings of liver fibrosis following COVID-19. BMC Gastroenterol 2021;21:370. [PMID: 34635073 DOI: 10.1186/s12876-021-01939-7] [Reference Citation Analysis]
53 Nagahara T, Shiraha H, Sawahara H, Uchida D, Takeuchi Y, Iwamuro M, Kataoka J, Horiguchi S, Kuwaki T, Onishi H, Nakamura S, Takaki A, Nouso K, Yamamoto K. Hepatic stellate cells promote upregulation of epithelial cell adhesion molecule and epithelial-mesenchymal transition in hepatic cancer cells. Oncol Rep 2015;34:1169-77. [PMID: 26165819 DOI: 10.3892/or.2015.4126] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
54 Liu W, Hou Y, Chen H, Wei H, Lin W, Li J, Zhang M, He F, Jiang Y. Sample preparation method for isolation of single-cell types from mouse liver for proteomic studies. Proteomics 2011;11:3556-64. [PMID: 21751380 DOI: 10.1002/pmic.201100157] [Cited by in Crossref: 64] [Cited by in F6Publishing: 65] [Article Influence: 5.8] [Reference Citation Analysis]
55 El Mourabit H, Loeuillard E, Lemoinne S, Cadoret A, Housset C. Culture Model of Rat Portal Myofibroblasts. Front Physiol 2016;7:120. [PMID: 27065888 DOI: 10.3389/fphys.2016.00120] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
56 Shirakami Y, Lee SA, Clugston RD, Blaner WS. Hepatic metabolism of retinoids and disease associations. Biochim Biophys Acta. 2012;1821:124-136. [PMID: 21763780 DOI: 10.1016/j.bbalip.2011.06.023] [Cited by in Crossref: 95] [Cited by in F6Publishing: 98] [Article Influence: 8.6] [Reference Citation Analysis]
57 Bollong MJ, Yang B, Vergani N, Beyer BA, Chin EN, Zambaldo C, Wang D, Chatterjee AK, Lairson LL, Schultz PG. Small molecule-mediated inhibition of myofibroblast transdifferentiation for the treatment of fibrosis. Proc Natl Acad Sci U S A 2017;114:4679-84. [PMID: 28416697 DOI: 10.1073/pnas.1702750114] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 7.4] [Reference Citation Analysis]
58 Liu X, Yue S, Li C, Yang L, You H, Li L. Essential roles of sphingosine 1-phosphate receptor types 1 and 3 in human hepatic stellate cells motility and activation. J Cell Physiol 2011;226:2370-7. [PMID: 21660960 DOI: 10.1002/jcp.22572] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 3.7] [Reference Citation Analysis]
59 Cho SS, Lee JH, Kim KM, Park EY, Ku SK, Cho IJ, Yang JH, Ki SH. REDD1 attenuates hepatic stellate cell activation and liver fibrosis via inhibiting of TGF-β/Smad signaling pathway. Free Radic Biol Med 2021;176:246-56. [PMID: 34614448 DOI: 10.1016/j.freeradbiomed.2021.10.002] [Reference Citation Analysis]
60 Sepulveda-Crespo D, Resino S, Martinez I. Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis. Drugs 2021;81:419-43. [PMID: 33400242 DOI: 10.1007/s40265-020-01458-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
61 Lee DY, Yun SM, Song MY, Ji SD, Son JG, Kim EH. Administration of Steamed and Freeze-Dried Mature Silkworm Larval Powder Prevents Hepatic Fibrosis and Hepatocellular Carcinogenesis by Blocking TGF-β/STAT3 Signaling Cascades in Rats. Cells 2020;9:E568. [PMID: 32121064 DOI: 10.3390/cells9030568] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
62 Kong X, Feng D, Mathews S, Gao B. Hepatoprotective and anti-fibrotic functions of interleukin-22: therapeutic potential for the treatment of alcoholic liver disease. J Gastroenterol Hepatol 2013;28 Suppl 1:56-60. [PMID: 23855297 DOI: 10.1111/jgh.12032] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 7.0] [Reference Citation Analysis]
63 Boey A, Ho HK. All Roads Lead to the Liver: Metal Nanoparticles and Their Implications for Liver Health. Small 2020;16:2000153. [DOI: 10.1002/smll.202000153] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
64 Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215-233. [PMID: 19167326 DOI: 10.1016/j] [Cited by in F6Publishing: 153] [Reference Citation Analysis]
65 Zhou Z, Xu MJ, Cai Y, Wang W, Jiang JX, Varga ZV, Feng D, Pacher P, Kunos G, Torok NJ, Gao B. Neutrophil-Hepatic Stellate Cell Interactions Promote Fibrosis in Experimental Steatohepatitis. Cell Mol Gastroenterol Hepatol 2018;5:399-413. [PMID: 29552626 DOI: 10.1016/j.jcmgh.2018.01.003] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 11.5] [Reference Citation Analysis]
66 Byun JS, Jeong WI. Involvement of hepatic innate immunity in alcoholic liver disease. Immune Netw. 2010;10:181-187. [PMID: 21286378 DOI: 10.4110/in.2010.10.6.181] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
67 Wang SN, Lee KT, Ker CG. Leptin in hepatocellular carcinoma. World J Gastroenterol 2010; 16(46): 5801-5809 [PMID: 21155000 DOI: 10.3748/wjg.v16.i46.5801] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
68 Li Y, Chen Y, Huang H, Shi M, Yang W, Kuang J, Yan J. Autophagy mediated by endoplasmic reticulum stress enhances the caffeine-induced apoptosis of hepatic stellate cells. Int J Mol Med 2017;40:1405-14. [PMID: 28949381 DOI: 10.3892/ijmm.2017.3145] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
69 Geng W, Zhou G, Zhao B, Xiao Q, Li C, Fan S, Dong P, Zheng J. Liquiritigenin suppresses the activation of hepatic stellate cells via targeting miR-181b/PTEN axis. Phytomedicine 2020;66:153108. [PMID: 31790896 DOI: 10.1016/j.phymed.2019.153108] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
70 Kostrzewski T, Snow S, Battle AL, Peel S, Ahmad Z, Basak J, Surakala M, Bornot A, Lindgren J, Ryaboshapkina M, Clausen M, Lindén D, Maass C, Young LM, Corrigan A, Ewart L, Hughes D. Modelling human liver fibrosis in the context of non-alcoholic steatohepatitis using a microphysiological system. Commun Biol 2021;4:1080. [PMID: 34526653 DOI: 10.1038/s42003-021-02616-x] [Reference Citation Analysis]
71 He C, Shu B, Zhou Y, Zhang R, Yang X. The miR-139-5p/peripheral myelin protein 22 axis modulates TGF-β-induced hepatic stellate cell activation and CCl4-induced hepatic fibrosis in mice. Life Sci 2021;276:119294. [PMID: 33675896 DOI: 10.1016/j.lfs.2021.119294] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Yazdani S, Bansal R, Prakash J. Drug targeting to myofibroblasts: Implications for fibrosis and cancer. Advanced Drug Delivery Reviews 2017;121:101-16. [DOI: 10.1016/j.addr.2017.07.010] [Cited by in Crossref: 69] [Cited by in F6Publishing: 70] [Article Influence: 13.8] [Reference Citation Analysis]
73 Zhu J, Lu J, Tung HC, Liu K, Li J, Grant DM, Xie W, Ma X. Cell Type-Specific Roles of CD38 in the Interactions of Isoniazid with NAD+ in the Liver. Drug Metab Dispos 2020;48:1372-9. [PMID: 33020065 DOI: 10.1124/dmd.120.000139] [Reference Citation Analysis]
74 Paulo JA, Kadiyala V, Banks PA, Conwell DL, Steen H. Mass spectrometry-based quantitative proteomic profiling of human pancreatic and hepatic stellate cell lines. Genomics Proteomics Bioinformatics. 2013;11:105-113. [PMID: 23528454 DOI: 10.1016/j.gpb.2013.01.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
75 Tacke F, Weiskirchen R. [Liver fibrosis - pathogenesis and novel therapeutic approaches]. Internist (Berl). 2010;51:21-29. [PMID: 20012930 DOI: 10.1007/s00108-009-2419-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
76 Burza MA, Motta BM, Mancina RM, Pingitore P, Pirazzi C, Lepore SM, Spagnuolo R, Doldo P, Russo C, Lazzaro V. DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection. Hepatology. 2016;63:418-427. [PMID: 26517016 DOI: 10.1002/hep.28322] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
77 McHaffie S, Chau YY. Isolation and Colony Formation of Murine Bone and Bone Marrow Cells. Methods Mol Biol 2016;1467:73-80. [PMID: 27417960 DOI: 10.1007/978-1-4939-4023-3_6] [Reference Citation Analysis]
78 Choi SS, Omenetti A, Witek RP, Moylan CA, Syn WK, Jung Y, Yang L, Sudan DL, Sicklick JK, Michelotti GA. Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis. Am J Physiol Gastrointest Liver Physiol. 2009;297:G1093-G1106. [PMID: 19815628 DOI: 10.1152/ajpqi.00292.2009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
79 Zhou Q, Patel D, Kwa T, Haque A, Matharu Z, Stybayeva G, Gao Y, Diehl AM, Revzin A. Liver injury-on-a-chip: microfluidic co-cultures with integrated biosensors for monitoring liver cell signaling during injury. Lab Chip 2015;15:4467-78. [PMID: 26480303 DOI: 10.1039/c5lc00874c] [Cited by in Crossref: 57] [Cited by in F6Publishing: 23] [Article Influence: 9.5] [Reference Citation Analysis]
80 Wu Y, Wan Y, Jin X, Ouyang B, Bai T, Zhao Y, Nan J. 25-OCH3-PPD induces the apoptosis of activated t-HSC/Cl-6 cells via c-FLIP-mediated NF-κB activation. Chemico-Biological Interactions 2011;194:106-12. [DOI: 10.1016/j.cbi.2011.08.010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
81 Saneyasu T, Akhtar R, Sakai T. Molecular Cues Guiding Matrix Stiffness in Liver Fibrosis. Biomed Res Int 2016;2016:2646212. [PMID: 27800489 DOI: 10.1155/2016/2646212] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
82 Häussinger D, Kordes C. Space of Disse: a stem cell niche in the liver. Biol Chem 2019;401:81-95. [PMID: 31318687 DOI: 10.1515/hsz-2019-0283] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
83 Kaur S, Siddiqui H, Bhat MH. Hepatic Progenitor Cells in Action. The American Journal of Pathology 2015;185:2342-50. [DOI: 10.1016/j.ajpath.2015.06.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
84 Li Z, Sun J, Yang X. Recent advances in molecular magnetic resonance imaging of liver fibrosis. Biomed Res Int 2015;2015:595467. [PMID: 25874221 DOI: 10.1155/2015/595467] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
85 Thoen LF, Guimarães EL, Dollé L, Mannaerts I, Najimi M, Sokal E, van Grunsven LA. A role for autophagy during hepatic stellate cell activation. Journal of Hepatology 2011;55:1353-60. [DOI: 10.1016/j.jhep.2011.07.010] [Cited by in Crossref: 212] [Cited by in F6Publishing: 214] [Article Influence: 19.3] [Reference Citation Analysis]
86 Lachiondo-Ortega S, Mercado-Gómez M, Serrano-Maciá M, Lopitz-Otsoa F, Salas-Villalobos TB, Varela-Rey M, Delgado TC, Martínez-Chantar ML. Ubiquitin-Like Post-Translational Modifications (Ubl-PTMs): Small Peptides with Huge Impact in Liver Fibrosis. Cells 2019;8:E1575. [PMID: 31817258 DOI: 10.3390/cells8121575] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
87 Zhu C, Kim K, Wang X, Bartolome A, Salomao M, Dongiovanni P, Meroni M, Graham MJ, Yates KP, Diehl AM, Schwabe RF, Tabas I, Valenti L, Lavine JE, Pajvani UB. Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis. Sci Transl Med 2018;10:eaat0344. [PMID: 30463916 DOI: 10.1126/scitranslmed.aat0344] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 18.0] [Reference Citation Analysis]
88 Caligiuri A, Gentilini A, Pastore M, Gitto S, Marra F. Cellular and Molecular Mechanisms Underlying Liver Fibrosis Regression. Cells 2021;10:2759. [PMID: 34685739 DOI: 10.3390/cells10102759] [Reference Citation Analysis]
89 Baglieri J, Zhang C, Liang S, Liu X, Nishio T, Rosenthal SB, Dhar D, Su H, Cong M, Jia J, Hosseini M, Karin M, Kisseleva T, Brenner DA. Nondegradable Collagen Increases Liver Fibrosis but Not Hepatocellular Carcinoma in Mice. Am J Pathol 2021;191:1564-79. [PMID: 34119473 DOI: 10.1016/j.ajpath.2021.05.019] [Reference Citation Analysis]
90 Gibb AA, Lazaropoulos MP, Elrod JW. Myofibroblasts and Fibrosis: Mitochondrial and Metabolic Control of Cellular Differentiation. Circ Res 2020;127:427-47. [PMID: 32673537 DOI: 10.1161/CIRCRESAHA.120.316958] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
91 Fan X, Chuan S, Hongshan W. Protein O glycosylation regulates activation of hepatic stellate cells. Inflammation 2013;36:1248-52. [PMID: 23743764 DOI: 10.1007/s10753-013-9662-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
92 Kubo N, Araki K, Kuwano H, Shirabe K. Cancer-associated fibroblasts in hepatocellular carcinoma. World J Gastroenterol 2016; 22(30): 6841-6850 [PMID: 27570421 DOI: 10.3748/wjg.v22.i30.6841] [Cited by in CrossRef: 63] [Cited by in F6Publishing: 59] [Article Influence: 10.5] [Reference Citation Analysis]
93 Jiao J, Friedman SL, Aloman C. Hepatic fibrosis. Curr Opin Gastroenterol. 2009;25:223-229. [PMID: 19396960 DOI: 10.1097/MOG.0b013e3283279668] [Cited by in Crossref: 149] [Cited by in F6Publishing: 82] [Article Influence: 11.5] [Reference Citation Analysis]
94 Guicciardi ME, Gores GJ. Apoptosis as a mechanism for liver disease progression. Semin Liver Dis. 2010;30:402-410. [PMID: 20960379 DOI: 10.1055/s-0030-1267540] [Cited by in Crossref: 105] [Cited by in F6Publishing: 108] [Article Influence: 8.8] [Reference Citation Analysis]
95 Lin YL, Lin CY, Chi CW, Huang YT. Study on antifibrotic effects of curcumin in rat hepatic stellate cells. Phytother Res. 2009;23:927-932. [PMID: 19152370 DOI: 10.1002/ptr.2764] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
96 Elchaninov AV, Fatkhudinov TK, Vishnyakova PA, Lokhonina AV, Sukhikh GT. Phenotypical and Functional Polymorphism of Liver Resident Macrophages. Cells 2019;8:E1032. [PMID: 31491903 DOI: 10.3390/cells8091032] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
97 Zhu L, Kong M, Han YP, Bai L, Zhang X, Chen Y, Zheng S, Yuan H, Duan Z. Spontaneous liver fibrosis induced by long term dietary vitamin D deficiency in adult mice is related to chronic inflammation and enhanced apoptosis. Can J Physiol Pharmacol. 2015;93:385-394. [PMID: 25894394 DOI: 10.1139/cjpp-2014-0275] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
98 Utoh R, Komori J, Kuge H, Tatsumi K, Yamada M, Hirohashi S, Tsutsumi M, Amanuma T, Yoshioka A, Nakajima Y, Wake K, Okano T, Lagasse E, Ohashi K. Adult hepatocytes direct liver organogenesis through non-parenchymal cell recruitment in the kidney. J Hepatol 2018;68:744-53. [PMID: 29288124 DOI: 10.1016/j.jhep.2017.12.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
99 Ma Y, Li Y, Zhang H, Wang Y, Wu C, Huang W. Malvidin induces hepatic stellate cell apoptosis via the endoplasmic reticulum stress pathway and mitochondrial pathway. Food Sci Nutr 2020;8:5095-106. [PMID: 32994970 DOI: 10.1002/fsn3.1810] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
100 Pratap A, Singh S, Mundra V, Yang N, Panakanti R, Eason JD, Mahato RI. Attenuation of early liver fibrosis by pharmacological inhibition of smoothened receptor signaling. J Drug Target. 2012;20:770-782. [PMID: 22994359 DOI: 10.3109/1061186X.2012.719900] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
101 Deshpande KT, Liu S, McCracken JM, Jiang L, Gaw TE, Kaydo LN, Richard ZC, O'Neil MF, Pritchard MT. Moderate (2%, v/v) Ethanol Feeding Alters Hepatic Wound Healing after Acute Carbon Tetrachloride Exposure in Mice. Biomolecules 2016;6:5. [PMID: 26751492 DOI: 10.3390/biom6010005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
102 Horst AK, Neumann K, Diehl L, Tiegs G. Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells. Cell Mol Immunol. 2016;13:277-292. [PMID: 27041638 DOI: 10.1038/cmi.2015.112] [Cited by in Crossref: 115] [Cited by in F6Publishing: 116] [Article Influence: 19.2] [Reference Citation Analysis]
103 Zheng B, Gao Z, Liang L, Lu Y, Kong Y, Chen W, Lin K, Chen W, Mai J, Li Y, Ma C. Autophagy of hepatic stellate cell induced by Clonorchis sinensis. Mol Biol Rep 2021. [PMID: 34825320 DOI: 10.1007/s11033-021-07001-9] [Reference Citation Analysis]
104 Martín-Vílchez S, Rodríguez-Muñoz Y, López-Rodríguez R, Hernández-Bartolomé, Borque-Iñurrita MJ, Molina-Jiménez F, García-Buey L, Moreno-Otero R, Sanz-Cameno P. Inhibition of tyrosine kinase receptor Tie2 reverts HCV-induced hepatic stellate cell activation. PLoS One 2014;9:e106958. [PMID: 25302785 DOI: 10.1371/journal.pone.0106958] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
105 Vidal-vanaclocha F. Architectural and Functional Aspects of the Liver with Implications for Cancer Metastasis. In: Brodt P, editor. Liver Metastasis: Biology and Clinical Management. Dordrecht: Springer Netherlands; 2011. pp. 9-42. [DOI: 10.1007/978-94-007-0292-9_2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
106 Iredale JP, Thompson A, Henderson NC. Extracellular matrix degradation in liver fibrosis: Biochemistry and regulation. Biochim Biophys Acta. 2013;1832:876-883. [PMID: 23149387 DOI: 10.1016/j.bbadis.2012.11.002] [Cited by in Crossref: 146] [Cited by in F6Publishing: 134] [Article Influence: 14.6] [Reference Citation Analysis]
107 Ibba-Manneschi L, Rosa I, Manetti M. Telocyte implications in human pathology: An overview. Semin Cell Dev Biol 2016;55:62-9. [PMID: 26805444 DOI: 10.1016/j.semcdb.2016.01.022] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.8] [Reference Citation Analysis]
108 Schulze RJ, Schott MB, Casey CA, Tuma PL, McNiven MA. The cell biology of the hepatocyte: A membrane trafficking machine. J Cell Biol 2019;218:2096-112. [PMID: 31201265 DOI: 10.1083/jcb.201903090] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 8.7] [Reference Citation Analysis]
109 Dong C, Yoon YH, Chen CM, Yi HY. Heavy alcohol use and premature death from hepatocellular carcinoma in the United States, 1999-2006. J Stud Alcohol Drugs 2011;72:892-902. [PMID: 22051203 DOI: 10.15288/jsad.2011.72.892] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
110 Mezaki Y, Yamaguchi N, Yoshikawa K, Miura M, Imai K, Itoh H, Senoo H. Insoluble, speckled cytosolic distribution of retinoic acid receptor alpha protein as a marker of hepatic stellate cell activation in vitro. J Histochem Cytochem. 2009;57:687-699. [PMID: 19332432 DOI: 10.1369/jhc.2009.953208] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
111 Hatton G, Alterio T, Nobili V, Mann JP. Unmet needs in pediatric NAFLD research: what do we need to prioritize for the future? Expert Review of Gastroenterology & Hepatology 2018;12:961-7. [DOI: 10.1080/17474124.2018.1512853] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
112 Yang JD, Nakamura I, Roberts LR. The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets. Semin Cancer Biol 2011;21:35-43. [PMID: 20946957 DOI: 10.1016/j.semcancer.2010.10.007] [Cited by in Crossref: 216] [Cited by in F6Publishing: 207] [Article Influence: 18.0] [Reference Citation Analysis]
113 Lotowska JM, Sobaniec-Lotowska ME, Lebensztejn DM. Ultrastructural characteristics of the respective forms of hepatic stellate cells in chronic hepatitis B as an example of high fibroblastic cell plasticity. The first assessment in children. Adv Med Sci 2018;63:127-33. [PMID: 29120853 DOI: 10.1016/j.advms.2017.09.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
114 Satilmis B, Sahin TT, Cicek E, Akbulut S, Yilmaz S. Hepatocellular Carcinoma Tumor Microenvironment and Its Implications in Terms of Anti-tumor Immunity: Future Perspectives for New Therapeutics. J Gastrointest Cancer 2021. [PMID: 34625923 DOI: 10.1007/s12029-021-00725-8] [Reference Citation Analysis]
115 Paradis V, Dargere D, Bieche Y, Asselah T, Marcellin P, Vidaud M, Bedossa P. SCG10 expression on activation of hepatic stellate cells promotes cell motility through interference with microtubules. Am J Pathol 2010;177:1791-7. [PMID: 20802173 DOI: 10.2353/ajpath.2010.100166] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
116 Carbone F, Montecucco F, Mach F, Pontremoli R, Viazzi F. The liver and the kidney: two critical organs influencing the atherothrombotic risk in metabolic syndrome. Thromb Haemost. 2013;110:940-958. [PMID: 23966104 DOI: 10.1160/th13-06-0499] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
117 Kremer A, VAN Hamme E, Bonnardel J, Borghgraef P, GuÉrin CJ, Guilliams M, Lippens S. A workflow for 3D-CLEM investigating liver tissue. J Microsc 2021;281:231-42. [PMID: 33034376 DOI: 10.1111/jmi.12967] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
118 Bility MT, Nio K, Li F, McGivern DR, Lemon SM, Feeney ER, Chung RT, Su L. Chronic hepatitis C infection-induced liver fibrogenesis is associated with M2 macrophage activation. Sci Rep 2016;6:39520. [PMID: 28000758 DOI: 10.1038/srep39520] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 5.5] [Reference Citation Analysis]
119 Tao L, Cheng Y, Ding D, Mei S, Xu J, Yu J, Ou-yang Q, Deng L, Chen Q, Li Q, Xu Z, Liu X. C/EBP-α ameliorates CCl4-induced liver fibrosis in mice through promoting apoptosis of hepatic stellate cells with little apoptotic effect on hepatocytes in vitro and in vivo. Apoptosis 2012;17:492-502. [DOI: 10.1007/s10495-012-0700-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
120 Koo JH, Lee HJ, Kim W, Kim SG. Endoplasmic Reticulum Stress in Hepatic Stellate Cells Promotes Liver Fibrosis via PERK-Mediated Degradation of HNRNPA1 and Up-regulation of SMAD2. Gastroenterology 2016;150:181-193.e8. [PMID: 26435271 DOI: 10.1053/j.gastro.2015.09.039] [Cited by in Crossref: 78] [Cited by in F6Publishing: 76] [Article Influence: 11.1] [Reference Citation Analysis]
121 Coll M, Perea L, Boon R, Leite SB, Vallverdú J, Mannaerts I, Smout A, El Taghdouini A, Blaya D, Rodrigo-Torres D, Graupera I, Aguilar-Bravo B, Chesne C, Najimi M, Sokal E, Lozano JJ, van Grunsven LA, Verfaillie CM, Sancho-Bru P. Generation of Hepatic Stellate Cells from Human Pluripotent Stem Cells Enables In Vitro Modeling of Liver Fibrosis. Cell Stem Cell 2018;23:101-113.e7. [PMID: 30049452 DOI: 10.1016/j.stem.2018.05.027] [Cited by in Crossref: 80] [Cited by in F6Publishing: 77] [Article Influence: 20.0] [Reference Citation Analysis]
122 Li J, Qiu SJ, She WM, Wang FP, Gao H, Li L, Tu CT, Wang JY, Shen XZ, Jiang W. Significance of the balance between regulatory T (Treg) and T helper 17 (Th17) cells during hepatitis B virus related liver fibrosis. PLoS One. 2012;7:e39307. [PMID: 22745730 DOI: 10.1371/journal.pone.0039307] [Cited by in Crossref: 82] [Cited by in F6Publishing: 87] [Article Influence: 8.2] [Reference Citation Analysis]
123 Lemaigre FP. Mechanisms of liver development: concepts for understanding liver disorders and design of novel therapies. Gastroenterology. 2009;137:62-79. [PMID: 19328801 DOI: 10.1053/j.gastro.2009.03.035] [Cited by in Crossref: 168] [Cited by in F6Publishing: 140] [Article Influence: 12.9] [Reference Citation Analysis]
124 Peng L, Jia X, Zhao J, Cui R, Yan M. Substance P promotes hepatic stellate cell proliferation and activation via the TGF-β1/Smad-3 signaling pathway. Toxicology and Applied Pharmacology 2017;329:293-300. [DOI: 10.1016/j.taap.2017.06.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
125 Panebianco C, Oben JA, Vinciguerra M, Pazienza V. Senescence in hepatic stellate cells as a mechanism of liver fibrosis reversal: a putative synergy between retinoic acid and PPAR-gamma signalings. Clin Exp Med. 2017;17:269-280. [PMID: 27655446 DOI: 10.1007/s10238-016-0438-x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 7.2] [Reference Citation Analysis]
126 Huang SC, Wang PW, Kuo PC, Hung HY, Pan TL. Hepatoprotective Principles and Other Chemical Constituents from the Mycelium of Phellinus linteus. Molecules 2018;23:E1705. [PMID: 30002357 DOI: 10.3390/molecules23071705] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
127 He X, Xie J, Wang Y, Fan X, Su Q, Sun Y, Lei N, Zhang D, Gao G, Pan W. Down-regulation of microRNA-203-3p initiates type 2 pathology during schistosome infection via elevation of interleukin-33. PLoS Pathog 2018;14:e1006957. [PMID: 29554131 DOI: 10.1371/journal.ppat.1006957] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
128 Pradere JP, Kluwe J, De Minicis S, Jiao JJ, Gwak GY, Dapito DH, Jang MK, Guenther ND, Mederacke I, Friedman R, Dragomir AC, Aloman C, Schwabe RF. Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice. Hepatology. 2013;58:1461-1473. [PMID: 23553591 DOI: 10.1002/hep.26429] [Cited by in Crossref: 295] [Cited by in F6Publishing: 283] [Article Influence: 32.8] [Reference Citation Analysis]
129 Mulaikal TA, Emond JC. Physiology and Anatomy of the Liver. In: Wagener G, editor. Liver Anesthesiology and Critical Care Medicine. Cham: Springer International Publishing; 2018. pp. 3-19. [DOI: 10.1007/978-3-319-64298-7_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
130 Tsukamoto H, Zhu NL, Wang J, Asahina K, Machida K. Morphogens and hepatic stellate cell fate regulation in chronic liver disease. J Gastroenterol Hepatol. 2012;27 Suppl 2:94-98. [PMID: 22320925 DOI: 10.1111/j.1440-1746.2011.07022.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
131 Hoffmann C, Djerir NEH, Danckaert A, Fernandes J, Roux P, Charrueau C, Lachagès AM, Charlotte F, Brocheriou I, Clément K, Aron-Wisnewsky J, Foufelle F, Ratziu V, Hainque B, Bonnefont-Rousselot D, Bigey P, Escriou V. Hepatic stellate cell hypertrophy is associated with metabolic liver fibrosis. Sci Rep 2020;10:3850. [PMID: 32123215 DOI: 10.1038/s41598-020-60615-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
132 Chen P, Li J, Huo Y, Lu J, Wan L, Yang Q, Huang J, Gan R, Guo C. Adenovirus-mediated expression of orphan nuclear receptor NR4A2 targeting hepatic stellate cell attenuates liver fibrosis in rats. Sci Rep 2016;6:33593. [PMID: 27646469 DOI: 10.1038/srep33593] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
133 Saiman Y, Sugiyama T, Simchoni N, Spirli C, Bansal MB. Biliary Epithelial Cells Are Not the Predominant Source of Hepatic CXCL12. Am J Pathol 2015;185:1859-66. [PMID: 25934614 DOI: 10.1016/j.ajpath.2015.03.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
134 Zhu J, Zhang Z, Zhang Y, Li W, Zheng W, Yu J, Wang B, Chen L, Zhuo Q, Chen L, Zhang J, Liu J. MicroRNA-212 activates hepatic stellate cells and promotes liver fibrosis via targeting SMAD7. Biochem Biophys Res Commun 2018;496:176-83. [PMID: 29307832 DOI: 10.1016/j.bbrc.2018.01.019] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
135 Friedman SL. Targeting siRNA to arrest fibrosis. Nat Biotechnol 2008;26:399-400. [PMID: 18392021 DOI: 10.1038/nbt0408-399] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
136 Du Y, Li N, Long M. Liver sinusoid on a chip. Methods Cell Biol 2018;146:105-34. [PMID: 30037457 DOI: 10.1016/bs.mcb.2018.06.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
137 Komolkriengkrai M, Nopparat J, Vongvatcharanon U, Anupunpisit V, Khimmaktong W. Effect of glabridin on collagen deposition in liver and amelioration of hepatocyte destruction in diabetes rats. Exp Ther Med 2019;18:1164-74. [PMID: 31316610 DOI: 10.3892/etm.2019.7664] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
138 Vallverdú J, Martínez García de la Torre RA, Mannaerts I, Verhulst S, Smout A, Coll M, Ariño S, Rubio-Tomás T, Aguilar-Bravo B, Martínez-Sánchez C, Blaya D, Verfaillie CM, van Grunsven LA, Sancho-Bru P. Directed differentiation of human induced pluripotent stem cells to hepatic stellate cells. Nat Protoc 2021;16:2542-63. [PMID: 33864055 DOI: 10.1038/s41596-021-00509-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
139 Lee TF, Mak KM, Rackovsky O, Lin YL, Kwong AJ, Loke JC, Friedman SL. Downregulation of hepatic stellate cell activation by retinol and palmitate mediated by adipose differentiation-related protein (ADRP). J Cell Physiol. 2010;223:648-657. [PMID: 20143336 DOI: 10.1002/jcp.22063] [Cited by in Crossref: 14] [Cited by in F6Publishing: 41] [Article Influence: 1.2] [Reference Citation Analysis]
140 Giraudi PJ, Becerra VJ, Marin V, Chavez-Tapia NC, Tiribelli C, Rosso N. The importance of the interaction between hepatocyte and hepatic stellate cells in fibrogenesis induced by fatty accumulation. Exp Mol Pathol. 2015;98:85-92. [PMID: 25533546 DOI: 10.1016/j.yexmp.2014.12.006] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
141 Gressner OA. Less Smad2 is good for you! A scientific update on coffee's liver benefits. Hepatology. 2009;50:970-978. [PMID: 19610047 DOI: 10.1002/hep.23097] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
142 Luo N, Li J, Wei Y, Lu J, Dong R. Hepatic Stellate Cell: A Double-Edged Sword in the Liver. Physiol Res 2021;70. [PMID: 34717063 DOI: 10.33549/physiolres.934755] [Reference Citation Analysis]
143 Park YJ, Jeon MS, Lee S, Kim JK, Jang TS, Chung KH, Kim KH. Anti-fibrotic effects of brevilin A in hepatic fibrosis via inhibiting the STAT3 signaling pathway. Bioorg Med Chem Lett 2021;41:127989. [PMID: 33794317 DOI: 10.1016/j.bmcl.2021.127989] [Reference Citation Analysis]
144 Hernández A, Arab JP, Reyes D, Lapitz A, Moshage H, Bañales JM, Arrese M. Extracellular Vesicles in NAFLD/ALD: From Pathobiology to Therapy. Cells 2020;9:E817. [PMID: 32231001 DOI: 10.3390/cells9040817] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
145 Wake K, Sato T. "The sinusoid" in the liver: lessons learned from the original definition by Charles Sedgwick Minot (1900). Anat Rec (Hoboken). 2015;298:2071-2080. [PMID: 26332299 DOI: 10.1002/ar.23263] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
146 El-Naggar ME, Al-Joufi F, Anwar M, Attia MF, El-Bana MA. Curcumin-loaded PLA-PEG copolymer nanoparticles for treatment of liver inflammation in streptozotocin-induced diabetic rats. Colloids Surf B Biointerfaces 2019;177:389-98. [PMID: 30785036 DOI: 10.1016/j.colsurfb.2019.02.024] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 15.3] [Reference Citation Analysis]
147 Bai L, Kong M, Zhang XH, Ding M, Zheng SJ, Chen Y, Duan ZP. Liver fibrosis protects mice against lethal injury induced by D-GalN/LPS. Shijie Huaren Xiaohua Zazhi 2014; 22(14): 1998-2002 [DOI: 10.11569/wcjd.v22.i14.1998] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
148 Mousavi SA, Fønhus MS, Kindberg GM, Tolleshaug H, Berg T. Enhanced activity of lysosomal proteases in activated rat hepatic stellate cells is associated with a concomitant increase in the number of the mannose-6-phosphate/insulin-like growth factor II receptor: Lysosomal enzymes in activated stellate cells. Cell Biol Int 2013;37:703-12. [DOI: 10.1002/cbin.10085] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
149 Yokomori H, Oda M, Yoshimura K, Hibi T. Enhanced expressions of apelin on proliferative hepatic arterial capillaries in human cirrhotic liver. Hepatol Res. 2012;42:508-514. [PMID: 22502744 DOI: 10.1111/j.1872-034x.2011.00945.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
150 Hu PF, Chen H, Zhong W, Lin Y, Zhang X, Chen YX, Xie WF. Adenovirus-mediated transfer of siRNA against PAI-1 mRNA ameliorates hepatic fibrosis in rats. J Hepatol. 2009;51:102-113. [PMID: 19446913 DOI: 10.1016/j.jhep.2009.02.025] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
151 Kim BM, Abdelfattah AM, Vasan R, Fuchs BC, Choi MY. Hepatic stellate cells secrete Ccl5 to induce hepatocyte steatosis. Sci Rep 2018;8:7499. [PMID: 29760499 DOI: 10.1038/s41598-018-25699-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
152 Roife D, Sarcar B, Fleming JB. Stellate Cells in the Tumor Microenvironment. Adv Exp Med Biol 2020;1263:67-84. [PMID: 32588324 DOI: 10.1007/978-3-030-44518-8_6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
153 Fathy M, Okabe M, Saad Eldien HM, Yoshida T. AT-MSCs Antifibrotic Activity is Improved by Eugenol through Modulation of TGF-β/Smad Signaling Pathway in Rats. Molecules 2020;25:E348. [PMID: 31952158 DOI: 10.3390/molecules25020348] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
154 Lee T, Chang H, Wen C, Huang T, Chang Y. Modulation of thioacetamide-induced hepatic inflammations, angiogenesis and fibrosis by andrographolide in mice. Journal of Ethnopharmacology 2014;158:423-30. [DOI: 10.1016/j.jep.2014.10.056] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
155 Van Beneden K, van Grunsven LA, Geers C, Pauwels M, Desmoulière A, Verbeelen D, Geerts A, Van den Branden C. CRBP-I in the renal tubulointerstitial compartment of healthy rats and rats with renal fibrosis. Nephrol Dial Transplant 2008;23:3464-71. [PMID: 18503097 DOI: 10.1093/ndt/gfn290] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
156 Chen S, Guo H, Xie M, Zhou C, Zheng M. Neutrophil: An emerging player in the occurrence and progression of metabolic associated fatty liver disease. Int Immunopharmacol 2021;97:107609. [PMID: 33887577 DOI: 10.1016/j.intimp.2021.107609] [Reference Citation Analysis]
157 Bozza PT, Bakker-Abreu I, Navarro-Xavier RA, Bandeira-Melo C. Lipid body function in eicosanoid synthesis: an update. Prostaglandins Leukot Essent Fatty Acids. 2011;85:205-213. [PMID: 21565480 DOI: 10.1016/j.plefa.2011.04.020] [Cited by in Crossref: 105] [Cited by in F6Publishing: 99] [Article Influence: 9.5] [Reference Citation Analysis]
158 Choi JH, Hwang YP, Park BH, Choi CY, Chung YC, Jeong HG. Anthocyanins isolated from the purple-fleshed sweet potato attenuate the proliferation of hepatic stellate cells by blocking the PDGF receptor. Environ Toxicol Pharmacol. 2011;31:212-219. [PMID: 21787688 DOI: 10.1016/j.etap.2010.10.011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
159 Khawar IA, Park JK, Jung ES, Lee MA, Chang S, Kuh HJ. Three Dimensional Mixed-Cell Spheroids Mimic Stroma-Mediated Chemoresistance and Invasive Migration in hepatocellular carcinoma. Neoplasia. 2018;20:800-812. [PMID: 29981501 DOI: 10.1016/j.neo.2018.05.008] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 11.0] [Reference Citation Analysis]
160 Zhang F, Wang F, He J, Lian N, Wang Z, Shao J, Ding H, Tan S, Chen A, Zhang Z, Wang S, Zheng S. Regulation of hepatic stellate cell contraction and cirrhotic portal hypertension by Wnt/β-catenin signalling via interaction with Gli1. Br J Pharmacol 2021;178:2246-65. [PMID: 33085791 DOI: 10.1111/bph.15289] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
161 Ruddell RG, Hoang-Le D, Barwood JM, Rutherford PS, Piva TJ, Watters DJ, Santambrogio P, Arosio P, Ramm GA. Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells. Hepatology. 2009;49:887-900. [PMID: 19241483 DOI: 10.1002/hep.22716] [Cited by in Crossref: 147] [Cited by in F6Publishing: 143] [Article Influence: 11.3] [Reference Citation Analysis]
162 Wang F, Malnassy G, Qiu W. The Epigenetic Regulation of Microenvironment in Hepatocellular Carcinoma. Front Oncol 2021;11:653037. [PMID: 33791228 DOI: 10.3389/fonc.2021.653037] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
163 Yang MD, Chiang YM, Higashiyama R, Asahina K, Mann DA, Mann J, Wang CC, Tsukamoto H. Rosmarinic acid and baicalin epigenetically derepress peroxisomal proliferator-activated receptor γ in hepatic stellate cells for their antifibrotic effect. Hepatology. 2012;55:1271-1281. [PMID: 22095555 DOI: 10.1002/hep.24792] [Cited by in Crossref: 87] [Cited by in F6Publishing: 79] [Article Influence: 8.7] [Reference Citation Analysis]
164 Holt AP, Salmon M, Buckley CD, Adams DH. Immune interactions in hepatic fibrosis. Clin Liver Dis. 2008;12:861-862, x. [PMID: 18984471 DOI: 10.1016/j.cld.2008.07.002] [Cited by in Crossref: 63] [Cited by in F6Publishing: 66] [Article Influence: 4.8] [Reference Citation Analysis]
165 Andrade CM, Lopez PL, Noronha BT, Wink MR, Borojevic R, Margis R, Lenz G, Battastini AM, Guma FC. Ecto-5'-nucleotidase/CD73 knockdown increases cell migration and mRNA level of collagen I in a hepatic stellate cell line. Cell Tissue Res 2011;344:279-86. [PMID: 21424267 DOI: 10.1007/s00441-011-1140-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
166 Azzam A, Jiyad Z, O'Beirne J. Is methotrexate hepatotoxicity associated with cumulative dose? A systematic review and meta-analysis. Australas J Dermatol 2021;62:130-40. [PMID: 33769558 DOI: 10.1111/ajd.13546] [Reference Citation Analysis]
167 Lebda MA, Sadek KM, Abouzed TK, Tohamy HG, El-Sayed YS. Melatonin mitigates thioacetamide-induced hepatic fibrosis via antioxidant activity and modulation of proinflammatory cytokines and fibrogenic genes. Life Sci 2018;192:136-43. [PMID: 29180002 DOI: 10.1016/j.lfs.2017.11.036] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
168 Lee YS, Kim SY, Ko E, Lee JH, Yi HS, Yoo YJ, Je J, Suh SJ, Jung YK, Kim JH, Seo YS, Yim HJ, Jeong WI, Yeon JE, Um SH, Byun KS. Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells. Sci Rep. 2017;7:3710. [PMID: 28623272 DOI: 10.1038/s41598-017-03389-2] [Cited by in Crossref: 78] [Cited by in F6Publishing: 81] [Article Influence: 15.6] [Reference Citation Analysis]
169 Avolio E, Alvino VV, Ghorbel MT, Campagnolo P. Perivascular cells and tissue engineering: Current applications and untapped potential. Pharmacol Ther 2017;171:83-92. [PMID: 27889329 DOI: 10.1016/j.pharmthera.2016.11.002] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 6.3] [Reference Citation Analysis]
170 Chen Z, Guo P, Xie X, Yu H, Wang Y, Chen G. The role of tumour microenvironment: a new vision for cholangiocarcinoma. J Cell Mol Med. 2019;23:59-69. [PMID: 30394682 DOI: 10.1111/jcmm.13953] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
171 Mohamed RH, Tarek M, Hamam GG, Ezzat SF. Zoledronic acid prevents the hepatic changes associated with high fat diet in rats; the potential role of mevalonic acid pathway in nonalcoholic steatohepatitis. European Journal of Pharmacology 2019;858:172469. [DOI: 10.1016/j.ejphar.2019.172469] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
172 Bian EB, Zhao B, Huang C, Wang H, Meng XM, Wu BM, Ma TT, Zhang L, Lv XW, Li J. New advances of DNA methylation in liver fibrosis, with special emphasis on the crosstalk between microRNAs and DNA methylation machinery. Cell Signal. 2013;25:1837-1844. [PMID: 23707524 DOI: 10.1016/j.cellsig.2013.05.017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
173 Davidson MD, Kukla DA, Khetani SR. Microengineered cultures containing human hepatic stellate cells and hepatocytes for drug development. Integr Biol (Camb) 2017;9:662-77. [PMID: 28702667 DOI: 10.1039/c7ib00027h] [Cited by in Crossref: 33] [Cited by in F6Publishing: 15] [Article Influence: 8.3] [Reference Citation Analysis]
174 Lukashyk SP, Tsyrkunov VM, Isaykina YI, Romanova ON, Shymanskiy AT, Aleynikova OV, Kravchuk RI. Mesenchymal bone marrow-derived stem cells transplantation in patients with HCV related liver cirrhosis. J Clin Transl Hepatol. 2014;2:217-221. [PMID: 26356872 DOI: 10.14218/JCTH.2014.00027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
175 Novo E, Parola M. Redox mechanisms in hepatic chronic wound healing and fibrogenesis. Fibrogenesis Tissue Repair 2008;1:5. [PMID: 19014652 DOI: 10.1186/1755-1536-1-5] [Cited by in Crossref: 246] [Cited by in F6Publishing: 210] [Article Influence: 17.6] [Reference Citation Analysis]
176 Zhang K, Chang Y, Shi Z, Han X, Han Y, Yao Q, Hu Z, Cui H, Zheng L, Han T, Hong W. ω-3 PUFAs ameliorate liver fibrosis and inhibit hepatic stellate cells proliferation and activation by promoting YAP/TAZ degradation. Sci Rep 2016;6:30029. [PMID: 27435808 DOI: 10.1038/srep30029] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
177 Zhu C, Tabas I, Schwabe RF, Pajvani UB. Maladaptive regeneration - the reawakening of developmental pathways in NASH and fibrosis. Nat Rev Gastroenterol Hepatol. 2021;18:131-142. [PMID: 33051603 DOI: 10.1038/s41575-020-00365-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
178 Ghosh S, Kaplan KJ, Schrum LW, Bonkovsky HL. Cytoskeletal proteins: shaping progression of hepatitis C virus-induced liver disease. Int Rev Cell Mol Biol 2013;302:279-319. [PMID: 23351713 DOI: 10.1016/B978-0-12-407699-0.00005-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
179 Li B, Liu J, Xin X, Zhang L, Zhou J, Xia C, Zhu W, Yu H. MiR-34c promotes hepatic stellate cell activation and Liver Fibrogenesis by suppressing ACSL1 expression. Int J Med Sci 2021;18:615-25. [PMID: 33437196 DOI: 10.7150/ijms.51589] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
180 da Silva CM, Caetano FH, Pereira FDC, Morales MAM, Sakane KK, Moraes KCM. Cellular and molecular effects of Baccharis dracunculifolia D.C. and Plectranthus barbatus Andrews medicinal plant extracts on retinoid metabolism in the human hepatic stellate cell LX-2. BMC Complement Altern Med 2019;19:222. [PMID: 31438947 DOI: 10.1186/s12906-019-2591-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
181 Khadem F, Gao X, Mou Z, Jia P, Movassagh H, Onyilagha C, Gounni AS, Wright MC, Uzonna JE. Hepatic stellate cells regulate liver immunity to visceral leishmaniasis through P110δ-dependent induction and expansion of regulatory T cells in mice: KHADEM ET AL. Hepatology 2016;63:620-32. [DOI: 10.1002/hep.28130] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
182 Liedtke C, Luedde T, Sauerbruch T, Scholten D, Streetz K, Tacke F, Tolba R, Trautwein C, Trebicka J, Weiskirchen R. Experimental liver fibrosis research: update on animal models, legal issues and translational aspects. Fibrogenesis Tissue Repair. 2013;6:19. [PMID: 24274743 DOI: 10.1186/1755-1536-6-19] [Cited by in Crossref: 199] [Cited by in F6Publishing: 192] [Article Influence: 22.1] [Reference Citation Analysis]
183 Hyun J, Wang S, Kim J, Rao KM, Park SY, Chung I, Ha CS, Kim SW, Yun YH, Jung Y. MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression. Nat Commun 2016;7:10993. [PMID: 27001906 DOI: 10.1038/ncomms10993] [Cited by in Crossref: 120] [Cited by in F6Publishing: 120] [Article Influence: 20.0] [Reference Citation Analysis]
184 Bruschi FV, Claudel T, Tardelli M, Starlinger P, Marra F, Trauner M. PNPLA3 I148M Variant Impairs Liver X Receptor Signaling and Cholesterol Homeostasis in Human Hepatic Stellate Cells. Hepatol Commun 2019;3:1191-204. [PMID: 31497741 DOI: 10.1002/hep4.1395] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
185 Yokomori H, Ando W, Oda M. Caveolin-1 is related to lipid droplet formation in hepatic stellate cells in human liver. Acta Histochem 2019;121:113-8. [PMID: 30446170 DOI: 10.1016/j.acthis.2018.10.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
186 Bian E, Huang C, Wang H, Chen X, Zhang L, Lv X, Li J. Repression of Smad7 mediated by DNMT1 determines hepatic stellate cell activation and liver fibrosis in rats. Toxicology Letters 2014;224:175-85. [DOI: 10.1016/j.toxlet.2013.10.038] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 5.8] [Reference Citation Analysis]
187 Kang LI, Mars WM, Michalopoulos GK. Signals and cells involved in regulating liver regeneration. Cells. 2012;1:1261-1292. [PMID: 24710554 DOI: 10.3390/cells1041261] [Cited by in Crossref: 70] [Cited by in F6Publishing: 59] [Article Influence: 7.0] [Reference Citation Analysis]
188 Seki N, Toh U, Kawaguchi K, Ninomiya M, Koketsu M, Watanabe K, Aoki M, Fujii T, Nakamura A, Akagi Y. Tricin inhibits proliferation of human hepatic stellate cells in vitro by blocking tyrosine phosphorylation of PDGF receptor and its signaling pathways. J Cell Biochem. 2012;113:2346-2355. [PMID: 22359269 DOI: 10.1002/jcb.24107] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
189 Garbuzenko DV, Arefyev NO, Belov DV. Mechanisms of adaptation of the hepatic vasculature to the deteriorating conditions of blood circulation in liver cirrhosis. World J Hepatol 2016; 8(16): 665-672 [PMID: 27326313 DOI: 10.4254/wjh.v8.i16.665] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
190 Jia W, Liang S, Cheng B, Ling C. The Role of Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and the Value of Traditional Chinese Medicine Treatment. Front Oncol 2021;11:763519. [PMID: 34868982 DOI: 10.3389/fonc.2021.763519] [Reference Citation Analysis]
191 Møller S, Kimer N, Barløse M, Bendtsen F. Pathophysiological-based treatments of complications of cirrhosis. Scand J Gastroenterol 2020;55:383-94. [PMID: 32233873 DOI: 10.1080/00365521.2020.1744709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
192 Wang S, Shi XL, Feng M, Wang X, Zhang ZH, Zhao X, Han B, Ma HC, Dai B, Ding YT. Puerarin protects against CCl4-induced liver fibrosis in mice: possible role of PARP-1 inhibition. Int Immunopharmacol 2016;38:238-45. [PMID: 27318789 DOI: 10.1016/j.intimp.2016.06.008] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
193 Bai Q, Yan H, Sheng Y, Jin Y, Shi L, Ji L, Wang Z. Long-term acetaminophen treatment induced liver fibrosis in mice and the involvement of Egr-1. Toxicology 2017;382:47-58. [PMID: 28286204 DOI: 10.1016/j.tox.2017.03.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
194 Moriya T, Kitamori K, Naito H, Yanagiba Y, Ito Y, Yamagishi N, Tamada H, Jia X, Tsuchikura S, Ikeda K, Yamori Y, Nakajima T. Simultaneous changes in high-fat and high-cholesterol diet-induced steatohepatitis and severe fibrosis and those underlying molecular mechanisms in novel SHRSP5/Dmcr rat. Environ Health Prev Med 2012;17:444-56. [PMID: 22407906 DOI: 10.1007/s12199-012-0273-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
195 Raicevic G, Najar M, Najimi M, El Taghdouini A, van Grunsven LA, Sokal E, Toungouz M. Influence of inflammation on the immunological profile of adult-derived human liver mesenchymal stromal cells and stellate cells. Cytotherapy. 2015;17:174-185. [PMID: 25455740 DOI: 10.1016/j.jcyt.2014.10.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
196 Odena G, Bataller R. Fibrogénesis hepática: fisiopatología. Gastroenterología y Hepatología 2012;35:3-9. [DOI: 10.1016/s0210-5705(12)70043-2] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
197 Liu Y, Saiyan S, Men TY, Gao HY, Wen C, Liu Y, Zhou X, Wu CT, Wang LS, Cui CP. Hepatopoietin Cn reduces ethanol-induced hepatoxicity via sphingosine kinase 1 and sphingosine 1-phosphate receptors. J Pathol 2013;230:365-76. [PMID: 23839903 DOI: 10.1002/path.4194] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
198 Cui G, Chen J, Wu Z, Huang H, Wang L, Liang Y, Zeng P, Yang J, Uede T, Diao H. Thrombin cleavage of osteopontin controls activation of hepatic stellate cells and is essential for liver fibrogenesis. J Cell Physiol. 2019;234:8988-8997. [PMID: 30350863 DOI: 10.1002/jcp.27571] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
199 Zhang W, Conway SJ, Liu Y, Snider P, Chen H, Gao H, Liu Y, Isidan K, Lopez KJ, Campana G, Li P, Ekser B, Francis H, Shou W, Kubal C. Heterogeneity of Hepatic Stellate Cells in Fibrogenesis of the Liver: Insights from Single-Cell Transcriptomic Analysis in Liver Injury. Cells 2021;10:2129. [PMID: 34440898 DOI: 10.3390/cells10082129] [Reference Citation Analysis]
200 Lim MC, Maubach G, Zhuo L. TGF-beta1 down-regulates connexin 43 expression and gap junction intercellular communication in rat hepatic stellate cells. Eur J Cell Biol. 2009;88:719-730. [PMID: 19781809 DOI: 10.1016/j.ejcb.2009.08.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
201 Sajic T, Hainard A, Scherl A, Wohlwend A, Negro F, Sanchez JC, Szanto I. STAT6 promotes bi-directional modulation of PKM2 in liver and adipose inflammatory cells in rosiglitazone-treated mice. Sci Rep 2013;3:2350. [PMID: 23917405 DOI: 10.1038/srep02350] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
202 Li W, Chen X, Yang Y, Huang H, Li H, Huang C, Meng X, Li J. Hesperitin derivative-11 suppress hepatic stellate cell activation and proliferation by targeting PTEN/AKT pathway. Toxicology 2017;381:75-86. [DOI: 10.1016/j.tox.2016.11.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
203 Tu X, Zhang H, Zhang J, Zhao S, Zheng X, Zhang Z, Zhu J, Chen J, Dong L, Zang Y. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway. J Pathol. 2014;234:46-59. [PMID: 24817606 DOI: 10.1002/path.4373] [Cited by in Crossref: 88] [Cited by in F6Publishing: 94] [Article Influence: 11.0] [Reference Citation Analysis]
204 Shin MO, Moon JO. Effect of dietary supplementation of grape skin and seeds on liver fibrosis induced by dimethylnitrosamine in rats. Nutr Res Pract 2010;4:369-74. [PMID: 21103082 DOI: 10.4162/nrp.2010.4.5.369] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
205 Mukherjee D, Ahmad R. COX-2/iNOS regulation during experimental hepatic injury and its mitigation by cloudy apple juice. Int J Biol Macromol 2019;140:1006-17. [PMID: 31445146 DOI: 10.1016/j.ijbiomac.2019.08.180] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
206 Moles A, Tarrats N, Fernández-Checa JC, Marí M. Cathepsins B and D drive hepatic stellate cell proliferation and promote their fibrogenic potential. Hepatology. 2009;49:1297-1307. [PMID: 19116891 DOI: 10.1002/hep.22753] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 4.9] [Reference Citation Analysis]
207 Jia YL, Shi L, Zhou JN, Fu CJ, Chen L, Yuan HF, Wang YF, Yan XL, Xu YC, Zeng Q. Epimorphin promotes human hepatocellular carcinoma invasion and metastasis through activation of focal adhesion kinase/extracellular signal-regulated kinase/matrix metalloproteinase-9 axis. Hepatology. 2011;54:1808-1818. [PMID: 22045676 DOI: 10.1002/hep.24562] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 5.9] [Reference Citation Analysis]
208 Soliman EM, Rodrigues MA, Gomes DA, Sheung N, Yu J, Amaya MJ, Nathanson MH, Dranoff JA. Intracellular calcium signals regulate growth of hepatic stellate cells via specific effects on cell cycle progression. Cell Calcium 2009;45:284-92. [PMID: 19131107 DOI: 10.1016/j.ceca.2008.11.006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
209 Qian H, Deng X, Huang ZW, Wei J, Ding CH, Feng RX, Zeng X, Chen YX, Ding J, Qiu L, Hu ZL, Zhang X, Wang HY, Zhang JP, Xie WF. An HNF1α-regulated feedback circuit modulates hepatic fibrogenesis via the crosstalk between hepatocytes and hepatic stellate cells. Cell Res 2015;25:930-45. [PMID: 26169608 DOI: 10.1038/cr.2015.84] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 5.4] [Reference Citation Analysis]
210 Liu K, Czaja MJ. Regulation of lipid stores and metabolism by lipophagy. Cell Death Differ. 2013;20:3-11. [PMID: 22595754 DOI: 10.1038/cdd.2012.63] [Cited by in Crossref: 291] [Cited by in F6Publishing: 273] [Article Influence: 29.1] [Reference Citation Analysis]
211 Miranda-bautista J, Bañares R, Vaquero J. The Gastrointestinal System. Gastrointestinal Tissue. Elsevier; 2017. pp. 3-20. [DOI: 10.1016/b978-0-12-805377-5.00001-1] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
212 He Q, Xia X, Yao K, Zeng J, Wang W, Wu Q, Tang R, Zou X. Amlexanox reversed non-alcoholic fatty liver disease through IKKε inhibition of hepatic stellate cell. Life Sciences 2019;239:117010. [DOI: 10.1016/j.lfs.2019.117010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
213 Arriazu E, Ruiz de Galarreta M, Cubero FJ, Varela-Rey M, Pérez de Obanos MP, Leung TM, Lopategi A, Benedicto A, Abraham-Enachescu I, Nieto N. Extracellular matrix and liver disease. Antioxid Redox Signal 2014;21:1078-97. [PMID: 24219114 DOI: 10.1089/ars.2013.5697] [Cited by in Crossref: 64] [Cited by in F6Publishing: 57] [Article Influence: 8.0] [Reference Citation Analysis]
214 Königshofer P, Brusilovskaya K, Petrenko O, Hofer BS, Schwabl P, Trauner M, Reiberger T. Nuclear Receptors in Liver Fibrosis. Biochim Biophys Acta Mol Basis Dis 2021;:166235. [PMID: 34339839 DOI: 10.1016/j.bbadis.2021.166235] [Reference Citation Analysis]
215 Jeon M, Kwon H, Kim YH, Han K, Nam K, Baik Y, Lee S, Kim W, Han M. Administration of rhIL-2 upregulates HGF in the cirrhotic liver of partial hepatectomized rats. Animal Cells and Systems 2013;17:179-85. [DOI: 10.1080/19768354.2013.801365] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
216 Scholten D, Weiskirchen R. Questioning the challenging role of epithelial-to-mesenchymal transition in liver injury. Hepatology 2011;53:1048-51. [PMID: 21374669 DOI: 10.1002/hep.24191] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
217 Magistri P, Leonard SY, Tang CM, Chan JC, Lee TE, Sicklick JK. The glypican 3 hepatocellular carcinoma marker regulates human hepatic stellate cells via Hedgehog signaling. J Surg Res 2014;187:377-85. [PMID: 24439425 DOI: 10.1016/j.jss.2013.12.010] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
218 Su Q, Kumar V, Sud N, Mahato RI. MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis. Adv Drug Deliv Rev. 2018;129:54-63. [PMID: 29391222 DOI: 10.1016/j.addr.2018.01.009] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 12.8] [Reference Citation Analysis]
219 Martínez-Esparza M, Tristán-Manzano M, Ruiz-Alcaraz AJ, García-Peñarrubia P. Inflammatory status in human hepatic cirrhosis. World J Gastroenterol 2015; 21(41): 11522-11541 [PMID: 26556984 DOI: 10.3748/wjg.v21.i41.11522] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
220 Kim KS, Yang HJ, Lee JY, Na YC, Kwon SY, Kim YC, Lee JH, Jang HJ. Effects of β-sitosterol derived from Artemisia capillaris on the activated human hepatic stellate cells and dimethylnitrosamine-induced mouse liver fibrosis. BMC Complement Altern Med 2014;14:363. [PMID: 25262005 DOI: 10.1186/1472-6882-14-363] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
221 Jin XY, Cong T, Zhao P. Cytokines, liver fibrosis, and principles of nutritional support in patients with liver fibrosis. Shijie Huaren Xiaohua Zazhi 2011; 19(26): 2760-2767 [DOI: 10.11569/wcjd.v19.i26.2760] [Reference Citation Analysis]
222 Tennakoon AH, Izawa T, Wijesundera KK, Murakami H, Katou-Ichikawa C, Tanaka M, Golbar HM, Kuwamura M, Yamate J. Immunohistochemical characterization of glial fibrillary acidic protein (GFAP)-expressing cells in a rat liver cirrhosis model induced by repeated injections of thioacetamide (TAA). Exp Toxicol Pathol 2015;67:53-63. [PMID: 25446803 DOI: 10.1016/j.etp.2014.09.008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
223 Wu Y, Li Z, Xiu AY, Meng DX, Wang SN, Zhang CQ. Carvedilol attenuates carbon tetrachloride-induced liver fibrosis and hepatic sinusoidal capillarization in mice. Drug Des Devel Ther 2019;13:2667-76. [PMID: 31534314 DOI: 10.2147/DDDT.S210797] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
224 Zhang B, Lapenta K, Wang Q, Nam JH, Chung D, Robert ME, Nathanson MH, Yang X. Trefoil factor 2 secreted from damaged hepatocytes activates hepatic stellate cells to induce fibrogenesis. J Biol Chem 2021;297:100887. [PMID: 34146542 DOI: 10.1016/j.jbc.2021.100887] [Reference Citation Analysis]
225 El Taghdouini A, Sørensen AL, Reiner AH, Coll M, Verhulst S, Mannaerts I, Øie CI, Smedsrød B, Najimi M, Sokal E. Genome-wide analysis of DNA methylation and gene expression patterns in purified, uncultured human liver cells and activated hepatic stellate cells. Oncotarget. 2015;6:26729-26745. [PMID: 26353929 DOI: 10.18632/oncotarget.4925] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 6.5] [Reference Citation Analysis]
226 Weiz G, Molejon MI, Malvicini M, Sukowati CHC, Tiribelli C, Mazzolini G, Breccia JD. Glycosylated 4-methylumbelliferone as a targeted therapy for hepatocellular carcinoma. Liver Int 2021. [PMID: 34800352 DOI: 10.1111/liv.15084] [Reference Citation Analysis]
227 Zhu X, Zhang F, Zhou L, Kong D, Chen L, Lu Y, Zheng S. Diallyl trisulfide attenuates carbon tetrachloride-caused liver injury and fibrogenesis and reduces hepatic oxidative stress in rats. Naunyn Schmiedebergs Arch Pharmacol 2014;387:445-55. [PMID: 24557053 DOI: 10.1007/s00210-014-0959-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
228 Chong YC, Lim TE, Fu Y, Shin EM, Tergaonkar V, Han W. Indian Hedgehog links obesity to development of hepatocellular carcinoma. Oncogene 2019;38:2206-22. [PMID: 30470823 DOI: 10.1038/s41388-018-0585-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
229 Chen L, Guo YZ, Li AD, Ma JJ, Hao HY, Zhang D, Wang Y, Ji CG, Qi W, Wang J, Jiang HQ. Knockdown of Astrocyte Elevated Gene-1 Inhibits Activation of Hepatic Stellate Cells. Dig Dis Sci 2016;61:1961-71. [PMID: 26879903 DOI: 10.1007/s10620-016-4075-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
230 Gu Y, Bi Y, Wei H, Li J, Huang Z, Liao C, Liao W, Huang Y. Expression and clinical significance of inhibitory receptor Leukocyte-associated immunoglobulin-like receptor-1 on peripheral blood T cells of chronic hepatitis B patients: A cross-sectional study. Medicine (Baltimore) 2021;100:e26667. [PMID: 34398030 DOI: 10.1097/MD.0000000000026667] [Reference Citation Analysis]
231 Novo E, Bocca C, Foglia B, Protopapa F, Maggiora M, Parola M, Cannito S. Liver fibrogenesis: un update on established and emerging basic concepts. Arch Biochem Biophys 2020;689:108445. [PMID: 32524998 DOI: 10.1016/j.abb.2020.108445] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
232 Hannivoort RA, Hernandez-Gea V, Friedman SL. Genomics and proteomics in liver fibrosis and cirrhosis. Fibrogenesis Tissue Repair 2012;5:1. [PMID: 22214245 DOI: 10.1186/1755-1536-5-1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
233 Domitrović R, Rashed K, Cvijanović O, Vladimir-knežević S, Škoda M, Višnić A. Myricitrin exhibits antioxidant, anti-inflammatory and antifibrotic activity in carbon tetrachloride-intoxicated mice. Chemico-Biological Interactions 2015;230:21-9. [DOI: 10.1016/j.cbi.2015.01.030] [Cited by in Crossref: 98] [Cited by in F6Publishing: 74] [Article Influence: 14.0] [Reference Citation Analysis]
234 Czaja AJ. Immune Inhibitory Properties and Therapeutic Prospects of Transforming Growth Factor-Beta and Interleukin 10 in Autoimmune Hepatitis. Dig Dis Sci 2021. [PMID: 33835375 DOI: 10.1007/s10620-021-06968-6] [Reference Citation Analysis]
235 Stone LC, Thorne LS, Weston CJ, Graham M, Hodges NJ. Cytoglobin expression in the hepatic stellate cell line HSC-T6 is regulated by extracellular matrix proteins dependent on FAK-signalling. Fibrogenesis Tissue Repair 2015;8:15. [PMID: 26300973 DOI: 10.1186/s13069-015-0032-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
236 Lu CH, Hou QR, Deng LF, Fei C, Xu WP, Zhang Q, Wu KM, Ning BF, Xie WF, Zhang X. MicroRNA-370 Attenuates Hepatic Fibrogenesis by Targeting Smoothened. Dig Dis Sci. 2015;60:2038-2048. [PMID: 25686745 DOI: 10.1007/s10620-015-3585-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
237 Milette S, Sicklick JK, Lowy AM, Brodt P. Molecular Pathways: Targeting the Microenvironment of Liver Metastases. Clin Cancer Res 2017;23:6390-9. [PMID: 28615370 DOI: 10.1158/1078-0432.CCR-15-1636] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 6.2] [Reference Citation Analysis]
238 Mußbach F, Ungefroren H, Günther B, Katenkamp K, Henklein P, Westermann M, Settmacher U, Lenk L, Sebens S, Müller JP, Böhmer FD, Kaufmann R. Proteinase-activated receptor 2 (PAR2) in hepatic stellate cells - evidence for a role in hepatocellular carcinoma growth in vivo. Mol Cancer 2016;15:54. [PMID: 27473374 DOI: 10.1186/s12943-016-0538-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
239 Chen Q, Chen L, Wu X, Zhang F, Jin H, Lu C, Shao J, Kong D, Wu L, Zheng S. Dihydroartemisinin prevents liver fibrosis in bile duct ligated rats by inducing hepatic stellate cell apoptosis through modulating the PI3K/Akt pathway: DHA Prevents Hepatic Fibrosis by Inducing HSC Apoptosis. IUBMB Life 2016;68:220-31. [DOI: 10.1002/iub.1478] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
240 Manojlovic Z, Stefanovic B. A novel role of RNA helicase A in regulation of translation of type I collagen mRNAs. RNA 2012;18:321-34. [PMID: 22190748 DOI: 10.1261/rna.030288.111] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 4.5] [Reference Citation Analysis]
241 Hsieh CC, Hung CH, Lu L, Qian S. Hepatic immune tolerance induced by hepatic stellate cells. World J Gastroenterol 2015; 21(42): 11887-11892 [PMID: 26576077 DOI: 10.3748/wjg.v21.i42.11887] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
242 Fathy M, Okabe M, M Othman E, Saad Eldien HM, Yoshida T. Preconditioning of Adipose-Derived Mesenchymal Stem-Like Cells with Eugenol Potentiates Their Migration and Proliferation In Vitro and Therapeutic Abilities in Rat Hepatic Fibrosis. Molecules 2020;25:E2020. [PMID: 32357508 DOI: 10.3390/molecules25092020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
243 Navarro-Corcuera A, López-Zabalza MJ, Martínez-Irujo JJ, Álvarez-Sola G, Ávila MA, Iraburu MJ, Ansorena E, Montiel-Duarte C. Role of AGAP2 in the profibrogenic effects induced by TGFβ in LX-2 hepatic stellate cells. Biochim Biophys Acta Mol Cell Res 2019;1866:673-85. [PMID: 30660615 DOI: 10.1016/j.bbamcr.2019.01.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
244 Sakata K, Eda S, Lee ES, Hara M, Imoto M, Kojima S. Neovessel formation promotes liver fibrosis via providing latent transforming growth factor-β. Biochem Biophys Res Commun. 2014;443:950-956. [PMID: 24361885 DOI: 10.1016/j.bbrc.2013.12.074] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
245 Brougham-Cook A, Jain I, Kukla DA, Masood F, Kimmel H, Ryoo H, Khetani SR, Underhill GH. High throughput interrogation of human liver stellate cells reveals microenvironmental regulation of phenotype. Acta Biomater 2021:S1742-7061(21)00756-X. [PMID: 34800715 DOI: 10.1016/j.actbio.2021.11.015] [Reference Citation Analysis]
246 Kasuya J, Sudo R, Masuda G, Mitaka T, Ikeda M, Tanishita K. Reconstruction of hepatic stellate cell-incorporated liver capillary structures in small hepatocyte tri-culture using microporous membranes. J Tissue Eng Regen Med 2015;9:247-56. [PMID: 23086892 DOI: 10.1002/term.1630] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
247 Xu X, Yu H, Sun L, Zheng C, Shan Y, Zhou Z, Wang C, Chen B. Adipose‑derived mesenchymal stem cells ameliorate dibutyltin dichloride‑induced chronic pancreatitis by inhibiting the PI3K/AKT/mTOR signaling pathway. Mol Med Rep 2020;21:1833-40. [PMID: 32319628 DOI: 10.3892/mmr.2020.10995] [Reference Citation Analysis]
248 Kordes C, Sawitza I, Götze S, Herebian D, Häussinger D. Hepatic stellate cells contribute to progenitor cells and liver regeneration. J Clin Invest. 2014;124:5503-5515. [PMID: 25401473 DOI: 10.1172/jci74119] [Cited by in Crossref: 112] [Cited by in F6Publishing: 63] [Article Influence: 14.0] [Reference Citation Analysis]
249 Page A, Paoli P, Moran Salvador E, White S, French J, Mann J. Hepatic stellate cell transdifferentiation involves genome-wide remodeling of the DNA methylation landscape. J Hepatol 2016;64:661-73. [PMID: 26632634 DOI: 10.1016/j.jhep.2015.11.024] [Cited by in Crossref: 69] [Cited by in F6Publishing: 65] [Article Influence: 9.9] [Reference Citation Analysis]
250 Luo J, Liang Y, Kong F, Qiu J, Liu X, Chen A, Luxon BA, Wu HW, Wang Y. Vascular endothelial growth factor promotes the activation of hepatic stellate cells in chronic schistosomiasis. Immunol Cell Biol 2017;95:399-407. [DOI: 10.1038/icb.2016.109] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
251 Bruschi FV, Claudel T, Tardelli M, Caligiuri A, Stulnig TM, Marra F, Trauner M. The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells. Hepatology 2017;65:1875-90. [PMID: 28073161 DOI: 10.1002/hep.29041] [Cited by in Crossref: 103] [Cited by in F6Publishing: 103] [Article Influence: 20.6] [Reference Citation Analysis]
252 Bian EB, Huang C, Wang H, Chen XX, Tao H, Zhang L, Lv XW, Li J. The role of methyl-CpG binding protein 2 in liver fibrosis. Toxicology 2013;309:9-14. [PMID: 23619607 DOI: 10.1016/j.tox.2013.04.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
253 Ji J, Yu F, Ji Q, Li Z, Wang K, Zhang J, Lu J, Chen L, E Q, Zeng Y. Comparative proteomic analysis of rat hepatic stellate cell activation: a comprehensive view and suppressed immune response. Hepatology. 2012;56:332-349. [PMID: 22331624 DOI: 10.1002/hep.25650] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
254 Eichmann TO, Grumet L, Taschler U, Hartler J, Heier C, Woblistin A, Pajed L, Kollroser M, Rechberger G, Thallinger GG, Zechner R, Haemmerle G, Zimmermann R, Lass A. ATGL and CGI-58 are lipid droplet proteins of the hepatic stellate cell line HSC-T6. J Lipid Res 2015;56:1972-84. [PMID: 26330055 DOI: 10.1194/jlr.M062372] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
255 Meli R, Mattace Raso G, Calignano A. Role of innate immune response in non-alcoholic Fatty liver disease: metabolic complications and therapeutic tools. Front Immunol 2014;5:177. [PMID: 24795720 DOI: 10.3389/fimmu.2014.00177] [Cited by in Crossref: 78] [Cited by in F6Publishing: 74] [Article Influence: 9.8] [Reference Citation Analysis]
256 Wang R, Ding Q, De Assuncao TM, Mounajjed T, Maiers JL, Dou C, Cao S, Yaqoob U, Huebert RC, Shah VH. Hepatic Stellate Cell Selective Disruption of Dynamin-2 GTPase Increases Murine Fibrogenesis through Up-Regulation of Sphingosine-1 Phosphate-Induced Cell Migration. Am J Pathol 2017;187:134-45. [PMID: 27840081 DOI: 10.1016/j.ajpath.2016.09.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
257 Tanikawa AA, Grotto RM, Silva GF, Ferrasi AC, Sarnighausen VC, Pardini MI. Platelet-derived growth factor A mRNA in platelets is associated with the degree of hepatic fibrosis in chronic hepatitis C. Rev Soc Bras Med Trop 2017;50:113-6. [PMID: 28327812 DOI: 10.1590/0037-8682-0302-2016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
258 Gressner OA. About coffee, cappuccino and connective tissue growth factor-Or how to protect your liver!? Environ Toxicol Pharmacol 2009;28:1-10. [PMID: 21783975 DOI: 10.1016/j.etap.2009.02.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
259 Shetty S, Lalor PF, Adams DH. Lymphocyte recruitment to the liver: molecular insights into the pathogenesis of liver injury and hepatitis. Toxicology 2008;254:136-46. [PMID: 18775762 DOI: 10.1016/j.tox.2008.08.003] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 3.0] [Reference Citation Analysis]
260 Chen Y, Fan Y, Guo DY, Xu B, Shi XY, Li JT, Duan LF. Study on the relationship between hepatic fibrosis and epithelial-mesenchymal transition in intrahepatic cells. Biomed Pharmacother 2020;129:110413. [PMID: 32570119 DOI: 10.1016/j.biopha.2020.110413] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
261 Li Y, Wang J, Asahina K. Mesothelial cells give rise to hepatic stellate cells and myofibroblasts via mesothelial-mesenchymal transition in liver injury. Proc Natl Acad Sci USA. 2013;110:2324-2329. [PMID: 23345421 DOI: 10.1073/pnas.1214136110] [Cited by in Crossref: 129] [Cited by in F6Publishing: 113] [Article Influence: 14.3] [Reference Citation Analysis]
262 Xu Y, Chen J, Jiang W, Zhao Y, Yang C, Wu Y, Li Q, Zhu C. Multiplexing Nanodrug Ameliorates Liver Fibrosis via ROS Elimination and Inflammation Suppression. Small 2021;:e2102848. [PMID: 34758098 DOI: 10.1002/smll.202102848] [Reference Citation Analysis]
263 Akbari S, Arslan N, Senturk S, Erdal E. Next-Generation Liver Medicine Using Organoid Models. Front Cell Dev Biol 2019;7:345. [PMID: 31921856 DOI: 10.3389/fcell.2019.00345] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
264 Weiskirchen R, Weimer J, Meurer SK, Kron A, Seipel B, Vater I, Arnold N, Siebert R, Xu L, Friedman SL, Bergmann C. Genetic characteristics of the human hepatic stellate cell line LX-2. PLoS One 2013;8:e75692. [PMID: 24116068 DOI: 10.1371/journal.pone.0075692] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
265 Nguyen DG, Funk J, Robbins JB, Crogan-Grundy C, Presnell SC, Singer T, Roth AB. Bioprinted 3D Primary Liver Tissues Allow Assessment of Organ-Level Response to Clinical Drug Induced Toxicity In Vitro. PLoS One 2016;11:e0158674. [PMID: 27387377 DOI: 10.1371/journal.pone.0158674] [Cited by in Crossref: 194] [Cited by in F6Publishing: 173] [Article Influence: 32.3] [Reference Citation Analysis]
266 Shi Y, Guo L, Shi L, Yu J, Song M, Li Y. Caffeic Acid Phenethyl Ester inhibit Hepatic Fibrosis by Nitric Oxide Synthase and Cystathionine Gamma-Lyase in Rats. Med Sci Monit. 2015;21:2774-2780. [PMID: 26378818 DOI: 10.12659/msm.895272] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
267 Huang SC, Kuo PC, Hung HY, Pan TL, Chen FA, Wu TS. Ionone Derivatives from the Mycelium of Phellinus linteus and the Inhibitory Effect on Activated Rat Hepatic Stellate Cells. Int J Mol Sci 2016;17:E681. [PMID: 27164091 DOI: 10.3390/ijms17050681] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
268 Miyazoe Y, Miuma S, Miyaaki H, Kanda Y, Nakashiki S, Sasaki R, Haraguchi M, Shibata H, Honda T, Taura N, Nakao K. Extracellular vesicles from senescent hepatic stellate cells promote cell viability of hepatoma cells through increasing EGF secretion from differentiated THP-1 cells. Biomed Rep 2020;12:163-70. [PMID: 32190304 DOI: 10.3892/br.2020.1279] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
269 Gentilini A, Pastore M, Marra F, Raggi C. The Role of Stroma in Cholangiocarcinoma: The Intriguing Interplay between Fibroblastic Component, Immune Cell Subsets and Tumor Epithelium. Int J Mol Sci. 2018;19. [PMID: 30249019 DOI: 10.3390/ijms19102885] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
270 Kukla DA, Khetani SR. Bioengineered Liver Models for Investigating Disease Pathogenesis and Regenerative Medicine. Semin Liver Dis 2021;41:368-92. [PMID: 34139785 DOI: 10.1055/s-0041-1731016] [Reference Citation Analysis]
271 Yokomori H, Ando W, Oda M. Cavin-1 is linked to lipid droplet formation in human hepatic stellate cells. Med Mol Morphol 2020;53:56-9. [PMID: 30877476 DOI: 10.1007/s00795-019-00219-4] [Reference Citation Analysis]
272 Larson EL, Joo DJ, Nelson ED, Amiot BP, Aravalli RN, Nyberg SL. Fumarylacetoacetate hydrolase gene as a knockout target for hepatic chimerism and donor liver production. Stem Cell Reports 2021;16:2577-88. [PMID: 34678209 DOI: 10.1016/j.stemcr.2021.09.018] [Reference Citation Analysis]
273 Bitencourt S, de Mesquita FC, Caberlon E, da Silva GV, Basso BS, Ferreira GA, de Oliveira JR. Capsaicin induces de-differentiation of activated hepatic stellate cell. Biochem Cell Biol 2012;90:683-90. [DOI: 10.1139/o2012-026] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
274 Arauz J, Zarco N, Hernández-Aquino E, Galicia-Moreno M, Favari L, Segovia J, Muriel P. Coffee consumption prevents fibrosis in a rat model that mimics secondary biliary cirrhosis in humans. Nutr Res 2017;40:65-74. [PMID: 28473062 DOI: 10.1016/j.nutres.2017.03.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
275 Wang Y, Zhang X, Yang Y, Yang X, Ye B. Study on the Antifibrotic Effects of Recombinant Shark Hepatical Stimulator Analogue (r-sHSA) in Vitro and in Vivo. Mar Drugs 2015;13:5201-18. [PMID: 26295240 DOI: 10.3390/md13085201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
276 Xu T, Ni MM, Xing-Li, Li XF, Meng XM, Huang C, Li J. NLRC5 regulates TGF-β1-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis. Int J Biochem Cell Biol 2016;70:92-104. [PMID: 26592197 DOI: 10.1016/j.biocel.2015.11.010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
277 Wilson CL, Mann J, Walsh M, Perrugoria MJ, Oakley F, Wright MC, Brignole C, Di Paolo D, Perri P, Ponzoni M, Karin M, Mann DA. Quiescent hepatic stellate cells functionally contribute to the hepatic innate immune response via TLR3. PLoS One 2014;9:e83391. [PMID: 24416163 DOI: 10.1371/journal.pone.0083391] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
278 Bae M, Lee Y, Park YK, Shin DG, Joshi P, Hong SH, Alder N, Koo SI, Lee JY. Astaxanthin attenuates the increase in mitochondrial respiration during the activation of hepatic stellate cells. J Nutr Biochem 2019;71:82-9. [PMID: 31302374 DOI: 10.1016/j.jnutbio.2019.06.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
279 Hasegawa D, Wallace MC, Friedman SL. Stellate Cells and Hepatic Fibrosis. Stellate Cells in Health and Disease. Elsevier; 2015. pp. 41-62. [DOI: 10.1016/b978-0-12-800134-9.00004-x] [Cited by in Crossref: 7] [Article Influence: 1.0] [Reference Citation Analysis]
280 Castro-Gil MP, Torres-Mena JE, Salgado RM, Muñoz-Montero SA, Martínez-Garcés JM, López-Torres CD, Mendoza-Vargas A, Gabiño-López NB, Villa-Treviño S, Del Pozo-Yauner L, Arellanes-Robledo J, Krötzsch E, Pérez-Carreón JI. The transcriptome of early GGT/KRT19-positive hepatocellular carcinoma reveals a downregulated gene expression profile associated with fatty acid metabolism. Genomics 2021;114:72-83. [PMID: 34861383 DOI: 10.1016/j.ygeno.2021.11.035] [Reference Citation Analysis]
281 Perez Aguilar RC, Honoré SM, Genta SB, Sánchez SS. Hepatic fibrogenesis and transforming growth factor/Smad signaling activation in rats chronically exposed to low doses of lead. J Appl Toxicol. 2014;34:1320-1331. [PMID: 25493318 DOI: 10.1002/jat.2955] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
282 Tsilimigras DI, Brodt P, Clavien PA, Muschel RJ, D'Angelica MI, Endo I, Parks RW, Doyle M, de Santibañes E, Pawlik TM. Liver metastases. Nat Rev Dis Primers 2021;7:27. [PMID: 33859205 DOI: 10.1038/s41572-021-00261-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
283 Miyoshi M, Kakinuma S, Kamiya A, Tsunoda T, Tsuchiya J, Sato A, Kaneko S, Nitta S, Kawai-Kitahata F, Murakawa M, Itsui Y, Nakagawa M, Azuma S, Nakauchi H, Asahina Y, Watanabe M. LIM homeobox 2 promotes interaction between human iPS-derived hepatic progenitors and iPS-derived hepatic stellate-like cells. Sci Rep 2019;9:2072. [PMID: 30765795 DOI: 10.1038/s41598-018-37430-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
284 Friedman SL, Nieto N. Cannabinoids provoke alcoholic steatosis through a conspiracy of neighbors. Cell Metab 2008;7:187-8. [PMID: 18316020 DOI: 10.1016/j.cmet.2008.02.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
285 Zhu Y, Men R, Wen M, Hu X, Liu X, Yang L. Blockage of TRPM7 channel induces hepatic stellate cell death through endoplasmic reticulum stress-mediated apoptosis. Life Sciences 2014;94:37-44. [DOI: 10.1016/j.lfs.2013.10.030] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
286 Huang J, Yu X, Fries JW, Zhang L, Odenthal M. MicroRNA function in the profibrogenic interplay upon chronic liver disease. Int J Mol Sci 2014;15:9360-71. [PMID: 24871365 DOI: 10.3390/ijms15069360] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
287 Abel T, El Filali E, Waern J, Schneider IC, Yuan Q, Münch RC, Hick M, Warnecke G, Madrahimov N, Kontermann RE, Schüttrumpf J, Müller UC, Seppen J, Ott M, Buchholz CJ. Specific gene delivery to liver sinusoidal and artery endothelial cells. Blood 2013;122:2030-8. [PMID: 23884859 DOI: 10.1182/blood-2012-11-468579] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
288 Aller MA, Arias N, Peral I, García-Higarza S, Arias JL, Arias J. Embrionary way to create a fatty liver in portal hypertension. World J Gastrointest Pathophysiol 2017; 8(2): 39-50 [PMID: 28573066 DOI: 10.4291/wjgp.v8.i2.39] [Reference Citation Analysis]
289 Kostallari E, Shah VH. Pericytes in the Liver. Adv Exp Med Biol 2019;1122:153-67. [PMID: 30937868 DOI: 10.1007/978-3-030-11093-2_9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
290 Cai S, Cheng X, Chen P, Pan X, Xu T, Huang C, Meng X, Li J. Transmembrane protein 88 attenuates liver fibrosis by promoting apoptosis and reversion of activated hepatic stellate cells. Molecular Immunology 2016;80:58-67. [DOI: 10.1016/j.molimm.2016.11.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
291 Devi P, Khan A, Chattopadhyay P, Mehta P, Sahni S, Sharma S, Pandey R. Co-infections as Modulators of Disease Outcome: Minor Players or Major Players? Front Microbiol 2021;12:664386. [PMID: 34295314 DOI: 10.3389/fmicb.2021.664386] [Reference Citation Analysis]
292 Li G, Zhu Y, Shao D, Chang H, Zhang X, Zhou D, Gao Y, Lan K, Deng Q. Recombinant covalently closed circular DNA of hepatitis B virus induces long-term viral persistence with chronic hepatitis in a mouse model. Hepatology 2018;67:56-70. [DOI: 10.1002/hep.29406] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
293 Reetz J, Genz B, Meier C, Kowtharapu BS, Timm F, Vollmar B, Herchenröder O, Abshagen K, Pützer BM. Development of Adenoviral Delivery Systems to Target Hepatic Stellate Cells In Vivo. PLoS One 2013;8:e67091. [PMID: 23825626 DOI: 10.1371/journal.pone.0067091] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
294 Cai FF, Wu R, Song YN, Xiong AZ, Chen XL, Yang MD, Yang L, Hu Y, Sun MY, Su SB. Yinchenhao Decoction Alleviates Liver Fibrosis by Regulating Bile Acid Metabolism and TGF-β/Smad/ERK Signalling Pathway. Sci Rep 2018;8:15367. [PMID: 30337590 DOI: 10.1038/s41598-018-33669-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
295 Akil A, Endsley M, Shanmugam S, Saldarriaga O, Somasunderam A, Spratt H, Stevenson HL, Utay NS, Ferguson M, Yi M. Fibrogenic Gene Expression in Hepatic Stellate Cells Induced by HCV and HIV Replication in a Three Cell Co-Culture Model System. Sci Rep 2019;9:568. [PMID: 30679661 DOI: 10.1038/s41598-018-37071-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
296 Jia Z, Zhao C, Wang M, Zhao X, Zhang W, Han T, Xia Q, Han Z, Lin R, Li X. Hepatotoxicity assessment of Rhizoma Paridis in adult zebrafish through proteomes and metabolome. Biomedicine & Pharmacotherapy 2020;121:109558. [DOI: 10.1016/j.biopha.2019.109558] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
297 Choi JS, Kim JK, Yang YJ, Kim Y, Kim P, Park SG, Cho EY, Lee DH, Choi JW. Identification of cromolyn sodium as an anti-fibrotic agent targeting both hepatocytes and hepatic stellate cells. Pharmacol Res 2015;102:176-83. [PMID: 26453959 DOI: 10.1016/j.phrs.2015.10.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
298 Ruan Q, Wang H, Burke LJ, Bridle KR, Li X, Zhao CX, Crawford DHG, Roberts MS, Liang X. Therapeutic modulators of hepatic stellate cells for hepatocellular carcinoma. Int J Cancer 2020;147:1519-27. [PMID: 32010970 DOI: 10.1002/ijc.32899] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
299 Yin C, Evason KJ, Asahina K, Stainier DY. Hepatic stellate cells in liver development, regeneration, and cancer. J Clin Invest. 2013;123:1902-1910. [PMID: 23635788 DOI: 10.1172/jci66369] [Cited by in Crossref: 363] [Cited by in F6Publishing: 213] [Article Influence: 40.3] [Reference Citation Analysis]
300 Chang J, Hisamatsu T, Shimamura K, Yoneno K, Adachi M, Naruse H, Igarashi T, Higuchi H, Matsuoka K, Kitazume MT. Activated hepatic stellate cells mediate the differentiation of macrophages. Hepatol Res. 2013;43:658-669. [PMID: 23107150 DOI: 10.1111/j.1872-034x.2012.01111.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
301 Suh YG, Jeong WI. Hepatic stellate cells and innate immunity in alcoholic liver disease. World J Gastroenterol 2011; 17(20): 2543-2551 [PMID: 21633659 DOI: 10.3748/wjg.v17.i20.2543] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
302 Lu C, Xu W, Shao J, Zhang F, Chen A, Zheng S. Nrf2 induces lipocyte phenotype via a SOCS3-dependent negative feedback loop on JAK2/STAT3 signaling in hepatic stellate cells. International Immunopharmacology 2017;49:203-11. [DOI: 10.1016/j.intimp.2017.06.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
303 Kühnl J, Tao TP, Brandmair K, Gerlach S, Rings T, Müller-Vieira U, Przibilla J, Genies C, Jaques-Jamin C, Schepky A, Marx U, Hewitt NJ, Maschmeyer I. Characterization of application scenario-dependent pharmacokinetics and pharmacodynamic properties of permethrin and hyperforin in a dynamic skin and liver multi-organ-chip model. Toxicology 2021;448:152637. [PMID: 33220337 DOI: 10.1016/j.tox.2020.152637] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
304 Gonçalves LR, de Oliveira da Silva B, Scarinci LD, Ramos LF, Moraes KC. MicroRNA-1254 contributes to the controlling of pro-fibrogenic environment in LX-2 cells by modulating SMAD3 and wound repair: new insights in hepatic fibrosis: MicroRNA-1254 contributes to the controlling of pro-fibrogenic environment. Cell Biol Int 2019;43:333-43. [DOI: 10.1002/cbin.11075] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
305 Wu X, Wu X, Ma Y, Shao F, Tan Y, Tan T, Gu L, Zhou Y, Sun B, Sun Y. CUG-binding protein 1 regulates HSC activation and liver fibrogenesis. Nat Commun. 2016;7:13498. [PMID: 27853137 DOI: 10.1038/ncomms13498] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 6.3] [Reference Citation Analysis]
306 Marchyshak T, Yakovenko T, Shmarakov I, Tkachuk Z. The Potential Protective Effect of Oligoribonucleotides-d-Mannitol Complexes against Thioacetamide-Induced Hepatotoxicity in Mice. Pharmaceuticals (Basel) 2018;11:E77. [PMID: 30082619 DOI: 10.3390/ph11030077] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
307 Zhang K, Zhang YQ, Ai WB, Hu QT, Zhang QJ, Wan LY, Wang XL, Liu CB, Wu JF. Hes1, an important gene for activation of hepatic stellate cells, is regulated by Notch1 and TGF-β/BMP signaling. World J Gastroenterol 2015; 21(3): 878-887 [PMID: 25624721 DOI: 10.3748/wjg.v21.i3.878] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
308 Buniatian GH, Weiskirchen R, Weiss TS, Schwinghammer U, Fritz M, Seferyan T, Proksch B, Glaser M, Lourhmati A, Buadze M, Borkham-Kamphorst E, Gaunitz F, Gleiter CH, Lang T, Schaeffeler E, Tremmel R, Cynis H, Frey WH 2nd, Gebhardt R, Friedman SL, Mikulits W, Schwab M, Danielyan L. Antifibrotic Effects of Amyloid-Beta and Its Loss in Cirrhotic Liver. Cells 2020;9:E452. [PMID: 32089540 DOI: 10.3390/cells9020452] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
309 Sauvant P, Cansell M, Atgié C. Vitamin A and lipid metabolism: relationship between hepatic stellate cells (HSCs) and adipocytes. J Physiol Biochem. 2011;67:487-496. [PMID: 21626400 DOI: 10.1007/s13105-011-0101-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
310 Riaz F, Chen Q, Lu K, Osoro EK, Wu L, Feng L, Zhao R, Yang L, Zhou Y, He Y, Zhu L, Du X, Sadiq M, Yang X, Li D. Inhibition of miR-188-5p alleviates hepatic fibrosis by significantly reducing the activation and proliferation of HSCs through PTEN/PI3K/AKT pathway. J Cell Mol Med 2021;25:4073-87. [PMID: 33689215 DOI: 10.1111/jcmm.16376] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
311 Mannaerts I, Thoen LFR, Eysackers N, Cubero FJ, Batista Leite S, Coldham I, Colle I, Trautwein C, van Grunsven LA. Unfolded protein response is an early, non-critical event during hepatic stellate cell activation. Cell Death Dis 2019;10:98. [PMID: 30718473 DOI: 10.1038/s41419-019-1327-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
312 Yang S, Tian Z, Wu Y, van Velkinburgh JC, Ni B. Pivotal roles of ILCs in hepatic diseases. Int Rev Immunol. 2015;34:509-522. [PMID: 25730441 DOI: 10.3109/08830185.2015.1008631] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
313 Trasino SE, Tang XH, Jessurun J, Gudas LJ. A retinoic acid receptor β2 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease. J Mol Med (Berl) 2016;94:1143-51. [PMID: 27271256 DOI: 10.1007/s00109-016-1434-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
314 Geevarghese A, Herman IM. Pericyte-endothelial crosstalk: implications and opportunities for advanced cellular therapies. Transl Res 2014;163:296-306. [PMID: 24530608 DOI: 10.1016/j.trsl.2014.01.011] [Cited by in Crossref: 110] [Cited by in F6Publishing: 112] [Article Influence: 13.8] [Reference Citation Analysis]
315 Friedman SL. Clarity and Challenges in Tissue Fibrosis. In: Nakao K, Minato N, Uemoto S, editors. Innovative Medicine. Tokyo: Springer Japan; 2015. pp. 187-94. [DOI: 10.1007/978-4-431-55651-0_16] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
316 Ding N, Hah N, Yu RT, Sherman MH, Benner C, Leblanc M, He M, Liddle C, Downes M, Evans RM. BRD4 is a novel therapeutic target for liver fibrosis. Proc Natl Acad Sci U S A 2015;112:15713-8. [PMID: 26644586 DOI: 10.1073/pnas.1522163112] [Cited by in Crossref: 105] [Cited by in F6Publishing: 101] [Article Influence: 15.0] [Reference Citation Analysis]
317 Cannito S, Novo E, di Bonzo LV, Busletta C, Colombatto S, Parola M. Epithelial-mesenchymal transition: from molecular mechanisms, redox regulation to implications in human health and disease. Antioxid Redox Signal. 2010;12:1383-1430. [PMID: 19903090 DOI: 10.1089/ars.2009.2737] [Cited by in Crossref: 156] [Cited by in F6Publishing: 159] [Article Influence: 13.0] [Reference Citation Analysis]
318 Ceni E, Mello T, Polvani S, Vasseur-Cognet M, Tarocchi M, Tempesti S, Cavalieri D, Beltrame L, Marroncini G, Pinzani M, Milani S, Galli A. The orphan nuclear receptor COUP-TFII coordinates hypoxia-independent proangiogenic responses in hepatic stellate cells. J Hepatol 2017;66:754-64. [PMID: 27866920 DOI: 10.1016/j.jhep.2016.11.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
319 Ogawa Y, Imajo K, Honda Y, Kessoku T, Tomeno W, Kato S, Fujita K, Yoneda M, Saito S, Saigusa Y, Hyogo H, Sumida Y, Itoh Y, Eguchi K, Yamanaka T, Wada K, Nakajima A. Palmitate-induced lipotoxicity is crucial for the pathogenesis of nonalcoholic fatty liver disease in cooperation with gut-derived endotoxin. Sci Rep 2018;8:11365. [PMID: 30054551 DOI: 10.1038/s41598-018-29735-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 8.3] [Reference Citation Analysis]
320 Ghafoory S, Varshney R, Robison T, Kouzbari K, Woolington S, Murphy B, Xia L, Ahamed J. Platelet TGF-β1 deficiency decreases liver fibrosis in a mouse model of liver injury. Blood Adv 2018;2:470-80. [PMID: 29490978 DOI: 10.1182/bloodadvances.2017010868] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
321 Leone A, Battezzati A, Bedogni G, Vignati L, Vanzulli A, De Amicis R, Foppiani A, Bertoli S. Sex- and Age-Related Differences in the Contribution of Ultrasound-Measured Visceral and Subcutaneous Abdominal Fat to Fatty Liver Index in Overweight and Obese Caucasian Adults. Nutrients 2019;11:E3008. [PMID: 31835303 DOI: 10.3390/nu11123008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
322 Basaranoglu M, Basaranoglu G, Sentürk H. From fatty liver to fibrosis: A tale of “second hit”. World J Gastroenterol 2013; 19(8): 1158-1165 [PMID: 23483818 DOI: 10.3748/wjg.v19.i8.1158] [Cited by in CrossRef: 100] [Cited by in F6Publishing: 96] [Article Influence: 11.1] [Reference Citation Analysis]
323 Kato H, Duarte S, Miller MG, Busuttil RW, Coito AJ. Overproduction of Tenascin-C Driven by Lipid Accumulation in the Liver Aggravates Hepatic Ischemia/Reperfusion Injury in Steatotic Mice. Liver Transpl 2019;25:288-301. [PMID: 30358115 DOI: 10.1002/lt.25365] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
324 Kurdi A, Hassan K, Venkataraman B, Rajesh M. Nootkatone confers hepatoprotective and anti-fibrotic actions in a murine model of liver fibrosis by suppressing oxidative stress, inflammation, and apoptosis. J Biochem Mol Toxicol 2018;32:e22017. [DOI: 10.1002/jbt.22017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
325 Nissim O, Melis M, Diaz G, Kleiner DE, Tice A, Fantola G, Zamboni F, Mishra L, Farci P. Liver regeneration signature in hepatitis B virus (HBV)-associated acute liver failure identified by gene expression profiling. PLoS One. 2012;7:e49611. [PMID: 23185381 DOI: 10.1371/journal.pone.0049611.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
326 Tabernilla A, Dos Santos Rodrigues B, Pieters A, Caufriez A, Leroy K, Van Campenhout R, Cooreman A, Gomes AR, Arnesdotter E, Gijbels E, Vinken M. In Vitro Liver Toxicity Testing of Chemicals: A Pragmatic Approach. Int J Mol Sci 2021;22:5038. [PMID: 34068678 DOI: 10.3390/ijms22095038] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
327 Liu X, Mi X, Wang Z, Zhang M, Hou J, Jiang S, Wang Y, Chen C, Li W. Ginsenoside Rg3 promotes regression from hepatic fibrosis through reducing inflammation-mediated autophagy signaling pathway. Cell Death Dis 2020;11:454. [PMID: 32532964 DOI: 10.1038/s41419-020-2597-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
328 Song J, Han X, Yao Y, Li Y, Zhang J, Shao D, Hou L, Fan Y, Song S, Lian L, Nan J, Wu Y. Acanthoic acid suppresses lipin1/2 via TLR4 and IRAK4 signalling pathways in EtOH- and lipopolysaccharide-induced hepatic lipogenesis. Journal of Pharmacy and Pharmacology 2018;70:393-403. [DOI: 10.1111/jphp.12877] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
329 Yang HY, Kim KS, Lee YH, Park JH, Kim JH, Lee SY, Kim YM, Kim IS, Kacew S, Lee BM, Kwak JH, Yoon K, Kim HS. Dendropanax morbifera Ameliorates Thioacetamide-Induced Hepatic Fibrosis via TGF-β1/Smads Pathways. Int J Biol Sci 2019;15:800-11. [PMID: 30906211 DOI: 10.7150/ijbs.30356] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
330 Heinrichs D, Knauel M, Offermanns C, Berres ML, Nellen A, Leng L, Schmitz P, Bucala R, Trautwein C, Weber C. Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74. Proc Natl Acad Sci U S A. 2011;108:17444-17449. [PMID: 21969590 DOI: 10.1073/pnas.1107023108] [Cited by in Crossref: 80] [Cited by in F6Publishing: 83] [Article Influence: 7.3] [Reference Citation Analysis]
331 Zhang M, Wang Y, Zhu G, Sun C, Wang J. Hepatoprotective effect and possible mechanism of phytoestrogen calycosin on carbon tetrachloride-induced liver fibrosis in mice. Naunyn Schmiedebergs Arch Pharmacol 2021;394:189-204. [PMID: 32474674 DOI: 10.1007/s00210-020-01891-5] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
332 Chiang DJ, Pritchard MT, Nagy LE. Obesity, diabetes mellitus, and liver fibrosis. Am J Physiol Gastrointest Liver Physiol. 2011;300:G697-G702. [PMID: 21350183 DOI: 10.1152/ajpgi.00426.2010] [Cited by in Crossref: 106] [Cited by in F6Publishing: 100] [Article Influence: 9.6] [Reference Citation Analysis]
333 Shi Z, Ren M, Rockey DC. Myocardin and myocardin-related transcription factor-A synergistically mediate actin cytoskeletal-dependent inhibition of liver fibrogenesis. Am J Physiol Gastrointest Liver Physiol 2020;318:G504-17. [PMID: 31928221 DOI: 10.1152/ajpgi.00302.2019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
334 Choi SS, Omenetti A, Witek RP, Moylan CA, Syn WK, Jung Y, Yang L, Sudan DL, Sicklick JK, Michelotti GA. Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis. Am J Physiol Gastrointest Liver Physiol. 2009;297:G1093-G1106. [PMID: 19815628 DOI: 10.1152/ajpgi.00292.2009] [Cited by in Crossref: 154] [Cited by in F6Publishing: 159] [Article Influence: 11.8] [Reference Citation Analysis]
335 Sitanggang EJ, Antarianto RD, Jusman SWA, Pawitan JA, Jusuf AA. Bone Marrow Stem Cells Anti-liver Fibrosis Potency: Inhibition of Hepatic Stellate Cells Activity and Extracellular Matrix Deposition. Int J Stem Cells 2017;10:69-75. [PMID: 28531915 DOI: 10.15283/ijsc16048] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
336 Bansal R, Prakash J, De Ruiter M, Poelstra K. Targeted recombinant fusion proteins of IFNγ and mimetic IFNγ with PDGFβR bicyclic peptide inhibits liver fibrogenesis in vivo. PLoS One 2014;9:e89878. [PMID: 24587093 DOI: 10.1371/journal.pone.0089878] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
337 Chen X, Tang Y, Chen S, Ling W, Wang Q. IGFBP-2 as a biomarker in NAFLD improves hepatic steatosis: an integrated bioinformatics and experimental study. Endocr Connect 2021;10:1315-25. [PMID: 34524971 DOI: 10.1530/EC-21-0353] [Reference Citation Analysis]
338 Wijesundera KK, Juniantito V, Golbar HM, Fujisawa K, Tanaka M, Ichikawa C, Izawa T, Kuwamura M, Yamate J. Expressions of Iba1 and galectin-3 (Gal-3) in thioacetamide (TAA)-induced acute rat liver lesions. Exp Toxicol Pathol. 2013;65:799-808. [PMID: 23265716 DOI: 10.1016/j.etp.2012.11.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
339 Vera-Ramirez L, Pérez-Lopez P, Varela-Lopez A, Ramirez-Tortosa M, Battino M, Quiles JL. Curcumin and liver disease. Biofactors. 2013;39:88-100. [PMID: 23303639 DOI: 10.1002/biof.1057] [Cited by in Crossref: 75] [Cited by in F6Publishing: 61] [Article Influence: 8.3] [Reference Citation Analysis]
340 Sunami Y, von Figura G, Kleger A, Strnad P, Hüser N, Hartmann D. The role of telomeres in liver disease. Prog Mol Biol Transl Sci 2014;125:159-72. [PMID: 24993702 DOI: 10.1016/B978-0-12-397898-1.00007-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
341 DeSantis DA, Ko CW, Wang L, Lee P, Croniger CM. Constitutive Activation of the Nlrc4 Inflammasome Prevents Hepatic Fibrosis and Promotes Hepatic Regeneration after Partial Hepatectomy. Mediators Inflamm 2015;2015:909827. [PMID: 26635450 DOI: 10.1155/2015/909827] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
342 Erkan M, Weis N, Pan Z, Schwager C, Samkharadze T, Jiang X, Wirkner U, Giese NA, Ansorge W, Debus J. Organ-, inflammation- and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cells. Mol Cancer. 2010;9:88. [PMID: 20416094 DOI: 10.1186/1476-4598-9-88] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 5.3] [Reference Citation Analysis]
343 Khadrawy SM, Mohamed HM, Mahmoud AM. Mesenchymal stem cells ameliorate oxidative stress, inflammation, and hepatic fibrosis via Nrf2/HO-1 signaling pathway in rats. Environ Sci Pollut Res Int 2021;28:2019-30. [PMID: 32865681 DOI: 10.1007/s11356-020-10637-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
344 Schreiber R, Taschler U, Preiss-Landl K, Wongsiriroj N, Zimmermann R, Lass A. Retinyl ester hydrolases and their roles in vitamin A homeostasis. Biochim Biophys Acta 2012;1821:113-23. [PMID: 21586336 DOI: 10.1016/j.bbalip.2011.05.001] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
345 Ramachandran P, Iredale JP. Reversibility of liver fibrosis. Ann Hepatol. 2009;8:283-291. [PMID: 20009126 DOI: 10.1016/s1665-2681(19)31740-5] [Cited by in Crossref: 69] [Cited by in F6Publishing: 1] [Article Influence: 5.8] [Reference Citation Analysis]
346 Seki E, De Minicis S, Gwak GY, Kluwe J, Inokuchi S, Bursill CA, Llovet JM, Brenner DA, Schwabe RF. CCR1 and CCR5 promote hepatic fibrosis in mice. J Clin Invest. 2009;119:1858-1870. [PMID: 19603542 DOI: 10.1172/jci37444] [Cited by in Crossref: 43] [Cited by in F6Publishing: 187] [Article Influence: 3.3] [Reference Citation Analysis]
347 Maharjan S, Bonilla D, Sindurakar P, Li H, Li W, Duarte S, Zarrinpar A, Zhang YS. 3D human nonalcoholic hepatic steatosis and fibrosis models. Bio-des Manuf 2021;4:157-70. [DOI: 10.1007/s42242-020-00121-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
348 Grumet L, Taschler U, Lass A. Hepatic Retinyl Ester Hydrolases and the Mobilization of Retinyl Ester Stores. Nutrients 2016;9:E13. [PMID: 28035980 DOI: 10.3390/nu9010013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
349 Wen M, Men R, Liu X, Yang L. Involvement of miR-30c in hepatic stellate cell activation through the repression of plasminogen activator inhibitor-1. Life Sciences 2016;155:21-8. [DOI: 10.1016/j.lfs.2016.04.034] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
350 Cui X, Dang S, Wang Y, Chen Y, Zhou J, Shen C, Kuang Y, Fei J, Lu L, Wang Z. Retinol dehydrogenase 13 deficiency diminishes carbon tetrachloride-induced liver fibrosis in mice. Toxicol Lett 2017;265:17-22. [PMID: 27865848 DOI: 10.1016/j.toxlet.2016.11.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
351 Coll M, El Taghdouini A, Perea L, Mannaerts I, Vila-Casadesús M, Blaya D, Rodrigo-Torres D, Affò S, Morales-Ibanez O, Graupera I, Lozano JJ, Najimi M, Sokal E, Lambrecht J, Ginès P, van Grunsven LA, Sancho-Bru P. Integrative miRNA and Gene Expression Profiling Analysis of Human Quiescent Hepatic Stellate Cells. Sci Rep 2015;5:11549. [PMID: 26096707 DOI: 10.1038/srep11549] [Cited by in Crossref: 60] [Cited by in F6Publishing: 59] [Article Influence: 8.6] [Reference Citation Analysis]
352 Stratton MS, Haldar SM, McKinsey TA. BRD4 inhibition for the treatment of pathological organ fibrosis. F1000Res 2017;6:F1000 Faculty Rev-1015. [PMID: 28721198 DOI: 10.12688/f1000research.11339.1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
353 Bocca C, Novo E, Miglietta A, Parola M. Angiogenesis and Fibrogenesis in Chronic Liver Diseases. Cell Mol Gastroenterol Hepatol 2015;1:477-88. [PMID: 28210697 DOI: 10.1016/j.jcmgh.2015.06.011] [Cited by in Crossref: 66] [Cited by in F6Publishing: 61] [Article Influence: 9.4] [Reference Citation Analysis]
354 Abdel Fattah NS, Ahmed NS. Evidence of intra-hepatic vascular proliferation remodeling early after cure in experimental schistosomiasis mansoni: An immunohistochemical descriptive study. Experimental Parasitology 2012;130:58-62. [DOI: 10.1016/j.exppara.2011.09.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
355 Costain AH, MacDonald AS, Smits HH. Schistosome Egg Migration: Mechanisms, Pathogenesis and Host Immune Responses. Front Immunol 2018;9:3042. [PMID: 30619372 DOI: 10.3389/fimmu.2018.03042] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 11.3] [Reference Citation Analysis]
356 Aw W, Fukuda S. Toward the comprehensive understanding of the gut ecosystem via metabolomics-based integrated omics approach. Semin Immunopathol 2015;37:5-16. [PMID: 25338280 DOI: 10.1007/s00281-014-0456-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
357 Liang YJ, Luo J, Yuan Q, Zheng D, Liu YP, Shi L, Zhou Y, Chen AL, Ren YY, Sun KY. New insight into the antifibrotic effects of praziquantel on mice in infection with Schistosoma japonicum. PLoS One. 2011;6:e20247. [PMID: 21629648 DOI: 10.1371/journal.pone.0020247] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 4.1] [Reference Citation Analysis]
358 Velasco-Loyden G, Pérez-Carreón JI, Agüero JF, Romero PC, Vidrio-Gómez S, Martínez-Pérez L, Yáñez-Maldonado L, Hernández-Muñoz R, Macías-Silva M, de Sánchez VC. Prevention of in vitro hepatic stellate cells activation by the adenosine derivative compound IFC305. Biochem Pharmacol 2010;80:1690-9. [PMID: 20813095 DOI: 10.1016/j.bcp.2010.08.017] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
359 Gupta B, Liu Y, Chopyk DM, Rai RP, Desai C, Kumar P, Farris AB, Nusrat A, Parkos CA, Anania FA, Raeman R. Western diet-induced increase in colonic bile acids compromises epithelial barrier in nonalcoholic steatohepatitis. FASEB J 2020;34:7089-102. [PMID: 32275114 DOI: 10.1096/fj.201902687R] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
360 Kim KH, Lee JM, Zhou Y, Harpavat S, Moore DD. Glucocorticoids Have Opposing Effects on Liver Fibrosis in Hepatic Stellate and Immune Cells. Mol Endocrinol 2016;30:905-16. [PMID: 27355192 DOI: 10.1210/me.2016-1029] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
361 Fausther M, Dranoff JA. Beyond scar formation: portal myofibroblast-mediated angiogenesis in the fibrotic liver. Hepatology 2015;61:766-8. [PMID: 25502320 DOI: 10.1002/hep.27653] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
362 Chan YT, Wang N, Tan HY, Li S, Feng Y. Targeting Hepatic Stellate Cells for the Treatment of Liver Fibrosis by Natural Products: Is It the Dawning of a New Era? Front Pharmacol 2020;11:548. [PMID: 32425789 DOI: 10.3389/fphar.2020.00548] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
363 Xu SJ, Ye LP, Wang W, Chen YH, Dong J, Mao XL, Li SW. Role of the Microenvironment in Mesenchymal Stem Cell-Based Strategies for Treating Human Liver Diseases. Stem Cells Int 2021;2021:5513309. [PMID: 34824587 DOI: 10.1155/2021/5513309] [Reference Citation Analysis]
364 Claveria-Cabello A, Colyn L, Arechederra M, Urman JM, Berasain C, Avila MA, Fernandez-Barrena MG. Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target? Cells 2020;9:E2321. [PMID: 33086678 DOI: 10.3390/cells9102321] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
365 Liao J, Zhang Z, Yuan Q, Liu Q, Kuang J, Fang Y, Hu X. A lncRNA Gpr137b-ps/miR-200a-3p/CXCL14 axis modulates hepatic stellate cell (HSC) activation. Toxicol Lett 2021;336:21-31. [PMID: 33069761 DOI: 10.1016/j.toxlet.2020.10.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
366 Kang KB, Jun JB, Kim JW, Kim HW, Sung SH. Ceanothane- and lupane-type triterpene esters from the roots of Hovenia dulcis and their antiproliferative activity on HSC-T6 cells. Phytochemistry. 2017;142:60-67. [PMID: 28686899 DOI: 10.1016/j.phytochem.2017.06.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
367 Charles R, Lu L, Qian S, Fung JJ. Stromal cell-based immunotherapy in transplantation. Immunotherapy 2011;3:1471-85. [PMID: 22091683 DOI: 10.2217/imt.11.132] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
368 Peng J, Li X, Feng Q, Chen L, Xu L, Hu Y. Anti-fibrotic effect of Cordyceps sinensis polysaccharide: Inhibiting HSC activation, TGF-β1/Smad signalling, MMPs and TIMPs. Exp Biol Med (Maywood) 2013;238:668-77. [PMID: 23918878 DOI: 10.1177/1535370213480741] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 4.2] [Reference Citation Analysis]
369 Marques NC, Mo Reira PRR, Bertolo PHL, Gava FN, Vasconcelos RO. Immunodetection of hepatic stellate cells in dogs with visceral leishmaniasis. Parasitol Res 2018;117:1829-37. [PMID: 29704121 DOI: 10.1007/s00436-018-5870-2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
370 Guimei M, Baddour N, Elkaffash D, Abdou L, Taher Y. Gremlin in the pathogenesis of hepatocellular carcinoma complicating chronic hepatitis C: an immunohistochemical and PCR study of human liver biopsies. BMC Res Notes 2012;5:390. [PMID: 22839096 DOI: 10.1186/1756-0500-5-390] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
371 Wu X, Zhi F, Lun W, Deng Q, Zhang W. Baicalin inhibits PDGF-BB-induced hepatic stellate cell proliferation, apoptosis, invasion, migration and activation via the miR-3595/ACSL4 axis. Int J Mol Med 2018;41:1992-2002. [PMID: 29393361 DOI: 10.3892/ijmm.2018.3427] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
372 Martin K, Hatab A, Athwal VS, Jokl E, Piper Hanley K. Genetic Contribution to Non-alcoholic Fatty Liver Disease and Prognostic Implications. Curr Diab Rep 2021;21:8. [PMID: 33544287 DOI: 10.1007/s11892-021-01377-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
373 Bale SS, Borenstein JT. Microfluidic Cell Culture Platforms to Capture Hepatic Physiology and Complex Cellular Interactions. Drug Metab Dispos 2018;46:1638-46. [DOI: 10.1124/dmd.118.083055] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
374 Ding BS, Nolan DJ, Butler JM, James D, Babazadeh AO, Rosenwaks Z, Mittal V, Kobayashi H, Shido K, Lyden D, Sato TN, Rabbany SY, Rafii S. Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration. Nature. 2010;468:310-315. [PMID: 21068842 DOI: 10.1038/nature09493] [Cited by in Crossref: 494] [Cited by in F6Publishing: 464] [Article Influence: 41.2] [Reference Citation Analysis]
375 Wells RG. Portal Fibroblasts in Biliary Fibrosis. Curr Pathobiol Rep 2014;2:185-90. [PMID: 25599013 DOI: 10.1007/s40139-014-0054-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
376 Baffy G. Potential mechanisms linking gut microbiota and portal hypertension. Liver Int. 2019;39:598-609. [PMID: 30312513 DOI: 10.1111/liv.13986] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
377 Yang Q, Yan C, Gong Z. Interaction of hepatic stellate cells with neutrophils and macrophages in the liver following oncogenic kras activation in transgenic zebrafish. Sci Rep 2018;8:8495. [PMID: 29855567 DOI: 10.1038/s41598-018-26612-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
378 Shi L, Qin E, Zhou J, Zhao J, Nie W, Jiang T, Chen W, Wu D, Huang L, Liu L, Lv L, Zhao M, Zhang Z, Wang F. HIV and HCV Co-Culture Promotes Profibrogenic Gene Expression through an Epimorphin-Mediated ERK Signaling Pathway in Hepatic Stellate Cells. PLoS One 2016;11:e0158386. [PMID: 27362846 DOI: 10.1371/journal.pone.0158386] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
379 Friedman A, Hao W. Mathematical modeling of liver fibrosis. Math Biosci Eng 2017;14:143-64. [PMID: 27879125 DOI: 10.3934/mbe.2017010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
380 Shin DS, Kim KW, Chung HY, Yoon S, Moon JO. Effect of sinapic acid against dimethylnitrosamine-induced hepatic fibrosis in rats. Arch Pharm Res. 2013;36:608-618. [PMID: 23435910 DOI: 10.1007/s12272-013-0033-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
381 Bona S, Rodrigues G, Moreira AJ, Di Naso FC, Dias AS, Da Silveira TR, Marroni CA, Marroni NP. Antifibrogenic effect of melatonin in rats with experimental liver cirrhosis induced by carbon tetrachloride. JGH Open 2018;2:117-23. [PMID: 30483575 DOI: 10.1002/jgh3.12055] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
382 Rodewald M, Bae H, Huschke S, Meyer-Zedler T, Schmitt M, Press AT, Schubert S, Bauer M, Popp J. In vivo coherent anti-Stokes Raman scattering microscopy reveals vitamin A distribution in the liver. J Biophotonics 2021;14:e202100040. [PMID: 33720518 DOI: 10.1002/jbio.202100040] [Reference Citation Analysis]
383 Jia Y, Wang F, Guo Q, Li M, Wang L, Zhang Z, Jiang S, Jin H, Chen A, Tan S, Zhang F, Shao J, Zheng S. Curcumol induces RIPK1/RIPK3 complex-dependent necroptosis via JNK1/2-ROS signaling in hepatic stellate cells. Redox Biol 2018;19:375-87. [PMID: 30237126 DOI: 10.1016/j.redox.2018.09.007] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 12.5] [Reference Citation Analysis]
384 Rahman K, Desai C, Iyer SS, Thorn NE, Kumar P, Liu Y, Smith T, Neish AS, Li H, Tan S, Wu P, Liu X, Yu Y, Farris AB, Nusrat A, Parkos CA, Anania FA. Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol. Gastroenterology. 2016;151:733-746.e12. [PMID: 27342212 DOI: 10.1053/j.gastro.2016.06.022] [Cited by in Crossref: 127] [Cited by in F6Publishing: 119] [Article Influence: 21.2] [Reference Citation Analysis]
385 Sanjeev S, Bidanchi RM, Murthy MK, Gurusubramanian G, Roy VK. Influence of ferulic acid consumption in ameliorating the cadmium-induced liver and renal oxidative damage in rats. Environ Sci Pollut Res Int 2019;26:20631-53. [PMID: 31104231 DOI: 10.1007/s11356-019-05420-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
386 Zhang F, Lu C, Xu W, Shao J, Wu L, Lu Y, Zheng S. Curcumin raises lipid content by Wnt pathway in hepatic stellate cell. J Surg Res 2016;200:460-6. [PMID: 26414021 DOI: 10.1016/j.jss.2015.08.040] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
387 Velázquez-Miranda E, Díaz-Muñoz M, Vázquez-Cuevas FG. Purinergic signaling in hepatic disease. Purinergic Signal 2019;15:477-89. [PMID: 31576486 DOI: 10.1007/s11302-019-09680-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
388 Lamash NE, Dolmatov IY. Proteases from the regenerating gut of the holothurian Eupentacta fraudatrix. PLoS One 2013;8:e58433. [PMID: 23505505 DOI: 10.1371/journal.pone.0058433] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
389 Hellerbrand C. Hepatic stellate cells--the pericytes in the liver. Pflugers Arch. 2013;465:775-778. [PMID: 23292551 DOI: 10.1007/s00424-012-1209-5] [Cited by in Crossref: 78] [Cited by in F6Publishing: 78] [Article Influence: 8.7] [Reference Citation Analysis]
390 Sikorska K, Bernat A, Wroblewska A. Molecular pathogenesis and clinical consequences of iron overload in liver cirrhosis. Hepatobiliary Pancreat Dis Int 2016;15:461-79. [PMID: 27733315 DOI: 10.1016/s1499-3872(16)60135-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
391 Güvendi GF, Eroğlu HA, Mustafa Makav, Güvendi B, Adalı Y. Selenium or ozone: Effects on liver injury caused by experimental iron overload. Life Sci 2020;262:118558. [PMID: 33038377 DOI: 10.1016/j.lfs.2020.118558] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
392 El-mansy A, Mazroa S, Hamed W, Yaseen A, El-mohandes E. Histological and immunohistochemical effects of Curcuma longa on activation of rat hepatic stellate cells after cadmium induced hepatotoxicity. Biotechnic & Histochemistry 2016;91:170-81. [DOI: 10.3109/10520295.2015.1116048] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
393 Zhang LT, Fang XQ, Chen QF, Chen H, Xiao P, Peng XB, Zhang SX, Li JF, Mao XR. Bone marrow-derived mesenchymal stem cells inhibit the proliferation of hepatic stellate cells by inhibiting the transforming growth factor β pathway. Mol Med Rep 2015;12:7227-32. [PMID: 26458849 DOI: 10.3892/mmr.2015.4362] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
394 Vosough M, Moslem M, Pournasr B, Baharvand H. Cell-based therapeutics for liver disorders. Br Med Bull 2011;100:157-72. [PMID: 21771778 DOI: 10.1093/bmb/ldr031] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
395 Charles R, Chou HS, Wang L, Fung JJ, Lu L, Qian S. Human hepatic stellate cells inhibit T-cell response through B7-H1 pathway. Transplantation 2013;96:17-24. [PMID: 23756770 DOI: 10.1097/TP.0b013e318294caae] [Cited by in Crossref: 39] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
396 Klironomos S, Notas G, Sfakianaki O, Kiagiadaki F, Xidakis C, Kouroumalis E. Octreotide modulates the effects on fibrosis of TNF-α, TGF-β and PDGF in activated rat hepatic stellate cells. Regul Pept. 2014;188:5-12. [PMID: 24291170 DOI: 10.1016/j.regpep.2013.11.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
397 Gopalan B, Ke Z, Zhang C, Kng Y, Suhaimi NM, Riduan SN, Zhang Y, Zhuo L. Metal-free imidazolium salts inhibit the growth of hepatocellular carcinoma in a mouse model. Lab Invest 2011;91:744-51. [DOI: 10.1038/labinvest.2011.4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
398 Chan AW, Patel YA, Choi S. Aging of the Liver: What This Means for Patients with HIV. Curr HIV/AIDS Rep 2016;13:309-17. [PMID: 27557619 DOI: 10.1007/s11904-016-0332-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
399 Kim J, Wang S, Hyun J, Choi SS, Cha H, Ock M, Jung Y. Hepatic stellate cells express thymosin Beta 4 in chronically damaged liver. PLoS One 2015;10:e0122758. [PMID: 25826335 DOI: 10.1371/journal.pone.0122758] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
400 Lim HK, Jeffrey GP, Ramm GA, Soekmadji C. Pathogenesis of Viral Hepatitis-Induced Chronic Liver Disease: Role of Extracellular Vesicles. Front Cell Infect Microbiol 2020;10:587628. [PMID: 33240824 DOI: 10.3389/fcimb.2020.587628] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
401 Frevert U, Nardin E. Cellular effector mechanisms against Plasmodium liver stages. Cell Microbiol 2008;10:1956-67. [PMID: 18647171 DOI: 10.1111/j.1462-5822.2008.01211.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
402 Liao R, Sun TW, Yi Y, Wu H, Li YW, Wang JX, Zhou J, Shi YH, Cheng YF, Qiu SJ. Expression of TREM-1 in hepatic stellate cells and prognostic value in hepatitis B-related hepatocellular carcinoma. Cancer Sci. 2012;103:984-992. [PMID: 22417086 DOI: 10.1111/j.1349-7006.2012.02273.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 5.3] [Reference Citation Analysis]
403 Kocabayoglu P, Zhang DY, Kojima K, Hoshida Y, Friedman SL. Induction and contribution of beta platelet-derived growth factor signalling by hepatic stellate cells to liver regeneration after partial hepatectomy in mice. Liver Int 2016;36:874-82. [PMID: 26256287 DOI: 10.1111/liv.12933] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
404 Zhang ZG, Zou J, Huang Y, Wu L. Kinetin inhibits proliferation of hepatic stellate cells by interrupting cell cycle and induces apoptosis by down-regulating ratio of Bcl-2/Bax. J Huazhong Univ Sci Technolog Med Sci 2015;35:672-8. [PMID: 26489620 DOI: 10.1007/s11596-015-1488-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
405 Allam A, Thomsen A, Gothwal M, Saha D, Maurer J, Brunner T. Pancreatic stellate cells in pancreatic cancer: In focus. Pancreatology 2017;17:514-22. [DOI: 10.1016/j.pan.2017.05.390] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
406 Sha M, Gao Y, Deng C, Wan Y, Zhuang Y, Hu X, Wang Y. Therapeutic effects of AdipoRon on liver inflammation and fibrosis induced by CCl4 in mice. Int Immunopharmacol 2020;79:106157. [PMID: 31911372 DOI: 10.1016/j.intimp.2019.106157] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
407 Tang Y, Masuo Y, Sakai Y, Wakayama T, Sugiura T, Harada R, Futatsugi A, Komura T, Nakamichi N, Sekiguchi H, Sutoh K, Usumi K, Iseki S, Kaneko S, Kato Y. Localization of Xenobiotic Transporter OCTN1/SLC22A4 in Hepatic Stellate Cells and Its Protective Role in Liver Fibrosis. J Pharm Sci 2016;105:1779-89. [PMID: 27020986 DOI: 10.1016/j.xphs.2016.02.023] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
408 Duan YJ, Yin NN, Gao QH, Wan Y, Ma WP, Zhang CW, Lv WL. Shenzhang granules inhibit cell proliferation and reduce α-SMA expression in hepatic stellate cells. Shijie Huaren Xiaohua Zazhi 2014; 22(10): 1396-1401 [DOI: 10.11569/wcjd.v22.i10.1396] [Reference Citation Analysis]
409 Zhang H, Wu P, Chen F, Hao Y, Lao Y, Ren L, Sun L, Sun W, Wei H, Chan DW, Jiang Y, He F. SILAC-based quantitative proteomic analysis of secretome between activated and reverted hepatic stellate cells. Proteomics 2014;14:1977-86. [DOI: 10.1002/pmic.201300539] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
410 Carraz M, Lavergne C, Jullian V, Wright M, Gairin JE, Gonzales de la Cruz M, Bourdy G. Antiproliferative activity and phenotypic modification induced by selected Peruvian medicinal plants on human hepatocellular carcinoma Hep3B cells. J Ethnopharmacol 2015;166:185-99. [PMID: 25701751 DOI: 10.1016/j.jep.2015.02.028] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
411 Han B, Mo H, Svarovskaia E, Mateo R. A primary human hepatocyte/hepatic stellate cell co-culture system for improved in vitro HBV replication. Virology 2021;559:40-5. [PMID: 33813211 DOI: 10.1016/j.virol.2021.03.012] [Reference Citation Analysis]
412 Nati M, Haddad D, Birkenfeld AL, Koch CA, Chavakis T, Chatzigeorgiou A. The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH). Rev Endocr Metab Disord. 2016;17:29-39. [PMID: 26847547 DOI: 10.1007/s11154-016-9339-2] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 12.8] [Reference Citation Analysis]
413 Mariño Z, Mensa L, Crespo G, Miquel R, Bruguera M, Pérez-Del-Pulgar S, Bosch J, Forns X, Navasa M. Early periportal sinusoidal fibrosis is an accurate marker of accelerated HCV recurrence after liver transplantation. J Hepatol 2014;61:270-7. [PMID: 24703854 DOI: 10.1016/j.jhep.2014.03.029] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
414 Galler K, Requardt RP, Glaser U, Markwart R, Bocklitz T, Bauer M, Popp J, Neugebauer U. Single cell analysis in native tissue: Quantification of the retinoid content of hepatic stellate cells. Sci Rep 2016;6:24155. [PMID: 27063397 DOI: 10.1038/srep24155] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
415 Mu X, Pradere JP, Affò S, Dapito DH, Friedman R, Lefkovitch JH, Schwabe RF. Epithelial Transforming Growth Factor-β Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma. Gastroenterology 2016;150:720-33. [PMID: 26627606 DOI: 10.1053/j.gastro.2015.11.039] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 5.6] [Reference Citation Analysis]
416 Kikuchi A, Pradhan-Sundd T, Singh S, Nagarajan S, Loizos N, Monga SP. Platelet-Derived Growth Factor Receptor α Contributes to Human Hepatic Stellate Cell Proliferation and Migration. Am J Pathol 2017;187:2273-87. [PMID: 28734947 DOI: 10.1016/j.ajpath.2017.06.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
417 Schwabl P, Hambruch E, Budas GR, Supper P, Burnet M, Liles JT, Birkel M, Brusilovskaya K, Königshofer P, Peck-Radosavljevic M, Watkins WJ, Trauner M, Breckenridge DG, Kremoser C, Reiberger T. The Non-Steroidal FXR Agonist Cilofexor Improves Portal Hypertension and Reduces Hepatic Fibrosis in a Rat NASH Model. Biomedicines 2021;9:60. [PMID: 33435509 DOI: 10.3390/biomedicines9010060] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
418 Sun L, Fan Z, Chen J, Tian W, Li M, Xu H, Wu X, Shao J, Bian Y, Fang M, Xu Y. Transcriptional repression of SIRT1 by protein inhibitor of activated STAT 4 (PIAS4) in hepatic stellate cells contributes to liver fibrosis. Sci Rep 2016;6:28432. [PMID: 27323886 DOI: 10.1038/srep28432] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
419 Xu W, Hu H, Tian Y, Wang S, Li J, Li J, Deng X, Qian H, Qiu L, Hu Z, Wu Q, Chai Y, Guo C, Xie W, Zhang J. Bioactive compound reveals a novel function for ribosomal protein S5 in hepatic stellate cell activation and hepatic fibrosis: XU, HU, ET AL. Hepatology 2014;60:648-60. [DOI: 10.1002/hep.27138] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
420 Nunes QM, Mournetas V, Lane B, Sutton R, Fernig DG, Vasieva O. The heparin-binding protein interactome in pancreatic diseases. Pancreatology 2013;13:598-604. [PMID: 24280576 DOI: 10.1016/j.pan.2013.08.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
421 Zheng H, Yang Z, Xin Z, Yang Y, Yu Y, Cui J, Liu H, Chen F. Glycogen synthase kinase-3β: a promising candidate in the fight against fibrosis. Theranostics 2020;10:11737-53. [PMID: 33052244 DOI: 10.7150/thno.47717] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
422 Domínguez M, Colmenero J, Bataller R. Tratamiento de la fibrosis hepática. Gastroenterología y Hepatología 2009;32:627-32. [DOI: 10.1016/j.gastrohep.2009.02.015] [Reference Citation Analysis]
423 Zhang D, Utsumi T, Huang HC, Gao L, Sangwung P, Chung C, Shibao K, Okamoto K, Yamaguchi K, Groszmann RJ, Jozsef L, Hao Z, Sessa WC, Iwakiri Y. Reticulon 4B (Nogo-B) is a novel regulator of hepatic fibrosis. Hepatology 2011;53:1306-15. [PMID: 21480333 DOI: 10.1002/hep.24200] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
424 Vainshtein JM, Kabarriti R, Mehta KJ, Roy-Chowdhury J, Guha C. Bone marrow-derived stromal cell therapy in cirrhosis: clinical evidence, cellular mechanisms, and implications for the treatment of hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2014;89:786-803. [PMID: 24969793 DOI: 10.1016/j.ijrobp.2014.02.017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
425 Tomoishi S, Fukushima S, Shinohara K, Katada T, Saito K. CREB3L2-mediated expression of Sec23A/Sec24D is involved in hepatic stellate cell activation through ER-Golgi transport. Sci Rep 2017;7:7992. [PMID: 28801610 DOI: 10.1038/s41598-017-08703-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 3.2] [Reference Citation Analysis]
426 Zhang K, Han Y, Hu Z, Zhang Z, Shao S, Yao Q, Zheng L, Wang J, Han X, Zhang Y, Chen T, Yao Z, Han T, Hong W. SCARNA10, a nuclear-retained long non-coding RNA, promotes liver fibrosis and serves as a potential biomarker. Theranostics 2019;9:3622-38. [PMID: 31281502 DOI: 10.7150/thno.32935] [Cited by in Crossref: 19] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
427 Fujii M, Yoneda A, Takei N, Sakai-Sawada K, Kosaka M, Minomi K, Yokoyama A, Tamura Y. Endoplasmic reticulum oxidase 1α is critical for collagen secretion from and membrane type 1-matrix metalloproteinase levels in hepatic stellate cells. J Biol Chem 2017;292:15649-60. [PMID: 28774960 DOI: 10.1074/jbc.M117.783126] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
428 Hintermann E, Bayer M, Conti CB, Fuchs S, Fausther M, Leung PS, Aurrand-Lions M, Taubert R, Pfeilschifter JM, Friedrich-Rust M, Schuppan D, Dranoff JA, Gershwin ME, Manns MP, Imhof BA, Christen U. Junctional adhesion molecules JAM-B and JAM-C promote autoimmune-mediated liver fibrosis in mice. J Autoimmun 2018;91:83-96. [PMID: 29753567 DOI: 10.1016/j.jaut.2018.05.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
429 Carter J, Wang S, Friedman SL. Ten Thousand Points of Light: Heterogeneity Among the Stars of NASH Fibrosis. Hepatology 2021;74:543-6. [PMID: 33724489 DOI: 10.1002/hep.31807] [Reference Citation Analysis]
430 Chavez-Tapia NC, Rosso N, Tiribelli C. Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease. BMC Gastroenterol. 2012;12:20. [PMID: 22380754 DOI: 10.1186/1471-230x-12-20] [Cited by in Crossref: 77] [Cited by in F6Publishing: 51] [Article Influence: 7.7] [Reference Citation Analysis]
431 Van Rossen E, Liu Z, Blijweert D, Eysackers N, Mannaerts I, Schroyen B, El Taghdouini A, Edwards B, Davies KE, Sokal E, Najimi M, Reynaert H, van Grunsven LA. Syncoilin is an intermediate filament protein in activated hepatic stellate cells. Histochem Cell Biol 2014;141:85-99. [PMID: 24043511 DOI: 10.1007/s00418-013-1142-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
432 van Beuge MM, Prakash J, Lacombe M, Post E, Reker-Smit C, Beljaars L, Poelstra K. Increased liver uptake and reduced hepatic stellate cell activation with a cell-specific conjugate of the Rho-kinase inhibitor Y27632. Pharm Res. 2011;28:2045-2054. [PMID: 21442374 DOI: 10.1007/s11095-011-0430-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
433 Brovold M, Keller D, Soker S. Differential fibrotic phenotypes of hepatic stellate cells within 3D liver organoids. Biotechnol Bioeng 2020;117:2516-26. [PMID: 32391915 DOI: 10.1002/bit.27379] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
434 Alolga RN, Nuer-allornuvor GF, Kuugbee ED, Yin X, Ma G. Ginsenoside Rg1 and the control of inflammation implications for the therapy of type 2 diabetes: A review of scientific findings and call for further research. Pharmacological Research 2020;152:104630. [DOI: 10.1016/j.phrs.2020.104630] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
435 Beaven SW, Wroblewski K, Wang J, Hong C, Bensinger S, Tsukamoto H, Tontonoz P. Liver X receptor signaling is a determinant of stellate cell activation and susceptibility to fibrotic liver disease. Gastroenterology. 2011;140:1052-1062. [PMID: 21134374 DOI: 10.1053/j.gastro.2010.11.053] [Cited by in Crossref: 76] [Cited by in F6Publishing: 76] [Article Influence: 6.3] [Reference Citation Analysis]
436 Xu W, Banerji S, Davie JR, Kassie F, Yee D, Kratzke R. Yin Yang gene expression ratio signature for lung cancer prognosis. PLoS One 2013;8:e68742. [PMID: 23874744 DOI: 10.1371/journal.pone.0068742] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
437 Correnti JM, Cook D, Aksamitiene E, Swarup A, Ogunnaike B, Vadigepalli R, Hoek JB. Adiponectin fine-tuning of liver regeneration dynamics revealed through cellular network modelling. J Physiol 2015;593:365-83. [PMID: 25630259 DOI: 10.1113/jphysiol.2014.284109] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
438 Dai X, Chen C, Xue J, Xiao T, Mostofa G, Wang D, Chen X, Xu H, Sun Q, Li J, Wei Y, Chen F, Quamruzzaman Q, Zhang A, Liu Q. Exosomal MALAT1 derived from hepatic cells is involved in the activation of hepatic stellate cells via miRNA-26b in fibrosis induced by arsenite. Toxicol Lett 2019;316:73-84. [PMID: 31513886 DOI: 10.1016/j.toxlet.2019.09.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
439 Borkham-Kamphorst E, Weiskirchen R. The PDGF system and its antagonists in liver fibrosis. Cytokine Growth Factor Rev. 2016;28:53-61. [PMID: 26547628 DOI: 10.1016/j.cytogfr.2015.10.002] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 10.1] [Reference Citation Analysis]
440 Hwang I, Lee EJ, Park H, Moon D, Kim HS. Retinol from hepatic stellate cells via STRA6 induces lipogenesis on hepatocytes during fibrosis. Cell Biosci 2021;11:3. [PMID: 33407858 DOI: 10.1186/s13578-020-00509-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
441 Choi SS, Witek RP, Yang L, Omenetti A, Syn WK, Moylan CA, Jung Y, Karaca GF, Teaberry VS, Pereira TA, Wang J, Ren XR, Diehl AM. Activation of Rac1 promotes hedgehog-mediated acquisition of the myofibroblastic phenotype in rat and human hepatic stellate cells. Hepatology 2010;52:278-90. [PMID: 20578145 DOI: 10.1002/hep.23649] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
442 Li XM, Peng JH, Sun ZL, Tian HJ, Duan XH, Liu L, Ma X, Feng Q, Liu P, Hu YY. Chinese medicine CGA formula ameliorates DMN-induced liver fibrosis in rats via inhibiting MMP2/9, TIMP1/2 and the TGF-β/Smad signaling pathways. Acta Pharmacol Sin 2016;37:783-93. [PMID: 27133300 DOI: 10.1038/aps.2016.35] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 5.5] [Reference Citation Analysis]
443 Howell J, Angus P, Gow P, Visvanathan K. Toll-like receptors in hepatitis C infection: Implications for pathogenesis and treatment: Toll-like receptors in hepatitis C. J Gastroenterol Hepatol 2013;28:766-76. [DOI: 10.1111/jgh.12170] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
444 Song J, Ge Z, Yang X, Luo Q, Wang C, You H, Ge T, Deng Y, Lin H, Cui Y. Hepatic stellate cells activated by acidic tumor microenvironment promote the metastasis of hepatocellular carcinoma via osteopontin. Cancer Lett. 2015;356:713-720. [PMID: 25449435 DOI: 10.1016/j.canlet.2014.10.021] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 5.0] [Reference Citation Analysis]
445 Elias MB, Oliveira FL, Guma FCR, Martucci RB, Borojevic R, Teodoro AJ. Lycopene inhibits hepatic stellate cell activation and modulates cellular lipid storage and signaling. Food Funct 2019;10:1974-84. [PMID: 30889234 DOI: 10.1039/c8fo02369g] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
446 Cha JJ, Mandal C, Ghee JY, Yoo JA, Lee MJ, Kang YS, Hyun YY, Lee JE, Kim HW, Han SY, Han JY, Chung AY, Yoon DW, Rhyu IJ, Oh J, Cha DR. Inhibition of Renal Stellate Cell Activation Reduces Renal Fibrosis. Biomedicines 2020;8:E431. [PMID: 33086608 DOI: 10.3390/biomedicines8100431] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
447 Hu M, Wang Y, Xu L, An S, Tang Y, Zhou X, Li J, Liu R, Huang L. Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy. Nat Commun 2019;10:2993. [PMID: 31278269 DOI: 10.1038/s41467-019-10893-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 11.7] [Reference Citation Analysis]
448 Mann J, Mann DA. Epigenetic regulation of wound healing and fibrosis. Current Opinion in Rheumatology 2013;25:101-7. [DOI: 10.1097/bor.0b013e32835b13e1] [Cited by in Crossref: 55] [Cited by in F6Publishing: 27] [Article Influence: 6.1] [Reference Citation Analysis]
449 Li L, Hu Z, Li W, Hu M, Ran J, Chen P, Sun Q. Establishment of a standardized liver fibrosis model with different pathological stages in rats. Gastroenterol Res Pract 2012;2012:560345. [PMID: 22761610 DOI: 10.1155/2012/560345] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
450 Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008;134:1655-1669. [PMID: 18471545 DOI: 10.1053/j.gastro.2008.03.003] [Cited by in Crossref: 1758] [Cited by in F6Publishing: 1753] [Article Influence: 125.6] [Reference Citation Analysis]
451 Wang H, Chen L. Tumor microenviroment and hepatocellular carcinoma metastasis. J Gastroenterol Hepatol 2013;28 Suppl 1:43-8. [PMID: 23855295 DOI: 10.1111/jgh.12091] [Cited by in Crossref: 52] [Cited by in F6Publishing: 58] [Article Influence: 6.5] [Reference Citation Analysis]
452 Bian EB, Wang YY, Yang Y, Wu BM, Xu T, Meng XM, Huang C, Zhang L, Lv XW, Xiong ZG, Li J. Hotair facilitates hepatic stellate cells activation and fibrogenesis in the liver. Biochim Biophys Acta Mol Basis Dis 2017;1863:674-86. [PMID: 27979710 DOI: 10.1016/j.bbadis.2016.12.009] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 6.5] [Reference Citation Analysis]
453 Popov Y, Schuppan D. Epithelial-to-mesenchymal transition in liver fibrosis: dead or alive? Gastroenterology. 2010;139:722-725. [PMID: 20682361 DOI: 10.1053/j.gastro.2010.07.015] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
454 Buechler MB, Turley SJ. A short field guide to fibroblast function in immunity. Semin Immunol. 2018;35:48-58. [PMID: 29198601 DOI: 10.1016/j.smim.2017.11.001] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 9.4] [Reference Citation Analysis]
455 Kim KM, Han CY, Kim JY, Cho SS, Kim YS, Koo JH, Lee JM, Lim SC, Kang KW, Kim JS, Hwang SJ, Ki SH, Kim SG. Gα12 overexpression induced by miR-16 dysregulation contributes to liver fibrosis by promoting autophagy in hepatic stellate cells. J Hepatol 2018;68:493-504. [PMID: 29080810 DOI: 10.1016/j.jhep.2017.10.011] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 10.0] [Reference Citation Analysis]
456 Zheng R, Fang X, Chen X, Huang Y, Xu G, He L, Li Y, Niu X, Yang L, Wang L, Li D, Geng H. Knockdown of lactate dehydrogenase by adeno-associated virus-delivered CRISPR/Cas9 system alleviates primary hyperoxaluria type 1. Clin Transl Med 2020;10:e261. [PMID: 33377632 DOI: 10.1002/ctm2.261] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
457 Rehman H, Ramshesh VK, Theruvath TP, Kim I, Currin RT, Giri S, Lemasters JJ, Zhong Z. NIM811 (N-methyl-4-isoleucine cyclosporine), a mitochondrial permeability transition inhibitor, attenuates cholestatic liver injury but not fibrosis in mice. J Pharmacol Exp Ther 2008;327:699-706. [PMID: 18801946 DOI: 10.1124/jpet.108.143578] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
458 Reiter FP, Wimmer R, Wottke L, Artmann R, Nagel JM, Carranza MO, Mayr D, Rust C, Fickert P, Trauner M, Gerbes AL, Hohenester S, Denk GU. Role of interleukin-1 and its antagonism of hepatic stellate cell proliferation and liver fibrosis in the Abcb4-/- mouse model. World J Hepatol 2016; 8(8): 401-410 [PMID: 27004088 DOI: 10.4254/wjh.v8.i8.401] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
459 Das D, Barnes MA, Nagy LE. Anaphylatoxin C5a modulates hepatic stellate cell migration. Fibrogenesis Tissue Repair 2014;7:9. [PMID: 24917887 DOI: 10.1186/1755-1536-7-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
460 Elsharkawy AM, Oakley F, Lin F, Packham G, Mann DA, Mann J. The NF-kappaB p50:p50:HDAC-1 repressor complex orchestrates transcriptional inhibition of multiple pro-inflammatory genes. J Hepatol 2010;53:519-27. [PMID: 20579762 DOI: 10.1016/j.jhep.2010.03.025] [Cited by in F6Publishing: 96] [Reference Citation Analysis]
461 Shen K, Chang W, Gao X, Wang H, Niu W, Song L, Qin X. Depletion of activated hepatic stellate cell correlates with severe liver damage and abnormal liver regeneration in acetaminophen-induced liver injury. Acta Biochim Biophys Sin (Shanghai). 2011;43:307-315. [PMID: 21335335 DOI: 10.1093/abbs/gmr005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
462 Rychik J, Veldtman G, Rand E, Russo P, Rome JJ, Krok K, Goldberg DJ, Cahill AM, Wells RG. The precarious state of the liver after a Fontan operation: summary of a multidisciplinary symposium. Pediatr Cardiol 2012;33:1001-12. [PMID: 22534759 DOI: 10.1007/s00246-012-0315-7] [Cited by in Crossref: 206] [Cited by in F6Publishing: 163] [Article Influence: 20.6] [Reference Citation Analysis]
463 Bae M, Lee Y, Pham TX, Hu S, Park YK, Lee JY. Astaxanthin inhibits the reduction of glycolysis during the activation of hepatic stellate cells. Life Sci 2020;256:117926. [PMID: 32535081 DOI: 10.1016/j.lfs.2020.117926] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
464 Guo Y, Ding Q, Chen L, Ji C, Hao H, Wang J, Qi W, Xie X, Ma J, Li A, Jiang X, Li X, Jiang H. Overexpression of Heparin-Binding Epidermal Growth Factor-Like Growth Factor Mediates Liver Fibrosis in Transgenic Mice. The American Journal of the Medical Sciences 2017;354:199-210. [DOI: 10.1016/j.amjms.2017.04.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
465 Mino M, Kanno K, Okimoto K, Sugiyama A, Kishikawa N, Kobayashi T, Ono J, Izuhara K, Kobayashi T, Ohigashi T, Ohdan H, Tazuma S. Periostin promotes malignant potential by induction of epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma. Hepatol Commun 2017;1:1099-109. [PMID: 29404445 DOI: 10.1002/hep4.1114] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
466 Li Z, Chiang YP, He M, Worgall TS, Zhou H, Jiang XC. Liver sphingomyelin synthase 1 deficiency causes steatosis, steatohepatitis, fibrosis, and tumorigenesis: An effect of glucosylceramide accumulation. iScience 2021;24:103449. [PMID: 34927020 DOI: 10.1016/j.isci.2021.103449] [Reference Citation Analysis]
467 Crawford JM, Bioulac-sage P, Hytiroglou P. Structure, Function, and Responses to Injury. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 1-87. [DOI: 10.1016/b978-0-7020-6697-9.00001-7] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
468 Wasmuth HE, Tag CG, Van de Leur E, Hellerbrand C, Mueller T, Berg T, Puhl G, Neuhaus P, Samuel D, Trautwein C, Kanse SM, Weiskirchen R. The Marburg I variant (G534E) of the factor VII-activating protease determines liver fibrosis in hepatitis C infection by reduced proteolysis of platelet-derived growth factor BB. Hepatology 2009;49:775-80. [DOI: 10.1002/hep.22707] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.6] [Reference Citation Analysis]
469 Rombouts K, Mello T, Liotta F, Galli A, Caligiuri A, Annunziato F, Pinzani M. MARCKS actin-binding capacity mediates actin filament assembly during mitosis in human hepatic stellate cells. Am J Physiol Cell Physiol. 2012;303:C357-C367. [PMID: 22555845 DOI: 10.1152/ajpcell.00093.2012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
470 Eraky SM, El-Mesery M, El-Karef A, Eissa LA, El-Gayar AM. Silymarin and caffeine combination ameliorates experimentally-induced hepatic fibrosis through down-regulation of LPAR1 expression. Biomed Pharmacother 2018;101:49-57. [PMID: 29477472 DOI: 10.1016/j.biopha.2018.02.064] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
471 Ibrahim SA, Mohamed MZ, El-Tahawy NF, Abdelrahman AM. Antifibrotic effects of bezafibrate and pioglitazone against thioacetamide-induced liver fibrosis in albino rats. Can J Physiol Pharmacol 2021;99:313-20. [PMID: 32721217 DOI: 10.1139/cjpp-2020-0159] [Reference Citation Analysis]
472 Ansari AW, Schmidt RE, Shankar EM, Kamarulzaman A. Immuno-pathomechanism of liver fibrosis: targeting chemokine CCL2-mediated HIV:HCV nexus. J Transl Med 2014;12:341. [PMID: 25528160 DOI: 10.1186/s12967-014-0341-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
473 Vickers AEM, Ulyanov AV, Fisher RL. Progression of Repair and Injury in Human Liver Slices. Int J Mol Sci 2018;19:E4130. [PMID: 30572671 DOI: 10.3390/ijms19124130] [Reference Citation Analysis]
474 Reungoat E, Grigorov B, Zoulim F, Pécheur EI. Molecular Crosstalk between the Hepatitis C Virus and the Extracellular Matrix in Liver Fibrogenesis and Early Carcinogenesis. Cancers (Basel) 2021;13:2270. [PMID: 34065048 DOI: 10.3390/cancers13092270] [Reference Citation Analysis]
475 Matharu Z, Patel D, Gao Y, Haque A, Zhou Q, Revzin A. Detecting transforming growth factor-β release from liver cells using an aptasensor integrated with microfluidics. Anal Chem 2014;86:8865-72. [PMID: 25105888 DOI: 10.1021/ac502383e] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 6.0] [Reference Citation Analysis]
476 Blaner WS, O’Byrne SM, Wongsiriroj N, Kluwe J, D’Ambrosio DM, Jiang H, Schwabe RF, Hillman EM, Piantedosi R, Libien J. Hepatic stellate cell lipid droplets: a specialized lipid droplet for retinoid storage. Biochim Biophys Acta. 2009;1791:467-473. [PMID: 19071229 DOI: 10.1016/j.bbalip.2008.11.001] [Cited by in Crossref: 230] [Cited by in F6Publishing: 220] [Article Influence: 16.4] [Reference Citation Analysis]
477 Li W, Deng M, Gong J, Zhang X, Ge S, Zhao L. Sodium Acetate Inhibit TGF-β1-Induced Activation of Hepatic Stellate Cells by Restoring AMPK or c-Jun Signaling. Front Nutr 2021;8:729583. [PMID: 34660662 DOI: 10.3389/fnut.2021.729583] [Reference Citation Analysis]
478 Shmarakov I, Fleshman MK, D'Ambrosio DN, Piantedosi R, Riedl KM, Schwartz SJ, Curley RW Jr, von Lintig J, Rubin LP, Harrison EH, Blaner WS. Hepatic stellate cells are an important cellular site for β-carotene conversion to retinoid. Arch Biochem Biophys 2010;504:3-10. [PMID: 20470748 DOI: 10.1016/j.abb.2010.05.010] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 4.2] [Reference Citation Analysis]
479 Shu JC, He YJ, Lv X, Zhao JR, Zhao J, Shen Y, Ye GR, Wang LX. Effect of curcumin on the proliferation and apoptosis of hepatic stellate cells. Braz J Med Biol Res. 2009;42:1173-1178. [PMID: 19918672 DOI: 10.1590/S0100-879X2009005000041] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
480 Chen L, Zhou Q, Liu E, Zhang J, Duan L, Zhu D, Chen J, Duan Y. rSjp40 inhibits activated hepatic stellate cells by promoting nuclear translocation of YB1 and inducing BMP-7/Smad1/5/8 pathway. Parasit Vectors 2019;12:279. [PMID: 31151477 DOI: 10.1186/s13071-019-3539-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
481 Schattenberg JM, Schuchmann M. Diabetes and apoptosis: liver. Apoptosis 2009;14:1459-71. [PMID: 19544096 DOI: 10.1007/s10495-009-0366-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
482 Weng TC, Shen CC, Chiu YT, Lin YL, Huang YT. Effects of armepavine against hepatic fibrosis induced by thioacetamide in rats. Phytother Res. 2012;26:344-353. [PMID: 21717514 DOI: 10.1002/ptr.3539] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
483 Pingitore P, Sasidharan K, Ekstrand M, Prill S, Lindén D, Romeo S. Human Multilineage 3D Spheroids as a Model of Liver Steatosis and Fibrosis. Int J Mol Sci 2019;20:E1629. [PMID: 30986904 DOI: 10.3390/ijms20071629] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 9.0] [Reference Citation Analysis]
484 Bennett RG, Simpson RL, Hamel FG. Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosis. World J Gastroenterol 2017; 23(22): 3999-4006 [PMID: 28652653 DOI: 10.3748/wjg.v23.i22.3999] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
485 Fernando DH, Forbes JM, Angus PW, Herath CB. Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products. Int J Mol Sci. 2019;20. [PMID: 31614491 DOI: 10.3390/ijms20205037] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
486 Xu J, Liu X, Koyama Y, Wang P, Lan T, Kim IG, Kim IH, Ma HY, Kisseleva T. The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies. Front Pharmacol 2014;5:167. [PMID: 25100997 DOI: 10.3389/fphar.2014.00167] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 6.5] [Reference Citation Analysis]
487 Zois CD, Baltayiannis GH, Karayiannis P, Tsianos EV. Systematic review: hepatic fibrosis - regression with therapy. Aliment Pharmacol Ther 2008;28:1175-87. [PMID: 18761707 DOI: 10.1111/j.1365-2036.2008.03840.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
488 Mederacke I, Hsu CC, Troeger JS, Huebener P, Mu X, Dapito DH, Pradere JP, Schwabe RF. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat Commun. 2013;4:2823. [PMID: 24264436 DOI: 10.1038/ncomms3823] [Cited by in Crossref: 621] [Cited by in F6Publishing: 606] [Article Influence: 77.6] [Reference Citation Analysis]
489 Park O, Jeong WI, Wang L, Wang H, Lian ZX, Gershwin ME, Gao B. Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride. Hepatology 2009;49:1683-94. [PMID: 19205035 DOI: 10.1002/hep.22813] [Cited by in Crossref: 127] [Cited by in F6Publishing: 121] [Article Influence: 9.8] [Reference Citation Analysis]
490 Isfoss BL, Holmqvist B, Sand E, Forsell J, Jernström H, Olsson H. Stellate cells and mesenchymal stem cells in benign mammary stroma are associated with risk factors for breast cancer - an observational study. BMC Cancer 2018;18:230. [PMID: 29486751 DOI: 10.1186/s12885-018-4151-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
491 Hong L, Shejiao D, Fenrong C, Gang Z, Lei D. Periostin down-regulation attenuates the pro-fibrogenic response of hepatic stellate cells induced by TGF-β1. J Cell Mol Med 2015;19:2462-8. [PMID: 26249143 DOI: 10.1111/jcmm.12636] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
492 Yan HJ, Kwon SY, Kim K, Jeong H, Kim Y, Chung WS, Lee J, Jang H. Anti-fibrotic effects of Kyungheechunggan-tang on activated hepatic stellate cells and rat liver. Mol Cell Toxicol 2014;10:411-21. [DOI: 10.1007/s13273-014-0046-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
493 Tuominen I, Fuqua BK, Pan C, Renaud N, Wroblewski K, Civelek M, Clerkin K, Asaryan A, Haroutunian SG, Loureiro J, Borawski J, Roma G, Knehr J, Carbone W, French S, Parks BW, Hui ST, Mehrabian M, Magyar C, Cantor RM, Ukomadu C, Lusis AJ, Beaven SW. The Genetic Architecture of Carbon Tetrachloride-Induced Liver Fibrosis in Mice. Cell Mol Gastroenterol Hepatol 2021;11:199-220. [PMID: 32866618 DOI: 10.1016/j.jcmgh.2020.08.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
494 Zhang Y, Miao H, Yan H, Sheng Y, Ji L. Hepatoprotective effect of Forsythiae Fructus water extract against carbon tetrachloride-induced liver fibrosis in mice. Journal of Ethnopharmacology 2018;218:27-34. [DOI: 10.1016/j.jep.2018.02.033] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
495 Meivar-Levy I, Sapir T, Berneman D, Weissbach T, Polak-Charcon S, Ravassard P, Tzakis AG, Mor E, Ricordi C, Ferber S. Human liver cells expressing albumin and mesenchymal characteristics give rise to insulin-producing cells. J Transplant 2011;2011:252387. [PMID: 21876779 DOI: 10.1155/2011/252387] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
496 de Gregorio E, Colell A, Morales A, Marí M. Relevance of SIRT1-NF-κB Axis as Therapeutic Target to Ameliorate Inflammation in Liver Disease. Int J Mol Sci 2020;21:E3858. [PMID: 32485811 DOI: 10.3390/ijms21113858] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
497 Pallett LJ, Gill US, Quaglia A, Sinclair LV, Jover-Cobos M, Schurich A, Singh KP, Thomas N, Das A, Chen A, Fusai G, Bertoletti A, Cantrell DA, Kennedy PT, Davies NA, Haniffa M, Maini MK. Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells. Nat Med. 2015;21:591-600. [PMID: 25962123 DOI: 10.1038/nm.3856] [Cited by in Crossref: 147] [Cited by in F6Publishing: 145] [Article Influence: 21.0] [Reference Citation Analysis]
498 Matye DJ, Wang H, Luo W, Sharp RR, Chen C, Gu L, Jones KL, Ding WX, Friedman JE, Li T. Combined ASBT Inhibitor and FGF15 Treatment Improves Therapeutic Efficacy in Experimental Nonalcoholic Steatohepatitis. Cell Mol Gastroenterol Hepatol 2021;12:1001-19. [PMID: 33965587 DOI: 10.1016/j.jcmgh.2021.04.013] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
499 Yeh YH, Liang CY, Chen ML, Tsai FM, Lin YY, Lee MC, Wu JS, Kuo CY. Apoptotic effects of hsian-tsao (Mesona procumbens Hemsley) on hepatic stellate cells mediated by reactive oxygen species and ERK, JNK, and caspase-3 pathways. Food Sci Nutr 2019;7:1891-8. [PMID: 31139404 DOI: 10.1002/fsn3.1046] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
500 Grzelak CA, Ghajar CM. Metastasis 'systems' biology: how are macro-environmental signals transmitted into microenvironmental cues for disseminated tumor cells? Curr Opin Cell Biol 2017;48:79-86. [PMID: 28715713 DOI: 10.1016/j.ceb.2017.06.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
501 Tuohetahuntila M, Molenaar MR, Spee B, Brouwers JF, Wubbolts R, Houweling M, Yan C, Du H, VanderVen BC, Vaandrager AB, Helms JB. Lysosome-mediated degradation of a distinct pool of lipid droplets during hepatic stellate cell activation. J Biol Chem 2017;292:12436-48. [PMID: 28615446 DOI: 10.1074/jbc.M117.778472] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 5.6] [Reference Citation Analysis]
502 Ramirez-Pedraza M, Fernández M. Interplay Between Macrophages and Angiogenesis: A Double-Edged Sword in Liver Disease. Front Immunol 2019;10:2882. [PMID: 31921146 DOI: 10.3389/fimmu.2019.02882] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
503 Ure DR, Trepanier DJ, Mayo PR, Foster RT. Cyclophilin inhibition as a potential treatment for nonalcoholic steatohepatitis (NASH). Expert Opinion on Investigational Drugs 2020;29:163-78. [DOI: 10.1080/13543784.2020.1703948] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
504 Bender D, Hildt E. Effect of Hepatitis Viruses on the Nrf2/Keap1-Signaling Pathway and Its Impact on Viral Replication and Pathogenesis. Int J Mol Sci 2019;20:E4659. [PMID: 31546975 DOI: 10.3390/ijms20184659] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
505 Klepeisz P, Sagmeister S, Haudek-Prinz V, Pichlbauer M, Grasl-Kraupp B, Gerner C. Phenobarbital induces alterations in the proteome of hepatocytes and mesenchymal cells of rat livers. PLoS One 2013;8:e76137. [PMID: 24204595 DOI: 10.1371/journal.pone.0076137] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
506 Sui G, Cheng G, Yuan J, Hou X, Kong X, Niu H. Interleukin (IL)-13, Prostaglandin E2 (PGE2), and Prostacyclin 2 (PGI2) Activate Hepatic Stellate Cells via Protein kinase C (PKC) Pathway in Hepatic Fibrosis. Med Sci Monit. 2018;24:2134-2141. [PMID: 29633755 DOI: 10.12659/msm.906442] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
507 Thapa M, Chinnadurai R, Velazquez VM, Tedesco D, Elrod E, Han JH, Sharma P, Ibegbu C, Gewirtz A, Anania F, Pulendran B, Suthar MS, Grakoui A. Liver fibrosis occurs through dysregulation of MyD88-dependent innate B-cell activity. Hepatology 2015;61:2067-79. [PMID: 25711908 DOI: 10.1002/hep.27761] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
508 Bárcena C, Stefanovic M, Tutusaus A, Martinez-Nieto GA, Martinez L, García-Ruiz C, de Mingo A, Caballeria J, Fernandez-Checa JC, Marí M, Morales A. Angiogenin secretion from hepatoma cells activates hepatic stellate cells to amplify a self-sustained cycle promoting liver cancer. Sci Rep 2015;5:7916. [PMID: 25604905 DOI: 10.1038/srep07916] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
509 Bosselut N, Housset C, Marcelo P, Rey C, Burmester T, Vinh J, Vaubourdolle M, Cadoret A, Baudin B. Distinct proteomic features of two fibrogenic liver cell populations: hepatic stellate cells and portal myofibroblasts. Proteomics. 2010;10:1017-1028. [PMID: 20049859 DOI: 10.1002/pmic.200900257] [Cited by in Crossref: 29] [Cited by in F6Publishing: 42] [Article Influence: 2.4] [Reference Citation Analysis]
510 Hernández-Gea V, Hilscher M, Rozenfeld R, Lim MP, Nieto N, Werner S, Devi LA, Friedman SL. Endoplasmic reticulum stress induces fibrogenic activity in hepatic stellate cells through autophagy. J Hepatol. 2013;59:98-104. [PMID: 23485523 DOI: 10.1016/j.jhep.2013.02.016] [Cited by in Crossref: 144] [Cited by in F6Publishing: 135] [Article Influence: 16.0] [Reference Citation Analysis]
511 Frazer DM, Anderson GJ, Ramm GA, Subramaniam VN, Powell LW. How much iron is too much? Expert Review of Gastroenterology & Hepatology 2014;2:287-90. [DOI: 10.1586/17474124.2.3.287] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
512 Bae M, Kim MB, Kang H, Park YK, Lee JY. Comparison of Carotenoids for Their Antifibrogenic Effects in Hepatic Stellate Cells. Lipids 2019;54:401-10. [PMID: 31140624 DOI: 10.1002/lipd.12157] [Reference Citation Analysis]
513 Norona LM, Nguyen DG, Gerber DA, Presnell SC, LeCluyse EL. Editor's Highlight: Modeling Compound-Induced Fibrogenesis In Vitro Using Three-Dimensional Bioprinted Human Liver Tissues. Toxicol Sci 2016;154:354-67. [PMID: 27605418 DOI: 10.1093/toxsci/kfw169] [Cited by in Crossref: 85] [Cited by in F6Publishing: 74] [Article Influence: 14.2] [Reference Citation Analysis]
514 Rogers AB, Dintzis RZ. Liver and Gallbladder. Comparative Anatomy and Histology. Elsevier; 2012. pp. 193-201. [DOI: 10.1016/b978-0-12-381361-9.00013-5] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
515 Zhang Z, Lin C, Peng L, Ouyang Y, Cao Y, Wang J, Friedman SL, Guo J. High mobility group box 1 activates Toll like receptor 4 signaling in hepatic stellate cells. Life Sci 2012;91:207-12. [PMID: 22841886 DOI: 10.1016/j.lfs.2012.07.009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
516 Pines M. Halofuginone for fibrosis, regeneration and cancer in the gastrointestinal tract. World J Gastroenterol 2014; 20(40): 14778-14786 [PMID: 25356039 DOI: 10.3748/wjg.v20.i40.14778] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
517 Zhang R, Gao X, Zuo J, Hu B, Yang J, Zhao J, Chen J. STMN1 upregulation mediates hepatocellular carcinoma and hepatic stellate cell crosstalk to aggravate cancer by triggering the MET pathway. Cancer Sci 2020;111:406-17. [PMID: 31785057 DOI: 10.1111/cas.14262] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
518 Brea R, Motiño O, Francés D, García-Monzón C, Vargas J, Fernández-Velasco M, Boscá L, Casado M, Martín-Sanz P, Agra N. PGE2 induces apoptosis of hepatic stellate cells and attenuates liver fibrosis in mice by downregulating miR-23a-5p and miR-28a-5p. Biochim Biophys Acta Mol Basis Dis 2018;1864:325-37. [PMID: 29109031 DOI: 10.1016/j.bbadis.2017.11.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
519 Feng G, Zhang JY, Zeng QL, Yu X, Zhang Z, Lv S, Xu X, Wang FS. Interleukin-21 mediates hepatitis B virus-associated liver cirrhosis by activating hepatic stellate cells. Hepatol Res. 2014;44:E198-E205. [PMID: 23905760 DOI: 10.1111/hepr.12215] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
520 Karsdal MA, Krarup H, Sand JM, Christensen PB, Gerstoft J, Leeming DJ, Weis N, Schaffalitzky de Muckadell OB, Krag A. Review article: the efficacy of biomarkers in chronic fibroproliferative diseases - early diagnosis and prognosis, with liver fibrosis as an exemplar. Aliment Pharmacol Ther. 2014;40:233-249. [PMID: 24909260 DOI: 10.1111/apt.12820] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 6.8] [Reference Citation Analysis]
521 Imai Y, Yoshida O, Watanabe T, Yukimoto A, Koizumi Y, Ikeda Y, Tokumoto Y, Hirooka M, Abe M, Hiasa Y. Stimulated hepatic stellate cell promotes progression of hepatocellular carcinoma due to protein kinase R activation. PLoS One 2019;14:e0212589. [PMID: 30794626 DOI: 10.1371/journal.pone.0212589] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
522 Kim JY, An HJ, Kim WH, Gwon MG, Gu H, Park YY, Park KK. Anti-fibrotic Effects of Synthetic Oligodeoxynucleotide for TGF-β1 and Smad in an Animal Model of Liver Cirrhosis. Mol Ther Nucleic Acids 2017;8:250-63. [PMID: 28918026 DOI: 10.1016/j.omtn.2017.06.022] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
523 Xia Y, Zhen L, Li H, Wang S, Chen S, Wang C, Yang X. MIRLET7BHG promotes hepatocellular carcinoma progression by activating hepatic stellate cells through exosomal SMO to trigger Hedgehog pathway. Cell Death Dis 2021;12:326. [PMID: 33771969 DOI: 10.1038/s41419-021-03494-1] [Reference Citation Analysis]
524 Elzamly S, Agina HA, Elbalshy AE, Abuhashim M, Saad E, Abd Elmageed ZY. Integration of VEGF and α-SMA Expression Improves the Prediction Accuracy of Fibrosis in Chronic Hepatitis C Liver Biopsy. Appl Immunohistochem Mol Morphol 2017;25:261-70. [PMID: 26990742 DOI: 10.1097/PAI.0000000000000299] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
525 Omar R, Yang J, Liu H, Davies NM, Gong Y. Hepatic Stellate Cells in Liver Fibrosis and siRNA-Based Therapy. Rev Physiol Biochem Pharmacol 2016;172:1-37. [PMID: 27534415 DOI: 10.1007/112_2016_6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
526 Delogu W, Caligiuri A, Provenzano A, Rosso C, Bugianesi E, Coratti A, Macias-Barragan J, Galastri S, Di Maira G, Marra F. Myostatin regulates the fibrogenic phenotype of hepatic stellate cells via c-jun N-terminal kinase activation. Dig Liver Dis 2019;51:1400-8. [PMID: 31005555 DOI: 10.1016/j.dld.2019.03.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
527 Lee YS, Jeong WI. Retinoic acids and hepatic stellate cells in liver disease. J Gastroenterol Hepatol. 2012;27 Suppl 2:75-79. [PMID: 22320921 DOI: 10.1111/j.1440-1746.2011.07007.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 56] [Article Influence: 5.8] [Reference Citation Analysis]
528 Liu H, Dong F, Li G, Niu M, Zhang C, Han Y, He L, Yin P, Wang B, Sang X, Li R, Wang J, Bai Z, Xiao X. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways. Journal of Ethnopharmacology 2018;210:232-41. [DOI: 10.1016/j.jep.2017.08.029] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
529 Guo J, Loke J, Zheng F, Hong F, Yea S, Fukata M, Tarocchi M, Abar OT, Huang H, Sninsky JJ, Friedman SL. Functional linkage of cirrhosis-predictive single nucleotide polymorphisms of Toll-like receptor 4 to hepatic stellate cell responses. Hepatology. 2009;49:960-968. [PMID: 19085953 DOI: 10.1002/hep.22697] [Cited by in Crossref: 147] [Cited by in F6Publishing: 148] [Article Influence: 11.3] [Reference Citation Analysis]
530 Xie ZY, Xiao ZH, Wang FF. Inhibition of autophagy reverses alcohol-induced hepatic stellate cells activation through activation of Nrf2-Keap1-ARE signaling pathway. Biochimie. 2018;147:55-62. [PMID: 29305174 DOI: 10.1016/j.biochi.2017.12.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
531 Xiong X, Kuang H, Ansari S, Liu T, Gong J, Wang S, Zhao XY, Ji Y, Li C, Guo L, Zhou L, Chen Z, Leon-Mimila P, Chung MT, Kurabayashi K, Opp J, Campos-Pérez F, Villamil-Ramírez H, Canizales-Quinteros S, Lyons R, Lumeng CN, Zhou B, Qi L, Huertas-Vazquez A, Lusis AJ, Xu XZS, Li S, Yu Y, Li JZ, Lin JD. Landscape of Intercellular Crosstalk in Healthy and NASH Liver Revealed by Single-Cell Secretome Gene Analysis. Mol Cell 2019;75:644-660.e5. [PMID: 31398325 DOI: 10.1016/j.molcel.2019.07.028] [Cited by in Crossref: 148] [Cited by in F6Publishing: 148] [Article Influence: 74.0] [Reference Citation Analysis]
532 Susutlertpanya W, Wakuda H, Otani N, Kuramoto T, Li L, Kuranari M, Sekiguchi A, Kudo H, Uchida T, Imai H, Uemura N. Histological evaluation of nintedanib in non-alcoholic steatohepatitis mice. Life Sciences 2019;228:251-7. [DOI: 10.1016/j.lfs.2019.05.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
533 Hauso O, Gustafsson BI, Nordrum IS, Waldum HL. The effect of terguride in carbon tetrachloride-induced liver fibrosis in rat. Exp Biol Med (Maywood) 2008;233:1385-8. [PMID: 18703754 DOI: 10.3181/0804-RM-137] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
534 Gellrich L, Merk D. Therapeutic Potential of Peroxisome Proliferator-Activated Receptor Modulation in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. Nuclear Receptor Research 2017;4. [DOI: 10.11131/2017/101310] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
535 Liu XY, Liu RX, Hou F, Cui LJ, Li CY, Chi C, Yi E, Wen Y, Yin CH. Fibronectin expression is critical for liver fibrogenesis in vivo and in vitro. Mol Med Rep. 2016;14:3669-3675. [PMID: 27572112 DOI: 10.3892/mmr.2016.5673] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 6.7] [Reference Citation Analysis]
536 Zhang R, Lin X, Liu H, Ma M, Chen J, Chen J, Gao D, Cui J, Chen R. Activated hepatic stellate cells promote progression of post-heat residual hepatocellular carcinoma from autophagic survival to proliferation. International Journal of Hyperthermia 2019;36:252-62. [DOI: 10.1080/02656736.2018.1558459] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
537 Lin N, Chen S, Pan W, Xu L, Hu K, Xu R. NP603, a novel and potent inhibitor of FGFR1 tyrosine kinase, inhibits hepatic stellate cell proliferation and ameliorates hepatic fibrosis in rats. Am J Physiol Cell Physiol 2011;301:C469-77. [PMID: 21543745 DOI: 10.1152/ajpcell.00452.2010] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
538 Karsdal MA, Manon-Jensen T, Genovese F, Kristensen JH, Nielsen MJ, Sand JM, Hansen NU, Bay-Jensen AC, Bager CL, Krag A, Blanchard A, Krarup H, Leeming DJ, Schuppan D. Novel insights into the function and dynamics of extracellular matrix in liver fibrosis. Am J Physiol Gastrointest Liver Physiol 2015;308:G807-30. [PMID: 25767261 DOI: 10.1152/ajpgi.00447.2014] [Cited by in Crossref: 138] [Cited by in F6Publishing: 132] [Article Influence: 19.7] [Reference Citation Analysis]
539 Zhang DY, Friedman SL. Fibrosis-dependent mechanisms of hepatocarcinogenesis. Hepatology 2012;56:769-75. [PMID: 22378017 DOI: 10.1002/hep.25670] [Cited by in Crossref: 249] [Cited by in F6Publishing: 240] [Article Influence: 24.9] [Reference Citation Analysis]
540 Li D, He L, Guo H, Chen H, Shan H. Targeting activated hepatic stellate cells (aHSCs) for liver fibrosis imaging. EJNMMI Res. 2015;5:71. [PMID: 26650603 DOI: 10.1186/s13550-015-0151-x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 5.6] [Reference Citation Analysis]
541 Biondo-Simões Mde L, Zamboni CG, Martins E, Lechinewski LD, Ioshii SO, Robes RR. Impact of hypertension in liver regeneration in rats. Acta Cir Bras 2012;27:460-4. [PMID: 22760830 DOI: 10.1590/s0102-86502012000700005] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
542 Rombouts K, Carloni V, Mello T, Omenetti S, Galastri S, Madiai S, Galli A, Pinzani M. Myristoylated Alanine-Rich protein Kinase C Substrate (MARCKS) expression modulates the metastatic phenotype in human and murine colon carcinoma in vitro and in vivo. Cancer Letters 2013;333:244-52. [DOI: 10.1016/j.canlet.2013.01.040] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
543 Lai KKY, Kweon SM, Chi F, Hwang E, Kabe Y, Higashiyama R, Qin L, Yan R, Wu RP, Lai K, Fujii N, French S, Xu J, Wang JY, Murali R, Mishra L, Lee JS, Ntambi JM, Tsukamoto H. Stearoyl-CoA Desaturase Promotes Liver Fibrosis and Tumor Development in Mice via a Wnt Positive-Signaling Loop by Stabilization of Low-Density Lipoprotein-Receptor-Related Proteins 5 and 6. Gastroenterology 2017;152:1477-91. [PMID: 28143772 DOI: 10.1053/j.gastro.2017.01.021] [Cited by in Crossref: 60] [Cited by in F6Publishing: 59] [Article Influence: 12.0] [Reference Citation Analysis]
544 Getachew Y, Cusimano FA, Gopal P, Reisman SA, Shay JW. The Synthetic Triterpenoid RTA 405 (CDDO-EA) Halts Progression of Liver Fibrosis and Reduces Hepatocellular Carcinoma Size Resulting in Increased Survival in an Experimental Model of Chronic Liver Injury. Toxicol Sci. 2016;149:111-120. [PMID: 26443840 DOI: 10.1093/toxsci/kfv213] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
545 Nguyen PT, Kanno K, Pham QT, Kikuchi Y, Kakimoto M, Kobayashi T, Otani Y, Kishikawa N, Miyauchi M, Arihiro K, Ito M, Tazuma S. Senescent hepatic stellate cells caused by deoxycholic acid modulates malignant behavior of hepatocellular carcinoma. J Cancer Res Clin Oncol 2020;146:3255-68. [PMID: 32870388 DOI: 10.1007/s00432-020-03374-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
546 Große-Segerath L, Lammert E. Role of vasodilation in liver regeneration and health. Biol Chem 2021;402:1009-19. [PMID: 33908220 DOI: 10.1515/hsz-2021-0155] [Reference Citation Analysis]
547 Paschos KA, Majeed AW, Bird NC. Natural history of hepatic metastases from colorectal cancer - pathobiological pathways with clinical significance. World J Gastroenterol 2014; 20(14): 3719-3737 [PMID: 24744570 DOI: 10.3748/wjg.v20.i14.3719] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 32] [Article Influence: 4.9] [Reference Citation Analysis]
548 Das D, Fayazzadeh E, Li X, Koirala N, Wadera A, Lang M, Zernic M, Panick C, Nesbitt P, McLennan G. Quiescent hepatic stellate cells induce toxicity and sensitivity to doxorubicin in cancer cells through a caspase-independent cell death pathway: Central role of apoptosis-inducing factor. J Cell Physiol 2020;235:6167-82. [PMID: 31975386 DOI: 10.1002/jcp.29545] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
549 Xinguang Y, Huixing Y, Xiaowei W, Xiaojun W, Linghua Y. R-spondin1 arguments hepatic fibrogenesis in vivo and in vitro. J Surg Res 2015;193:598-605. [PMID: 25218283 DOI: 10.1016/j.jss.2014.08.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
550 Liu D, Yovchev MI, Zhang J, Alfieri AA, Tchaikovskaya T, Laconi E, Dabeva MD. Identification and characterization of mesenchymal-epithelial progenitor-like cells in normal and injured rat liver. Am J Pathol. 2015;185:110-128. [PMID: 25447047 DOI: 10.1016/j.ajpath.2014.08.029] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
551 Liang YJ, Luo J, Lu Q, Zhou Y, Wu HW, Zheng D, Ren YY, Sun KY, Wang Y, Zhang ZS. Gene profile of chemokines on hepatic stellate cells of schistosome-infected mice and antifibrotic roles of CXCL9/10 on liver non-parenchymal cells. PLoS One 2012;7:e42490. [PMID: 22905138 DOI: 10.1371/journal.pone.0042490] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
552 Erlinger S. The Thalidomide renaissance. Gastroentérologie Clinique et Biologique 2010;34:426-8. [DOI: 10.1016/j.gcb.2010.06.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
553 Grünwald B, Harant V, Schaten S, Frühschütz M, Spallek R, Höchst B, Stutzer K, Berchtold S, Erkan M, Prokopchuk O, Martignoni M, Esposito I, Heikenwalder M, Gupta A, Siveke J, Saftig P, Knolle P, Wohlleber D, Krüger A. Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver. Gastroenterology 2016;151:1011-1024.e7. [PMID: 27506299 DOI: 10.1053/j.gastro.2016.07.043] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 8.5] [Reference Citation Analysis]
554 Luo X, Zhang D, Xie J, Su Q, He X, Bai R, Gao G, Pan W. MicroRNA-96 Promotes Schistosomiasis Hepatic Fibrosis in Mice by Suppressing Smad7. Mol Ther Methods Clin Dev 2018;11:73-82. [PMID: 30406154 DOI: 10.1016/j.omtm.2018.10.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
555 Zhu NL, Asahina K, Wang J, Ueno A, Lazaro R, Miyaoka Y, Miyajima A, Tsukamoto H. Hepatic stellate cell-derived delta-like homolog 1 (DLK1) protein in liver regeneration. J Biol Chem. 2012;287:10355-10367. [PMID: 22298767 DOI: 10.1074/jbc.m111.312751] [Cited by in Crossref: 62] [Cited by in F6Publishing: 36] [Article Influence: 6.2] [Reference Citation Analysis]
556 Lee SW, Kim SM, Hur W, Kang BY, Lee HL, Nam H, Yoo SH, Sung PS, Kwon JH, Jang JW, Kim SJ, Yoon SK. Tenofovir disoproxil fumarate directly ameliorates liver fibrosis by inducing hepatic stellate cell apoptosis via downregulation of PI3K/Akt/mTOR signaling pathway. PLoS One 2021;16:e0261067. [PMID: 34879114 DOI: 10.1371/journal.pone.0261067] [Reference Citation Analysis]
557 Riaz F, Li D. Non-coding RNA Associated Competitive Endogenous RNA Regulatory Network: Novel Therapeutic Approach in Liver Fibrosis. Curr Gene Ther 2019;19:305-17. [PMID: 31696817 DOI: 10.2174/1566523219666191107113046] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
558 Zhang Y, Miao H, Guan H, Wang C, Wang Z, Ji L. Long-term diosbulbin B treatment induced liver fibrosis in mice. Chemico-Biological Interactions 2019;298:15-23. [DOI: 10.1016/j.cbi.2018.10.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
559 Kim BH, Yoon JH, Yang JI, Myung SJ, Lee JH, Jung EU, Yu SJ, Kim YJ, Lee HS, Kim CY. Guggulsterone attenuates activation and survival of hepatic stellate cell by inhibiting nuclear factor kappa B activation and inducing apoptosis. J Gastroenterol Hepatol 2013;28:1859-68. [PMID: 23808824 DOI: 10.1111/jgh.12314] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
560 Meier RP, Mahou R, Morel P, Meyer J, Montanari E, Muller YD, Christofilopoulos P, Wandrey C, Gonelle-Gispert C, Bühler LH. Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice. J Hepatol. 2015;62:634-641. [PMID: 25450712 DOI: 10.1016/j.jhep.2014.10.030] [Cited by in Crossref: 86] [Cited by in F6Publishing: 82] [Article Influence: 10.8] [Reference Citation Analysis]
561 Qu K, Liu T, Lin T, Zhang X, Cui R, Liu S, Meng F, Zhang J, Tai M, Wan Y, Liu C. Tyrosine kinase inhibitors: friends or foe in treatment of hepatic fibrosis? Oncotarget 2016;7:67650-60. [PMID: 27588502 DOI: 10.18632/oncotarget.11767] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
562 Gan DK, Zhu X. Role of RhoA in occurrence and development of liver fibrosis. Shijie Huaren Xiaohua Zazhi 2016; 24(11): 1682-1687 [DOI: 10.11569/wcjd.v24.i11.1682] [Reference Citation Analysis]
563 Fausther M, Goree JR, Lavoie ÉG, Graham AL, Sévigny J, Dranoff JA. Establishment and characterization of rat portal myofibroblast cell lines. PLoS One 2015;10:e0121161. [PMID: 25822334 DOI: 10.1371/journal.pone.0121161] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
564 Duval F, Moreno-Cuevas JE, González-Garza MT, Maldonado-Bernal C, Cruz-Vega DE. Liver fibrosis and mechanisms of the protective action of medicinal plants targeting inflammation and the immune response. Int J Inflam 2015;2015:943497. [PMID: 25954568 DOI: 10.1155/2015/943497] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 4.1] [Reference Citation Analysis]
565 Wong JSL, Kwok GGW, Tang V, Li BCW, Leung R, Chiu J, Ma KW, She WH, Tsang J, Lo CM, Cheung TT, Yau T. Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors. J Immunother Cancer 2021;9:e001945. [PMID: 33563773 DOI: 10.1136/jitc-2020-001945] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
566 Fujii H, Kawada N. Inflammation and fibrogenesis in steatohepatitis. J Gastroenterol. 2012;47:215-225. [PMID: 22310735 DOI: 10.1007/s00535-012-0527-x] [Cited by in Crossref: 99] [Cited by in F6Publishing: 99] [Article Influence: 9.9] [Reference Citation Analysis]
567 Povero D, Panera N, Eguchi A, Johnson CD, Papouchado BG, de Araujo Horcel L, Pinatel EM, Alisi A, Nobili V, Feldstein AE. Lipid-induced hepatocyte-derived extracellular vesicles regulate hepatic stellate cell via microRNAs targeting PPAR-γ. Cell Mol Gastroenterol Hepatol 2015;1:646-663.e4. [PMID: 26783552 DOI: 10.1016/j.jcmgh.2015.07.007] [Cited by in Crossref: 82] [Cited by in F6Publishing: 87] [Article Influence: 11.7] [Reference Citation Analysis]
568 Dang SS, Li YP. Advances in understanding the role of transforming growth factor-β1 in the pathogenesis of liver fibrosis. Shijie Huaren Xiaohua Zazhi 2010; 18(16): 1631-1636 [DOI: 10.11569/wcjd.v18.i16.1631] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
569 Mantovani A, Taliento A, Zusi C, Baselli G, Prati D, Granata S, Zaza G, Colecchia A, Maffeis C, Byrne CD, Valenti L, Targher G. PNPLA3 I148M gene variant and chronic kidney disease in type 2 diabetic patients with NAFLD: Clinical and experimental findings. Liver Int 2020;40:1130-41. [PMID: 32125756 DOI: 10.1111/liv.14419] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
570 Gordon JR, Ma Y, Churchman L, Gordon SA, Dawicki W. Regulatory dendritic cells for immunotherapy in immunologic diseases. Front Immunol. 2014;5:7. [PMID: 24550907 DOI: 10.3389/fimmu.2014.00007] [Cited by in Crossref: 116] [Cited by in F6Publishing: 111] [Article Influence: 14.5] [Reference Citation Analysis]
571 Chatani N, Kamada Y, Kizu T, Ogura S, Furuta K, Egawa M, Hamano M, Ezaki H, Kiso S, Shimono A, Ouchi N, Yoshida Y, Takehara T. Secreted frizzled-related protein 5 (Sfrp5) decreases hepatic stellate cell activation and liver fibrosis. Liver Int 2015;35:2017-26. [DOI: 10.1111/liv.12757] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
572 Fujimoto M, Tsuneyama K, Chen SY, Nishida T, Chen JL, Chen YC, Fujimoto T, Imura J, Shimada Y. Study of the effects of monacolin k and other constituents of red yeast rice on obesity, insulin-resistance, hyperlipidemia, and nonalcoholic steatohepatitis using a mouse model of metabolic syndrome. Evid Based Complement Alternat Med 2012;2012:892697. [PMID: 23320041 DOI: 10.1155/2012/892697] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
573 Wang Y, Qu A, Wang H. Signal transducer and activator of transcription 4 in liver diseases. Int J Biol Sci 2015;11:448-55. [PMID: 25798064 DOI: 10.7150/ijbs.11164] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
574 Ma X, Luo Q, Zhu H, Liu X, Dong Z, Zhang K, Zou Y, Wu J, Ge J, Sun A. Aldehyde dehydrogenase 2 activation ameliorates CCl4 -induced chronic liver fibrosis in mice by up-regulating Nrf2/HO-1 antioxidant pathway. J Cell Mol Med 2018. [PMID: 29799157 DOI: 10.1111/jcmm.13677] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
575 Fujimoto J, Iimuro Y. Carbon Tetrachloride-Induced Hepatotoxicity*. Comprehensive Toxicology. Elsevier; 2010. pp. 437-55. [DOI: 10.1016/b978-0-08-046884-6.01018-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
576 Gupta G, Khadem F, Uzonna JE. Role of hepatic stellate cell (HSC)-derived cytokines in hepatic inflammation and immunity. Cytokine 2019;124:154542. [PMID: 30241896 DOI: 10.1016/j.cyto.2018.09.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
577 Abshagen K, Rotberg T, Genz B, Vollmar B. No significant impact of Foxf1 siRNA treatment in acute and chronic CCl4 liver injury. Exp Biol Med (Maywood) 2017;242:1389-97. [PMID: 28629226 DOI: 10.1177/1535370217716425] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
578 Asahina K, Zhou B, Pu WT, Tsukamoto H. Septum transversum-derived mesothelium gives rise to hepatic stellate cells and perivascular mesenchymal cells in developing mouse liver. Hepatology. 2011;53:983-995. [PMID: 21294146 DOI: 10.1002/hep.24119] [Cited by in Crossref: 198] [Cited by in F6Publishing: 188] [Article Influence: 18.0] [Reference Citation Analysis]
579 Perugorria MJ, Olaizola P, Labiano I, Esparza-Baquer A, Marzioni M, Marin JJG, Bujanda L, Banales JM. Wnt-β-catenin signalling in liver development, health and disease. Nat Rev Gastroenterol Hepatol 2019;16:121-36. [PMID: 30451972 DOI: 10.1038/s41575-018-0075-9] [Cited by in Crossref: 105] [Cited by in F6Publishing: 112] [Article Influence: 35.0] [Reference Citation Analysis]
580 Pritchard MT, McCracken JM. Identifying Novel Targets for Treatment of Liver Fibrosis: What Can We Learn from Injured Tissues which Heal Without a Scar? Curr Drug Targets 2015;16:1332-46. [PMID: 26302807 DOI: 10.2174/1389450116666150825111439] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
581 Ivanov AV, Valuev-Elliston VT, Tyurina DA, Ivanova ON, Kochetkov SN, Bartosch B, Isaguliants MG. Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis. Oncotarget. 2017;8:3895-3932. [PMID: 27965466 DOI: 10.18632/oncotarget.13904] [Cited by in Crossref: 67] [Cited by in F6Publishing: 60] [Article Influence: 16.8] [Reference Citation Analysis]
582 Hirsova P, Ibrahim SH, Verma VK, Morton LA, Shah VH, LaRusso NF, Gores GJ, Malhi H. Extracellular vesicles in liver pathobiology: Small particles with big impact. Hepatology. 2016;64:2219-2233. [PMID: 27628960 DOI: 10.1002/hep.28814] [Cited by in Crossref: 111] [Cited by in F6Publishing: 105] [Article Influence: 18.5] [Reference Citation Analysis]
583 Zhao H, Li Y, He L, Pu W, Yu W, Li Y, Wu YT, Xu C, Wei Y, Ding Q, Song BL, Huang H, Zhou B. In Vivo AAV-CRISPR/Cas9-Mediated Gene Editing Ameliorates Atherosclerosis in Familial Hypercholesterolemia. Circulation 2020;141:67-79. [PMID: 31779484 DOI: 10.1161/CIRCULATIONAHA.119.042476] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
584 Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev. 2017;121:27-42. [PMID: 28506744 DOI: 10.1016/j.addr.2017.05.007] [Cited by in Crossref: 359] [Cited by in F6Publishing: 356] [Article Influence: 71.8] [Reference Citation Analysis]
585 Lim HJ, Kim M. EZH2 as a Potential Target for NAFLD Therapy. Int J Mol Sci 2020;21:E8617. [PMID: 33207561 DOI: 10.3390/ijms21228617] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
586 Kawada N, Parola M. Interactions of Stellate Cells with Other Non-Parenchymal Cells. Stellate Cells in Health and Disease. Elsevier; 2015. pp. 185-207. [DOI: 10.1016/b978-0-12-800134-9.00012-9] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
587 Wang X, Zhao W, Wang J, Shi K, Qin X, Kong Q, Wang G, Mu L, Li H, Sun B. Bone marrow stromal cells inhibit the activation of liver cirrhotic fat-storing cells via adrenomedullin secretion. Dig Dis Sci. 2015;60:1325-1334. [PMID: 25445161 DOI: 10.1007/s10620-014-3423-9] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
588 Le Guilcher C, Garcin I, Dellis O, Cauchois F, Tebbi A, Doignon I, Guettier C, Julien B, Tordjmann T. The P2X4 purinergic receptor regulates hepatic myofibroblast activation during liver fibrogenesis. J Hepatol 2018;69:644-53. [PMID: 29802948 DOI: 10.1016/j.jhep.2018.05.020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
589 Liu Z, van Grunsven LA, Van Rossen E, Schroyen B, Timmermans JP, Geerts A, Reynaert H. Blebbistatin inhibits contraction and accelerates migration in mouse hepatic stellate cells. Br J Pharmacol. 2010;159:304-315. [PMID: 20039876 DOI: 10.1111/j.1476-5381.2009.00477.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 4.1] [Reference Citation Analysis]
590 Zhang F, Ni C, Kong D, Zhang X, Zhu X, Chen L, Lu Y, Zheng S. Ligustrazine attenuates oxidative stress-induced activation of hepatic stellate cells by interrupting platelet-derived growth factor-β receptor-mediated ERK and p38 pathways. Toxicol Appl Pharmacol. 2012;265:51-60. [PMID: 23022513 DOI: 10.1016/j.taap.2012.09.016] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 3.8] [Reference Citation Analysis]
591 Samuel CS, Royce SG, Hewitson TD, Denton KM, Cooney TE, Bennett RG. Anti-fibrotic actions of relaxin. Br J Pharmacol 2017;174:962-76. [PMID: 27250825 DOI: 10.1111/bph.13529] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 9.2] [Reference Citation Analysis]
592 Kluwe J, Pradere JP, Gwak GY, Mencin A, De Minicis S, Osterreicher CH, Colmenero J, Bataller R, Schwabe RF. Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition. Gastroenterology. 2010;138:347-359. [PMID: 19782079 DOI: 10.1053/j.gastro.2009.09.015] [Cited by in Crossref: 141] [Cited by in F6Publishing: 142] [Article Influence: 10.8] [Reference Citation Analysis]
593 Davidson MD, Song KH, Lee MH, Llewellyn J, Du Y, Baker BM, Wells RG, Burdick JA. Engineered Fibrous Networks To Investigate the Influence of Fiber Mechanics on Myofibroblast Differentiation. ACS Biomater Sci Eng 2019;5:3899-908. [PMID: 33438429 DOI: 10.1021/acsbiomaterials.8b01276] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 7.3] [Reference Citation Analysis]
594 MadanKumar P, NaveenKumar P, Manikandan S, Devaraj H, NiranjaliDevaraj S. Morin ameliorates chemically induced liver fibrosis in vivo and inhibits stellate cell proliferation in vitro by suppressing Wnt/β-catenin signaling. Toxicol Appl Pharmacol 2014;277:210-20. [PMID: 24657339 DOI: 10.1016/j.taap.2014.03.008] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 5.3] [Reference Citation Analysis]
595 Wu M, Miao H, Fu R, Zhang J, Zheng W. Hepatic Stellate Cell: A Potential Target for Hepatocellular Carcinoma. Curr Mol Pharmacol 2020;13:261-72. [PMID: 32091349 DOI: 10.2174/1874467213666200224102820] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
596 Momen-Heravi F, Catalano D, Talis A, Szabo G, Bala S. Protective effect of LNA-anti-miR-132 therapy on liver fibrosis in mice. Mol Ther Nucleic Acids 2021;25:155-67. [PMID: 34458001 DOI: 10.1016/j.omtn.2021.05.007] [Reference Citation Analysis]
597 [DOI: 10.1101/733931] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
598 Choi SS, Syn WK, Karaca GF, Omenetti A, Moylan CA, Witek RP, Agboola KM, Jung Y, Michelotti GA, Diehl AM. Leptin promotes the myofibroblastic phenotype in hepatic stellate cells by activating the hedgehog pathway. J Biol Chem. 2010;285:36551-36560. [PMID: 20843817 DOI: 10.1074/jbc.m110.168542] [Cited by in Crossref: 110] [Cited by in F6Publishing: 71] [Article Influence: 9.2] [Reference Citation Analysis]
599 Affo S, Nair A, Brundu F, Ravichandra A, Bhattacharjee S, Matsuda M, Chin L, Filliol A, Wen W, Song X, Decker A, Worley J, Caviglia JM, Yu L, Yin D, Saito Y, Savage T, Wells RG, Mack M, Zender L, Arpaia N, Remotti HE, Rabadan R, Sims P, Leblond AL, Weber A, Riener MO, Stockwell BR, Gaublomme J, Llovet JM, Kalluri R, Michalopoulos GK, Seki E, Sia D, Chen X, Califano A, Schwabe RF. Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations. Cancer Cell 2021;39:866-882.e11. [PMID: 33930309 DOI: 10.1016/j.ccell.2021.03.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
600 Kim KH, Chen CC, Alpini G, Lau LF. CCN1 induces hepatic ductular reaction through integrin αvβ₅-mediated activation of NF-κB. J Clin Invest 2015;125:1886-900. [PMID: 25822023 DOI: 10.1172/JCI79327] [Cited by in Crossref: 60] [Cited by in F6Publishing: 39] [Article Influence: 8.6] [Reference Citation Analysis]
601 Arguello G, Balboa E, Arrese M, Zanlungo S. Recent insights on the role of cholesterol in non-alcoholic fatty liver disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2015;1852:1765-78. [DOI: 10.1016/j.bbadis.2015.05.015] [Cited by in Crossref: 127] [Cited by in F6Publishing: 134] [Article Influence: 18.1] [Reference Citation Analysis]
602 Lin J, Wu JF, Zhang Q, Zhang HW, Cao GW. Virus-related liver cirrhosis: Molecular basis and therapeutic options. World J Gastroenterol 2014; 20(21): 6457-6469 [PMID: 24914367 DOI: 10.3748/wjg.v20.i21.6457] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
603 Acquaviva A, Vecchio D, Arezzini B, Comporti M, Gardi C. Signaling pathways involved in isoprostane-mediated fibrogenic effects in rat hepatic stellate cells. Free Radical Biology and Medicine 2013;65:201-7. [DOI: 10.1016/j.freeradbiomed.2013.06.023] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
604 Sadik NAH, Shaker OG, Ghanem HZ, Hassan HA, Abdel-hamid AZ. Single-nucleotide polymorphism of Toll-like receptor 4 and interleukin-10 in response to interferon-based therapy in Egyptian chronic hepatitis C patients. Arch Virol 2015;160:2181-95. [DOI: 10.1007/s00705-015-2493-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
605 Lu L, Feng M, Gu J, Xia Z, Zhang H, Zheng S, Duan Z, Hu R, Wang J, Shi W, Ji C, Shen Y, Chen G, Zheng SG, Han YP. Restoration of intrahepatic regulatory T cells through MMP-9/13-dependent activation of TGF-β is critical for immune homeostasis following acute liver injury. J Mol Cell Biol 2013;5:369-79. [PMID: 24280647 DOI: 10.1093/jmcb/mjt042] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
606 Buonaguro L, Tagliamonte M, Petrizzo A, Damiano E, Tornesello ML, Buonaguro FM. Cellular prognostic markers in hepatocellular carcinoma. Future Oncol 2015;11:1591-8. [PMID: 26043213 DOI: 10.2217/fon.15.39] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
607 Crawford JM. Histologic findings in alcoholic liver disease. Clin Liver Dis. 2012;16:699-716. [PMID: 23101978 DOI: 10.1016/j.cld.2012.08.004] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
608 Nadanaka S, Kagiyama S, Kitagawa H. Roles of EXTL2, a member of the EXT family of tumour suppressors, in liver injury and regeneration processes. Biochem J 2013;454:133-45. [PMID: 23734945 DOI: 10.1042/BJ20130323] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
609 Dewdney B, Hebbard L. Implementing genetic screening for the management of hepatic disease. Hepatobiliary Surg Nutr 2017;6:359-62. [PMID: 29152490 DOI: 10.21037/hbsn.2017.07.06] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
610 Pohl K, Moodley P, Dhanda AD. Alcohol's Impact on the Gut and Liver. Nutrients 2021;13:3170. [PMID: 34579046 DOI: 10.3390/nu13093170] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
611 Paiva LA, Coelho KA, Luna-Gomes T, El-Cheikh MC, Borojevic R, Perez SA, Bozza PT, Bandeira-Melo C. Schistosome infection-derived Hepatic Stellate Cells are cellular source of prostaglandin D₂: role in TGF-β-stimulated VEGF production. Prostaglandins Leukot Essent Fatty Acids 2015;95:57-62. [PMID: 25687497 DOI: 10.1016/j.plefa.2015.01.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
612 Greenbaum LE, Wells RG. The role of stem cells in liver repair and fibrosis. Int J Biochem Cell Biol. 2011;43:222-229. [PMID: 19914396 DOI: 10.1016/j.biocel.2009.11.006] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 3.6] [Reference Citation Analysis]
613 Chen R, Sain NM, Harlow KT, Chen YJ, Shires PK, Heller R, Beebe SJ. A protective effect after clearance of orthotopic rat hepatocellular carcinoma by nanosecond pulsed electric fields. Eur J Cancer. 2014;50:2705-2713. [PMID: 25081978 DOI: 10.1016/j.ejca.2014.07.006] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 5.8] [Reference Citation Analysis]
614 Fahey S, Dempsey E, Long A. The role of chemokines in acute and chronic hepatitis C infection. Cell Mol Immunol 2014;11:25-40. [PMID: 23954947 DOI: 10.1038/cmi.2013.37] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 4.8] [Reference Citation Analysis]
615 Li T, Liu J, Wang Y, Zhou C, Shi Q, Huang S, Yang C, Chen Y, Bai Y, Xiong B. Liver fibrosis promotes immunity escape but limits the size of liver tumor in a rat orthotopic transplantation model. Sci Rep 2021;11:22846. [PMID: 34819565 DOI: 10.1038/s41598-021-02155-9] [Reference Citation Analysis]
616 Khanam A, Saleeb PG, Kottilil S. Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured? Cells 2021;10:1097. [PMID: 34064375 DOI: 10.3390/cells10051097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
617 Ezquer F, Bahamonde J, Huang YL, Ezquer M. Administration of multipotent mesenchymal stromal cells restores liver regeneration and improves liver function in obese mice with hepatic steatosis after partial hepatectomy. Stem Cell Res Ther 2017;8:20. [PMID: 28129776 DOI: 10.1186/s13287-016-0469-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
618 Yang L, Jin GH, Zhou JY. The Role of Ceramide in the Pathogenesis of Alcoholic Liver Disease. Alcohol Alcohol 2016;51:251-7. [PMID: 26511776 DOI: 10.1093/alcalc/agv119] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
619 Brandon-Warner E, Benbow JH, Swet JH, Feilen NA, Culberson CR, McKillop IH, deLemos AS, Russo MW, Schrum LW. Adeno-Associated Virus Serotype 2 Vector-Mediated Reintroduction of microRNA-19b Attenuates Hepatic Fibrosis. Hum Gene Ther 2018;29:674-86. [PMID: 29281894 DOI: 10.1089/hum.2017.035] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
620 Kim J, Jung Y. Thymosin Beta 4 Is a Potential Regulator of Hepatic Stellate Cells. Vitam Horm. 2016;102:121-149. [PMID: 27450733 DOI: 10.1016/bs.vh.2016.04.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
621 Yang L, Li LC, Lamaoqiezhong, Wang X, Wang WH, Wang YC, Xu CR. The contributions of mesoderm-derived cells in liver development. Semin Cell Dev Biol 2019;92:63-76. [PMID: 30193996 DOI: 10.1016/j.semcdb.2018.09.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
622 Huebener P, Schwabe RF. Regulation of wound healing and organ fibrosis by toll-like receptors. Biochim Biophys Acta. 2013;1832:1005-1017. [PMID: 23220258 DOI: 10.1016/j.bbadis.2012.11.017] [Cited by in Crossref: 86] [Cited by in F6Publishing: 85] [Article Influence: 8.6] [Reference Citation Analysis]
623 El-Eshmawy MM, Arafa MM, Elzehery RR, Elhelaly RM, Elrakhawy MM, El-Baiomy AA. Relationship between vitamin A deficiency and the thyroid axis in clinically stable patients with liver cirrhosis related to hepatitis C virus. Appl Physiol Nutr Metab. 2016;41:985-991. [PMID: 27557336 DOI: 10.1139/apnm-2016-0056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
624 Kim J, Hyun J, Wang S, Lee C, Lee JW, Moon EY, Cha H, Diehl AM, Jung Y. Thymosin beta-4 regulates activation of hepatic stellate cells via hedgehog signaling. Sci Rep 2017;7:3815. [PMID: 28630423 DOI: 10.1038/s41598-017-03782-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
625 Villesen IF, Daniels SJ, Leeming DJ, Karsdal MA, Nielsen MJ. Review article: the signalling and functional role of the extracellular matrix in the development of liver fibrosis. Aliment Pharmacol Ther 2020;52:85-97. [PMID: 32419162 DOI: 10.1111/apt.15773] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
626 Weaver L, Hamoud AR, Stec DE, Hinds TD Jr. Biliverdin reductase and bilirubin in hepatic disease. Am J Physiol Gastrointest Liver Physiol 2018;314:G668-76. [PMID: 29494209 DOI: 10.1152/ajpgi.00026.2018] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
627 Dunning S, Ur Rehman A, Tiebosch MH, Hannivoort RA, Haijer FW, Woudenberg J, van den Heuvel FA, Buist-Homan M, Faber KN, Moshage H. Glutathione and antioxidant enzymes serve complementary roles in protecting activated hepatic stellate cells against hydrogen peroxide-induced cell death. Biochim Biophys Acta. 2013;1832:2027-2034. [PMID: 23871839 DOI: 10.1016/j.bbadis.2013.07.008] [Cited by in Crossref: 76] [Cited by in F6Publishing: 65] [Article Influence: 8.4] [Reference Citation Analysis]
628 Napoli JL. Physiological insights into all-trans-retinoic acid biosynthesis. Biochim Biophys Acta 2012;1821:152-67. [PMID: 21621639 DOI: 10.1016/j.bbalip.2011.05.004] [Cited by in Crossref: 204] [Cited by in F6Publishing: 207] [Article Influence: 18.5] [Reference Citation Analysis]
629 Lo RC, Kim H. Histopathological evaluation of liver fibrosis and cirrhosis regression. Clin Mol Hepatol. 2017;23:302-307. [PMID: 29281870 DOI: 10.3350/cmh.2017.0078] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 8.0] [Reference Citation Analysis]
630 Ahsan MK, Mehal WZ. Activation of adenosine receptor A2A increases HSC proliferation and inhibits death and senescence by down-regulation of p53 and Rb. Front Pharmacol. 2014;5:69. [PMID: 24782773 DOI: 10.3389/fphar.2014.00069] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
631 Wang S, Shuai C, Gao S, Jiang J, Luan J, Lv X. Chemokine CXCL14 acts as a potential genetic target for liver fibrosis. Int Immunopharmacol 2020;89:107067. [PMID: 33039963 DOI: 10.1016/j.intimp.2020.107067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
632 Cong M, Liu T, Wang P, Fan X, Yang A, Bai Y, Peng Z, Wu P, Tong X, Chen J. Antifibrotic effects of a recombinant adeno-associated virus carrying small interfering RNA targeting TIMP-1 in rat liver fibrosis. Am J Pathol. 2013;182:1607-1616. [PMID: 23474083 DOI: 10.1016/j.ajpath.2013.01.036] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
633 Drosos I, Kolios G. Stem cells in liver regeneration and their potential clinical applications. Stem Cell Rev Rep 2013;9:668-84. [PMID: 23526206 DOI: 10.1007/s12015-013-9437-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
634 Huang YJ, Cao J, Lee CY, Wu YM. Umbilical cord blood plasma-derived exosomes as a novel therapy to reverse liver fibrosis. Stem Cell Res Ther 2021;12:568. [PMID: 34772443 DOI: 10.1186/s13287-021-02641-x] [Reference Citation Analysis]
635 Carotti S, Perrone G, Amato M, Vespasiani Gentilucci U, Righi D, Francesconi M, Pellegrini C, Zalfa F, Zingariello M, Picardi A, Onetti Muda A, Morini S. Reelin expression in human liver of patients with chronic hepatitis C infection. Eur J Histochem 2017;61:2745. [PMID: 28348420 DOI: 10.4081/ejh.2017.2745] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
636 Pittala S, Krelin Y, Shoshan-Barmatz V. Targeting Liver Cancer and Associated Pathologies in Mice with a Mitochondrial VDAC1-Based Peptide. Neoplasia 2018;20:594-609. [PMID: 29747160 DOI: 10.1016/j.neo.2018.02.012] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
637 Ribatti D, Tamma R, Annese T. The role of vascular niche and endothelial cells in organogenesis and regeneration. Exp Cell Res 2021;398:112398. [PMID: 33271129 DOI: 10.1016/j.yexcr.2020.112398] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
638 Gryshchenko O, Gerasimenko JV, Gerasimenko OV, Petersen OH. Calcium signalling in pancreatic stellate cells: Mechanisms and potential roles. Cell Calcium 2016;59:140-4. [DOI: 10.1016/j.ceca.2016.02.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
639 Tan H, He Q, Li R, Lei F, Lei X. Trillin Reduces Liver Chronic Inflammation and Fibrosis in Carbon Tetrachloride (CCl4) Induced Liver Injury in Mice. Immunol Invest 2016;45:371-82. [PMID: 27219527 DOI: 10.3109/08820139.2015.1137935] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
640 Carson JP, Robinson MW, Ramm GA, Gobert GN. RNA sequencing of LX-2 cells treated with TGF-β1 identifies genes associated with hepatic stellate cell activation. Mol Biol Rep 2021;48:7677-88. [PMID: 34648138 DOI: 10.1007/s11033-021-06774-3] [Reference Citation Analysis]
641 Luo Y, Huo Y, Song P, Zhang X, Liao M. Validation and functional analysis of the critical proteins in combination with taurine, epigallocatechin gallate and genistein against liver fibrosis in rats. Biomedicine & Pharmacotherapy 2019;115:108975. [DOI: 10.1016/j.biopha.2019.108975] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
642 Wang BB, Cheng JY, Gao HH, Zhang Y, Chen ZN, Bian H. Hepatic stellate cells in inflammation-fibrosis-carcinoma axis. Anat Rec (Hoboken). 2010;293:1492-1496. [PMID: 20652939 DOI: 10.1002/ar.21173] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
643 Katsounas A, Schlaak JF, Lempicki RA. CCL5: a double-edged sword in host defense against the hepatitis C virus. Int Rev Immunol 2011;30:366-78. [PMID: 22053974 DOI: 10.3109/08830185.2011.593105] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
644 Li H, Ding P, Peng B, Ming YZ. Cross-talk between hepatic stellate cells and T lymphocytes in liver fibrosis. Hepatobiliary Pancreat Dis Int 2021;20:207-14. [PMID: 33972160 DOI: 10.1016/j.hbpd.2021.04.007] [Reference Citation Analysis]
645 Kweon SM, Chi F, Higashiyama R, Lai K, Tsukamoto H. Wnt Pathway Stabilizes MeCP2 Protein to Repress PPAR-γ in Activation of Hepatic Stellate Cells. PLoS One. 2016;11:e0156111. [PMID: 27214381 DOI: 10.1371/journal.pone.0156111] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
646 Huang Q, Wei J, Wei L, Zhang X, Bai F, Wen S, Wei Y, Tan S, Lu Z, Lin X. Retracted : Role of RKIP in human hepatic stellate cell proliferation, invasion, and metastasis. J Cell Biochem 2019;120:6168-77. [DOI: 10.1002/jcb.27904] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
647 Khodayari N, Oshins R, Holliday LS, Clark V, Xiao Q, Marek G, Mehrad B, Brantly M. Alpha-1 antitrypsin deficient individuals have circulating extracellular vesicles with profibrogenic cargo. Cell Commun Signal 2020;18:140. [PMID: 32887613 DOI: 10.1186/s12964-020-00648-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
648 Zou Y, Cai Y, Lu D, Zhou Y, Yao Q, Zhang S. MicroRNA-146a-5p attenuates liver fibrosis by suppressing profibrogenic effects of TGFβ1 and lipopolysaccharide. Cell Signal 2017;39:1-8. [PMID: 28739486 DOI: 10.1016/j.cellsig.2017.07.016] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
649 Li H, Lan J, Han C, Guo K, Wang G, Hu J, Gong J, Luo X, Cao Z. Brg1 promotes liver fibrosis via activation of hepatic stellate cells. Experimental Cell Research 2018;364:191-7. [DOI: 10.1016/j.yexcr.2018.02.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
650 Lee YA, Friedman SL. Inflammatory and fibrotic mechanisms in NAFLD-Implications for new treatment strategies. J Intern Med 2021. [PMID: 34564899 DOI: 10.1111/joim.13380] [Reference Citation Analysis]
651 Muñiz-Hernández S, Huerta-Yepez S, Hernández-Pedro N, Ramírez-Tirado LA, Aviles-Salas A, Maldonado A, Hernández-Cueto D, Baay-Guzmán G, Arrieta O. Association between nuclear expression of retinoic acid receptor alpha and beta and clinicopathological features and prognosis of advanced non-small cell lung cancer. Int J Clin Oncol 2016;21:1051-61. [PMID: 27306217 DOI: 10.1007/s10147-016-1002-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
652 Jing F, Geng Y, Xu XY, Xu HY, Shi JS, Xu ZH. MicroRNA29a Reverts the Activated Hepatic Stellate Cells in the Regression of Hepatic Fibrosis through Regulation of ATPase H⁺ Transporting V1 Subunit C1. Int J Mol Sci 2019;20:E796. [PMID: 30781750 DOI: 10.3390/ijms20040796] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
653 Dhar D, Baglieri J, Kisseleva T, Brenner DA. Mechanisms of liver fibrosis and its role in liver cancer. Exp Biol Med (Maywood) 2020;245:96-108. [PMID: 31924111 DOI: 10.1177/1535370219898141] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
654 Guidolin D, Marcoli M, Tortorella C, Maura G, Agnati LF. Receptor-Receptor Interactions as a Widespread Phenomenon: Novel Targets for Drug Development? Front Endocrinol (Lausanne) 2019;10:53. [PMID: 30833931 DOI: 10.3389/fendo.2019.00053] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
655 Sun B, Zhang X, Cheng X, Zhang Y, Chen L, Shi L, Liu Z, Qian H, Wu M, Yin Z. Intratumoral hepatic stellate cells as a poor prognostic marker and a new treatment target for hepatocellular carcinoma. PLoS One 2013;8:e80212. [PMID: 24278260 DOI: 10.1371/journal.pone.0080212] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
656 Weerawatanakorn M, Hsieh S, Tsai M, Lai C, Wu L, Badmaev V, Ho C, Pan M. Inhibitory effect of tetrahydrocurcumin on dimethylnitrosamine-induced liver fibrosis in rats. Journal of Functional Foods 2014;7:305-13. [DOI: 10.1016/j.jff.2014.01.030] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
657 Gao W, Sun J, Wang F, Lu Y, Wen C, Bian Q, Wu H. Deoxyelephantopin suppresses hepatic stellate cells activation associated with inhibition of aerobic glycolysis via hedgehog pathway. Biochem Biophys Res Commun 2019;516:1222-8. [PMID: 31296386 DOI: 10.1016/j.bbrc.2019.07.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
658 Mahmoud AA, Hassan EZ, Askar EM. Long-term influence of sialoadenectomy on the liver of male albino rat. Ultrastruct Pathol 2017;41:265-74. [PMID: 28506098 DOI: 10.1080/01913123.2017.1319886] [Reference Citation Analysis]
659 Hah N, Sherman MH, Yu RT, Downes M, Evans RM. Targeting Transcriptional and Epigenetic Reprogramming in Stromal Cells in Fibrosis and Cancer. Cold Spring Harb Symp Quant Biol. 2015;80:249-255. [PMID: 26801159 DOI: 10.1101/sqb.2015.80.027185] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
660 Xu H, Zhou Y, Lu C, Ping J, Xu LM. Salvianolic acid B lowers portal pressure in cirrhotic rats and attenuates contraction of rat hepatic stellate cells by inhibiting RhoA signaling pathway. Lab Invest. 2012;92:1738-1748. [PMID: 22986787 DOI: 10.1038/labinvest.2012.113] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
661 Aravalli RN, Steer CJ. Immune-Mediated Therapies for Liver Cancer. Genes (Basel) 2017;8:E76. [PMID: 28218682 DOI: 10.3390/genes8020076] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
662 Duval F, Moreno-Cuevas JE, González-Garza MT, Rodríguez-Montalvo C, Cruz-Vega DE. Protective mechanisms of medicinal plants targeting hepatic stellate cell activation and extracellular matrix deposition in liver fibrosis. Chin Med 2014;9:27. [PMID: 25606051 DOI: 10.1186/s13020-014-0027-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
663 Michalopoulos GK. Principles of liver regeneration and growth homeostasis. Compr Physiol. 2013;3:485-513. [PMID: 23720294 DOI: 10.1002/cphy.c120014] [Cited by in Crossref: 28] [Cited by in F6Publishing: 92] [Article Influence: 3.1] [Reference Citation Analysis]
664 Aravinthan A, Shannon N, Heaney J, Hoare M, Marshall A, Alexander GJ. The senescent hepatocyte gene signature in chronic liver disease. Experimental Gerontology 2014;60:37-45. [DOI: 10.1016/j.exger.2014.09.011] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
665 Wang R, Song F, Li S, Wu B, Gu Y, Yuan Y. Salvianolic acid A attenuates CCl4-induced liver fibrosis by regulating the PI3K/AKT/mTOR, Bcl-2/Bax and caspase-3/cleaved caspase-3 signaling pathways. Drug Des Devel Ther 2019;13:1889-900. [PMID: 31213776 DOI: 10.2147/DDDT.S194787] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
666 He L, Yuan H, Liang J, Hong J, Qu C. Expression of hepatic stellate cell activation-related genes in HBV-, HCV-, and nonalcoholic fatty liver disease-associated fibrosis. PLoS One 2020;15:e0233702. [PMID: 32442221 DOI: 10.1371/journal.pone.0233702] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
667 Bessone F, Dirchwolf M, Rodil MA, Razori MV, Roma MG. Review article: drug-induced liver injury in the context of nonalcoholic fatty liver disease - a physiopathological and clinical integrated view. Aliment Pharmacol Ther 2018;48:892-913. [PMID: 30194708 DOI: 10.1111/apt.14952] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 8.5] [Reference Citation Analysis]
668 Guimarães EL, Stradiot L, Mannaerts I, Schroyen B, van Grunsven LA. P311 modulates hepatic stellate cells migration. Liver Int 2015;35:1253-64. [DOI: 10.1111/liv.12691] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
669 Parola M, Pinzani M. Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med. 2019;65:37-55. [PMID: 30213667 DOI: 10.1016/j.mam.2018.09.002] [Cited by in Crossref: 121] [Cited by in F6Publishing: 127] [Article Influence: 30.3] [Reference Citation Analysis]
670 Li J, Ghazwani M, Zhang Y, Lu J, Li J, Fan J, Gandhi CR, Li S. miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression. J Hepatol. 2013;58:522-528. [PMID: 23178710 DOI: 10.1016/j.jhep.2012.11] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
671 Singh HD, Otano I, Rombouts K, Singh KP, Peppa D, Gill US, Böttcher K, Kennedy PTF, Oben J, Pinzani M, Walczak H, Fusai G, Rosenberg WMC, Maini MK. TRAIL regulatory receptors constrain human hepatic stellate cell apoptosis. Sci Rep 2017;7:5514. [PMID: 28717244 DOI: 10.1038/s41598-017-05845-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
672 Zhou X, Wu W, Hu H, Milosevic J, Konishi K, Kaminski N, Wenzel SE. Genomic differences distinguish the myofibroblast phenotype of distal lung fibroblasts from airway fibroblasts. Am J Respir Cell Mol Biol 2011;45:1256-62. [PMID: 21757679 DOI: 10.1165/rcmb.2011-0065OC] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
673 Gao Y, Li X, Gao Q, Fan L, Jin H, Guo Y. Differential effects of olive oil, soybean oil, corn oil and lard oil on carbon tetrachloride-induced liver fibrosis in mice. Biosci Rep 2019;39:BSR20191913. [PMID: 31481526 DOI: 10.1042/BSR20191913] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
674 Jiang Y, Wang C, Li YY, Wang XC, An JD, Wang YJ, Wang XJ. Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-β/Smad interference. J Ethnopharmacol 2014;158 Pt A:230-8. [PMID: 25456431 DOI: 10.1016/j.jep.2014.10.028] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
675 Marra F, Parola M. Cells in the Liver—Functions in Health and Disease. In: Ginès P, Kamath PS, Arroyo V, editors. Chronic Liver Failure. Totowa: Humana Press; 2011. pp. 3-32. [DOI: 10.1007/978-1-60761-866-9_1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
676 Böttcher K, Pinzani M. Pathophysiology of liver fibrosis and the methodological barriers to the development of anti-fibrogenic agents. Adv Drug Deliv Rev 2017;121:3-8. [PMID: 28600202 DOI: 10.1016/j.addr.2017.05.016] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 10.4] [Reference Citation Analysis]
677 Feili X, Wu S, Ye W, Tu J, Lou L. MicroRNA-34a-5p inhibits liver fibrosis by regulating TGF-β1/Smad3 pathway in hepatic stellate cells. Cell Biol Int 2018;42:1370-6. [PMID: 29957876 DOI: 10.1002/cbin.11022] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
678 Gentilini A, Caligiuri A, Raggi C, Rombouts K, Pinzani M, Lori G, Correnti M, Invernizzi P, Rovida E, Navari N, Di Matteo S, Alvaro D, Banales JM, Rodrigues P, Raschioni C, Donadon M, Di Tommaso L, Marra F. CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cells. Biochim Biophys Acta Mol Basis Dis. 2019;1865:2246-2256. [PMID: 31059778 DOI: 10.1016/j.bbadis.2019.04.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
679 Lambrecht J, Verhulst S, Mannaerts I, Reynaert H, van Grunsven LA. Prospects in non-invasive assessment of liver fibrosis: Liquid biopsy as the future gold standard? Biochim Biophys Acta Mol Basis Dis. 2018;1864:1024-1036. [PMID: 29329986 DOI: 10.1016/j.bbadis.2018.01.009] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
680 Cohen JI, Nagy LE. Pathogenesis of alcoholic liver disease: interactions between parenchymal and non-parenchymal cells. J Dig Dis. 2011;12:3-9. [PMID: 21091930 DOI: 10.1111/j.1751-2980.2010.00468.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 4.9] [Reference Citation Analysis]
681 Guo X, Cen Y, Wang J, Jiang H. CXCL10-induced IL-9 promotes liver fibrosis via Raf/MEK/ERK signaling pathway. Biomed Pharmacother. 2018;105:282-289. [PMID: 29860220 DOI: 10.1016/j.biopha.2018.05.128] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
682 McCracken JM, Chalise P, Briley SM, Dennis KL, Jiang L, Duncan FE, Pritchard MT. C57BL/6 Substrains Exhibit Different Responses to Acute Carbon Tetrachloride Exposure: Implications for Work Involving Transgenic Mice. Gene Expr 2017;17:187-205. [PMID: 28234577 DOI: 10.3727/105221617X695050] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
683 Ibba-Manneschi L, Rosa I, Manetti M. Telocytes in Chronic Inflammatory and Fibrotic Diseases. Adv Exp Med Biol 2016;913:51-76. [PMID: 27796880 DOI: 10.1007/978-981-10-1061-3_4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
684 Wu Z, Huang S, Zheng X, Gu S, Xu Q, Gong Y, Zhang J, Fu B, Tang L. Regulatory long non-coding RNAs of hepatic stellate cells in liver fibrosis (Review). Exp Ther Med 2021;21:351. [PMID: 33732324 DOI: 10.3892/etm.2021.9782] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
685 Inoue A, Obayashi K, Sonoda Y, Nakamura A, Ueno T, Kuhara S, Tashiro K. Regulation of matrix metalloproteinase-1 and alpha-smooth muscle actin expression by interleukin-1 alpha and tumour necrosis factor alpha in hepatic stellate cells. Cytotechnology 2017;69:461-8. [PMID: 26825680 DOI: 10.1007/s10616-016-9948-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
686 Sánchez PS, Rigual MDM, Djouder N. Inflammatory and Non-Inflammatory Mechanisms Controlling Cirrhosis Development. Cancers (Basel) 2021;13:5045. [PMID: 34680192 DOI: 10.3390/cancers13205045] [Reference Citation Analysis]
687 Møller S, Henriksen JH, Bendtsen F. Extrahepatic complications to cirrhosis and portal hypertension: Haemodynamic and homeostatic aspects. World J Gastroenterol 2014; 20(42): 15499-15517 [PMID: 25400435 DOI: 10.3748/wjg.v20.i42.15499] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 32]